<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100340</article-id><article-id pub-id-type="doi">10.7554/eLife.100340</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.100340.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ozkan</surname><given-names>Abdulkadir</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2499-7637</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Padmanabhan</surname><given-names>Hari K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2289-0249</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Shipman</surname><given-names>Seth L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Azim</surname><given-names>Eiman</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1015-1772</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Priyanka</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sadegh</surname><given-names>Cameron</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa3">#</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Basak</surname><given-names>A Nazli</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3662-9698</contrib-id><email>jeffrey_macklis@harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Department of Stem Cell and Regenerative Biology, and Center for Brain Science, Harvard University</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jzwgz36</institution-id><institution>Koç University, School of Medicine Translational Medicine Research Center</institution></institution-wrap><addr-line><named-content content-type="city">Istanbul</named-content></addr-line><country>Turkiye</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Corbin</surname><given-names>Joshua</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wa2q724</institution-id><institution>Children's National Hospital</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Gladstone Institute of Data Science and Biotechnology, San Francisco, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, United States</p></fn><fn fn-type="present-address" id="pa3"><label>#</label><p>Department of Neurological Surgery, University of California Davis, Sacramento, United States</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>27</day><month>01</month><year>2026</year></pub-date><volume>13</volume><elocation-id>RP100340</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-18"><day>18</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-04-23"><day>23</day><month>04</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.04.21.590488"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-27"><day>27</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100340.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-08-05"><day>05</day><month>08</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100340.2"/></event></pub-history><permissions><copyright-statement>© 2024, Ozkan, Padmanabhan et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Ozkan, Padmanabhan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100340-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100340-figures-v1.pdf"/><abstract><p>Corticospinal neurons (CSN) centrally degenerate in amyotrophic lateral sclerosis (ALS), along with spinal motor neurons, and loss of voluntary motor function in spinal cord injury (SCI) results from damage to CSN axons. For functional regeneration of specifically affected neuronal circuitry <italic>in vivo</italic>, or for optimally informative disease modeling and/or therapeutic screening <italic>in vitro</italic>, it is important to reproduce the type or subtype of neurons involved. No such appropriate <italic>in vitro</italic> models exist with which to investigate CSN selective vulnerability and degeneration in ALS, or to investigate routes to regeneration of CSN circuitry for ALS or SCI, critically limiting the relevance of much research. Here, we identify that the HMG-domain transcription factor <italic>Sox6</italic> is expressed by a subset of NG2+ endogenous cortical progenitors in postnatal and adult cortex, and that <italic>Sox6</italic> suppresses a latent neurogenic program by repressing proneural <italic>Neurog2</italic> expression by progenitors. We FACS-purify these progenitors from postnatal mouse cortex and establish a culture system to investigate their potential for directed differentiation into CSN. We then employ a multi-component construct with complementary and differentiation-sharpening transcriptional controls (activating <italic>Neurog2</italic>, <italic>Fezf2</italic>, while antagonizing <italic>Olig2</italic> with <italic>VP16:Olig2</italic>). We generate corticospinal-like neurons from SOX6+/NG2+ cortical progenitors and find that these neurons differentiate with remarkable fidelity compared with corticospinal neurons in vivo. They possess appropriate morphological, molecular, transcriptomic, and electrophysiological characteristics, without characteristics of the alternate intracortical or other neuronal subtypes. We identify that these critical specifics of differentiation are not reproduced by commonly employed <italic>Neurog2</italic>-driven differentiation. Neurons induced by <italic>Neurog2</italic> instead exhibit aberrant multi-axon morphology and express molecular hallmarks of alternate cortical projection subtypes, often in mixed form. Together, this developmentally-based directed differentiation from cortical progenitors sets a precedent and foundation for <italic>in vitro</italic> mechanistic and therapeutic disease modeling, and toward regenerative neuronal repopulation and circuit repair.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SOX6+/NG2+ progenitors</kwd><kwd>corticospinal neurons</kwd><kwd>CSN</kwd><kwd>directed differentiation</kwd><kwd>disease modeling</kwd><kwd>neuron regeneration</kwd><kwd>circuit repair</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS045523</award-id><principal-award-recipient><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>DP1 NS106665</award-id><principal-award-recipient><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS049553</award-id><principal-award-recipient><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Emily and Robert Pearlstein Fund for Nervous System Repair</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Max and Anne Wien Professor of Life Sciences Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Suna and Inan Kirac Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ozkan</surname><given-names>Abdulkadir</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0040b6869</institution-id><institution>International Brain Research Organization</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Padmanabhan</surname><given-names>Hari K</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>McKnight Brain Research Institute</institution></institution-wrap></funding-source><award-id>Regeneration Project Fellowship</award-id><principal-award-recipient><name><surname>Padmanabhan</surname><given-names>Hari K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Developmentally-based directed differentiation from cortical progenitors sets a foundation for in vitro mechanistic and therapeutic disease modeling, and toward regenerative neuronal repopulation and circuit repair.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Whether toward functional regeneration of specifically affected neuronal circuitry in disorders of the central nervous system <italic>in vivo</italic>, or for appropriate disease modeling and/or therapeutic screening <italic>in vitro</italic>, reliable approaches to accurately differentiate specific types of affected and relevant neurons are required. Overly broad classes of generic or only regionally similar neurons do not adequately reflect the selective vulnerability of neuronal subtypes in most human neurodegenerative or acquired disorders. Molecular and therapeutic findings using broad or only regionally linked classes of neurons not affected in the disorder of interest are frequently not applicable for the neurons centrally involved.</p><p>Extraordinarily diverse neurons across the nervous system, in particular within the cerebral cortex, display many distinctive features, including cellular morphology, laminar and anatomical position, patterns of input and output connectivity, cardinal molecular identifiers, electrophysiology, neurochemical properties, and ultimately their functional roles (<xref ref-type="bibr" rid="bib36">Fishell and Rudy, 2011</xref>; <xref ref-type="bibr" rid="bib44">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Harris and Shepherd, 2015</xref>; <xref ref-type="bibr" rid="bib116">Ramón y Cajal, 1995</xref>; <xref ref-type="bibr" rid="bib143">Sugino et al., 2006</xref>; <xref ref-type="bibr" rid="bib146">Tasic et al., 2018</xref>; <xref ref-type="bibr" rid="bib154">Veeraraghavan et al., 2024</xref>). Diversity exists not only between broad cell types (e.g. excitatory projection neurons vs. inhibitory interneurons; intratelencephalic vs. cortical output (‘corticofugal;’ projecting away from cortex) neurons; ipsilateral associative vs. commissural), but even within seemingly homogenous populations of neurons. For example, striking and sharp molecular, connectivity, and functional distinctions exist between both spatially separated subsets and interspersed subsets of CSN, with each molecularly distinct neuronal subpopulation programmed to project to distinct segments of the spinal cord, innervate topographically distinct gray matter areas, and synapse onto distinct subsets of interneurons (<xref ref-type="bibr" rid="bib129">Sahni et al., 2021b</xref>; <xref ref-type="bibr" rid="bib128">Sahni et al., 2021a</xref>; <xref ref-type="bibr" rid="bib63">Itoh et al., 2023</xref>). Importantly, these diverse segmentally specific subsets have selective vulnerability and/or involvement in distinct human disorders (<xref ref-type="bibr" rid="bib127">Sahni et al., 2020</xref>).</p><p>Such selective involvement reflects differences between specific neuronal subtypes in their molecular regulation during development and/or maturity. Specific subtypes of neurons are thus affected in distinct developmental, neurodegenerative, and acquired disorders of the central nervous system (CNS), typically resulting in irreversible functional deficits (<xref ref-type="bibr" rid="bib132">Saxena and Caroni, 2011</xref>; <xref ref-type="bibr" rid="bib30">Durak et al., 2022</xref>). Particularly relevant to the work presented here, corticospinal neurons (CSN; sometimes termed ‘upper motor neurons,’ UMN) centrally degenerate in amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, along with spinal cord ‘lower motor neurons,’ of entirely different developmental origin and function. Furthermore, loss of voluntary and skilled motor function in spinal cord injury results from damage to CSN axons in the corticospinal tract (<xref ref-type="bibr" rid="bib123">Rösler et al., 2000</xref>; <xref ref-type="bibr" rid="bib47">Hains et al., 2003</xref>).</p><p>Notably, no appropriate <italic>in vitro</italic> models exist with which to investigate CSN/UMN selective vulnerability and degeneration in ALS, critically limiting the relevance of much research. In contrast, the availability of useful <italic>in vitro</italic> models of at least immature spinal motor neurons has enabled substantial success in the spinal muscular atrophy (SMA) field, with both modeling and therapeutics (for more detailed discussion, see <xref ref-type="bibr" rid="bib130">Sances et al., 2016</xref>).</p><p>Importantly, and in parallel to <italic>in vitro</italic> modeling, one potential regenerative approach for neurodegenerative or acquired disorders is to restore elements of the affected circuitry with new neurons that are engineered to re-establish circuit-appropriate input and output connectivity (<xref ref-type="bibr" rid="bib115">Qian et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Czupryn et al., 2011</xref>; <xref ref-type="bibr" rid="bib160">Wuttke et al., 2018</xref>). Previous studies have demonstrated that active and quiescent progenitors exist in restricted regions of the adult brain (<xref ref-type="bibr" rid="bib118">Rietze et al., 2001</xref>; <xref ref-type="bibr" rid="bib84">Lois and Alvarez-Buylla, 1993</xref>; <xref ref-type="bibr" rid="bib75">Kuhn et al., 1997</xref>; <xref ref-type="bibr" rid="bib117">Reynolds and Weiss, 1992</xref>), and that new neurons can integrate into preexisting neural circuitry, supporting the feasibility of cellular repair in the CNS (<xref ref-type="bibr" rid="bib24">Czupryn et al., 2011</xref>; <xref ref-type="bibr" rid="bib66">Kempermann et al., 2015</xref>; <xref ref-type="bibr" rid="bib34">Feliciano et al., 2015</xref>; <xref ref-type="bibr" rid="bib89">Magavi et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Brill et al., 2009</xref>; <xref ref-type="bibr" rid="bib107">Ohira et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Chen et al., 2004</xref>). Although transplantation of <italic>in vitro</italic> generated neurons, either from pluripotent stem cells (PSC) or from other developmentally distant cell types, is one potential approach (<xref ref-type="bibr" rid="bib96">Michelsen et al., 2015</xref>), either <italic>ex vivo</italic> directed differentiation or <italic>in situ</italic> generation of type- or subtype-specific neurons from optimally appropriate, regionally specified resident progenitors offers several advantages. First, either approach is potentially more likely to recapitulate appropriate neuronal identity than pluripotent stem cell approaches, since presumptive partially fate-restricted resident progenitors and the desired neurons share common developmental lineage, originate from the same neural progenitor domains, and were exposed to the same diffusible and local signaling during embryonic development, thus are likely to share significant epigenomic and transcriptomic commonality (<xref ref-type="bibr" rid="bib121">Roessler et al., 2014</xref>; <xref ref-type="bibr" rid="bib150">Treutlein et al., 2016</xref>; <xref ref-type="bibr" rid="bib15">Cahoy et al., 2008</xref>). Avoiding transplantation via <italic>in situ</italic> neurogenesis would offer the additional advantage of circumventing the requirement for new neurons to migrate long distances to their sites of ultimate incorporation from an injection site with favorable local growth conditions, potentially enabling desired integration of newly recruited neurons at the single-cell level (<xref ref-type="bibr" rid="bib160">Wuttke et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Michelsen et al., 2015</xref>; <xref ref-type="bibr" rid="bib32">Espuny-Camacho et al., 2013</xref>), emulating endogenous adult neurogenesis (<xref ref-type="bibr" rid="bib39">Gage, 2019</xref>; <xref ref-type="bibr" rid="bib11">Bond et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Kempermann, 2016</xref>); and avoiding pathological heterotopias.</p><p>Substantial progress has been made in efforts to reprogram reactive glia <italic>in vitro</italic> and <italic>in vivo</italic> to acquire some form of neuronal identity (<xref ref-type="bibr" rid="bib42">Gascón et al., 2016</xref>; <xref ref-type="bibr" rid="bib120">Rivetti di Val Cervo et al., 2017</xref>; <xref ref-type="bibr" rid="bib159">Wu et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Heinrich et al., 2014</xref>; <xref ref-type="bibr" rid="bib149">Torper et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Grande et al., 2013</xref>; <xref ref-type="bibr" rid="bib104">Niu et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Heinrich et al., 2010</xref>; <xref ref-type="bibr" rid="bib35">Felske et al., 2023</xref>; <xref ref-type="bibr" rid="bib55">Herrero-Navarro et al., 2021</xref>). However, functional repair of specific circuitry requires highly directed differentiation of specific neuronal subtypes (beyond a generic neurotransmitter identity, e.g.), so new neurons can form circuit-appropriate input and output connectivity (<xref ref-type="bibr" rid="bib93">Mattugini et al., 2019</xref>). Work from our lab and others have advanced this goal by identifying central molecular programs that first broadly, then increasingly precisely, control and regulate specification, diversity, and connectivity of specific cortical projection neuron subtypes during the period of their differentiation (<xref ref-type="bibr" rid="bib44">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib154">Veeraraghavan et al., 2024</xref>; <xref ref-type="bibr" rid="bib129">Sahni et al., 2021b</xref>; <xref ref-type="bibr" rid="bib128">Sahni et al., 2021a</xref>; <xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>; <xref ref-type="bibr" rid="bib83">Lodato and Arlotta, 2015</xref>; <xref ref-type="bibr" rid="bib111">Ozkan et al., 2020</xref>; <xref ref-type="bibr" rid="bib135">Shibata et al., 2015</xref>; <xref ref-type="bibr" rid="bib105">Nord et al., 2015</xref>; <xref ref-type="bibr" rid="bib147">Taverna et al., 2014</xref>; <xref ref-type="bibr" rid="bib140">Srinivasan et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Lui et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">O’Leary et al., 2007</xref>; <xref ref-type="bibr" rid="bib45">Greig et al., 2016</xref>; <xref ref-type="bibr" rid="bib158">Woodworth et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Galazo et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Galazo et al., 2023</xref>). According to an emerging model, complementary and exclusionary sets of proneural and class-, type-, and subtype-specific transcriptional controls act in a subtype-, stage-, and dose-dependent manner to direct distinct projection neuron differentiation trajectories, while repressing alternative fates (<xref ref-type="bibr" rid="bib111">Ozkan et al., 2020</xref>). This sharpens subtype identities and distinctions.</p><p>In the work reported here, we build on prior work from our lab (<xref ref-type="bibr" rid="bib7">Azim et al., 2009a</xref>) identifying <italic>Sox6</italic> as a unique stage-specific, combined temporal and spatial, control over all cortical projection neuron development that is both expressed by all cortical-pallial/excitatory projection neuron progenitors and excluded from subpallial/interneuron progenitors, and that effectively represses the transcriptional expression of the proneural gene neurogenin 2 (<italic>Neurog2</italic>). We identify that a subset of NG2+ (Nerve-Glial antigen 2 is a transmembrane chondroitin sulfate proteoglycan, with the protein component encoded by the gene <italic>Cspg4</italic>) endogenous cortical progenitors continue to express <italic>Sox6</italic>, which continues to repress <italic>Neurog2</italic> expression and neuronal differentiation. We take advantage of genetic access to FACS-purify these endogenous cortical progenitors and establish a culture system to investigate the potential for their directed differentiation into cortical output neurons, the type of clinically relevant neurons that centrally includes CSN.</p><p>We then synthesized and applied a multi-component gene expression construct with complementary and differentiation-sharpening transcriptional controls (activating <italic>Neurog2</italic> and <italic>Fezf2</italic>, while antagonizing <italic>Olig2</italic> with <italic>VP16:Olig2</italic>) to these purified, partially fate-restricted progenitors from postnatal mouse cortex. We find that this approach directs highly specific acquisition of many cardinal morphological, molecular, and functional characteristics of endogenous corticospinal neurons, and not of the alternative intracortical or other CNS neuronal subtypes. We further investigate these results in several directions, finding, e.g., that <italic>Neurog2</italic> alone is not sufficient to induce a specific neuronal identity; that neurons induced by <italic>Neurog2</italic> instead exhibit aberrant multi-axon morphology and express molecular hallmarks of alternate cortical projection subtypes, often in mixed form.</p><p>As a proof of concept, we employ synthetically modified RNAs to control timing and dosage of the exogenous transcription factors, finding that a single pulse of <italic>Neurog2</italic> combined with <italic>Fezf2</italic> induces projection neuron differentiation from cultured SOX6+/NG2+ endogenous cortical progenitors, further highlighting the seemingly ‘poised’ and already partially cortical neuron fate-directed potential of these specialized progenitors. Our results demonstrate the feasibility of achieving molecularly directed, subtype-specific neuronal differentiation from a widely distributed endogenous progenitor population, with significant implications for both <italic>in vitro</italic> disease modeling and efforts toward therapeutic <italic>in situ</italic> repopulation of degenerated or injured cortical circuitry.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of SOX6+/NG2+ cortical progenitors in postnatal and adult neocortex</title><p>Progenitors and glia in postnatal and adult cortex share a common ancestry with cortical neurons (<xref ref-type="bibr" rid="bib31">Elsherbiny and Dobreva, 2021</xref>). Therefore, we hypothesized that at least some of these progenitors and glia might have dormant neurogenic potential, and that a subset might have molecular characteristics that might enable their enhanced and potentially appropriate differentiation into cortical projection neurons (<xref ref-type="bibr" rid="bib31">Elsherbiny and Dobreva, 2021</xref>; <xref ref-type="bibr" rid="bib162">Zhang et al., 2014</xref>).</p><p>To identify this potential subset, we labeled proliferative cells in postnatal and adult cortex with an injection of BrdU (see Methods), and immunolabeled for PAX6, TBR2, SOX6, and FEZF2 –transcriptional controls that play key roles in embryonic pallial progenitors (<xref ref-type="bibr" rid="bib44">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Hevner, 2006</xref>; <xref ref-type="bibr" rid="bib157">Woodworth et al., 2012</xref>). This experiment revealed that many BrdU+ proliferative cells continue to express SOX6 in postnatal and adult mouse cortex (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). <italic>Sox6</italic> controls molecular segregation of dorsal and ventral telencephalic progenitors during telencephalon parcellation in important part by blocking ectopic proneural gene expression by pallial progenitors and subpallial mantle zones (<xref ref-type="bibr" rid="bib7">Azim et al., 2009a</xref>). To investigate whether <italic>Sox6</italic> has parallel function in postnatal proliferative cells, we investigated proneural gene expression in <italic>Sox6</italic> null brains. Strikingly, the proneural gene <italic>Neurog2</italic> is ectopically expressed throughout <italic>Sox6</italic>-null cortex at postnatal day 6 (P6) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). This result indicates that a subset of postnatal cortical progenitors maintains latent neurogenic programs that are actively suppressed by <italic>Sox6</italic>, similar to its function in embryonic progenitors.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Identification and culture of SOX6+/NG2+ cortical progenitors with high purity and fidelity.</title><p>(<bold>A</bold>) Confocal micrograph of mouse neocortex at postnatal day 7 (P7) showing expression of SOX6 by a subset of BrdU+ proliferative cells. See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. (<bold>B</bold>) <italic>In situ</italic> hybridization of <italic>Neurog2</italic> in <italic>Sox6</italic> wild-type (wt) (left) and knockout (KO) (right) cortex at P6. (<bold>B’</bold>) Insets showing the boxed areas in B. Loss of <italic>Sox6</italic> results in widespread ectopic expression of <italic>Neurog2</italic> (<bold>B’</bold>). See also <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. (<bold>C</bold>) Immunofluorescence showing expression of SOX6 by DsRed+ NG2+ progenitors in cortex at P5. (<bold>D</bold>) Immunostaining of NG2 proteoglycan in NG2-DsRed cortex at P5 shows expression of DsRed by NG2+ progenitors. Inset: a cell with a strong DsRed signal in the cell body and NG2 proteoglycan around the main cell body and in cellular processes. See also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–C</xref>. (<bold>E</bold>) Representative FACS plot of neocortical cells from NG2-DsRed transgenic cortex showing distinct DsRed-Bright, -Dim, and -negative populations. (<bold>F</bold>) qPCR analysis of <italic>Sox6</italic>, <italic>Olig2</italic>, and <italic>Cspg4</italic> from acutely sorted DsRed-Negative, -Dim, and -Bright populations, as well as cultured DsRed-Bright cells (5DIV), demonstrates that SOX6+/NG2+ progenitors are enriched in DsRed-Bright population and maintain key gene expression <italic>in vitro</italic>. See also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D–G</xref>. Data are presented as mean ± SD, n=4, biological replicates, <italic>Actb</italic> normalized data relative to DsRed-negative population. ∗∗∗∗<italic>p</italic>&lt;0.0001, <italic>p</italic>≥0.05, no statistically significant difference (n.s.); ANOVA Tukey’s post hoc test. (<bold>G</bold>) Volcano plot comparing fold difference in average expression of progenitor genes between acutely sorted DsRed-Bright and -Dim populations (RNA-seq, n=5, biological replicates). See also <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>. (<bold>H</bold>) Representative brightfield image of cultured SOX6+/NG2+ (DsRed-Bright) progenitors at 5 DIV showing preserved progenitor multipolar morphology. See also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3J–P</xref>. (<bold>I, J</bold>) Cultured progenitors continue expressing the key progenitor-specific molecules NG2, SOX10 (<bold>I</bold>), OLIG2, and SOX6 (<bold>J</bold>) at 7 DIV. (<bold>K</bold>) Quantification of TUJ1+ and GFAP+ cells at 3-, 5-, and 7 DIV shows essentially no contaminant cells in culture. Data are presented as mean ± SD, n=2, biological replicates. See also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3Q</xref>. (<bold>L</bold>) Pearson correlation analysis of progenitor genes shows high similarity between acutely sorted and cultured SOX6+/NG2+ (DsRed-Bright) progenitors (<italic>R</italic>=0.84, <italic>p</italic>&lt;2.2e-16). Data points represent log2 fold differences in gene expression relative to acutely sorted DsRed-Dim population. See also <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>. (<bold>M</bold>) Heatmap of the top five marker genes for seven major cell types in brain shows that SOX6+/NG2+ progenitors are enriched in DsRed-Bright populations and that progenitor cultures are free of potential contaminants. Counts are variance-stabilizing transformed (vst) normalized data in log2 scale. (<bold>N</bold>) Volcano plot comparing fold differences in average expression of the top 500 genes for major cell types between cultured SOX6+/NG2+ (DsRed-Bright) progenitors and acutely sorted cells. n=5/6, biological replicates. See also <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>. Scale bars (<bold>A, C, H</bold>) 50 μm; (<bold>D, I, J</bold>) 100 μm. cc: corpus callosum, ctx: cortex.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Identification of SOX6+ cortical progenitors in postnatal and adult neocortex.</title><p>(<bold>A</bold>) Schematic of BrdU cumulative labeling experiments. (<bold>B–D</bold>) Confocal photomicrographs of cortex sagittal sections showing BrdU+ proliferative cells at P7 (<bold>B</bold>), a subset of which express SOX6 in the caudal cortical SVZ and cortical parenchyma (<bold>C, D</bold>). BrdU was injected from P3 to P7 in wild-type c57bl/6 mouse (50 µg/mg of body weight). (<bold>E–G</bold>) Same experiment as (<bold>B–D</bold>), but BrdU administration is from P23-P28. Fewer BrdU-labeled cells are labeled in P28 neocortex (<bold>E</bold>), subset of which express SOX6 (<bold>F, G</bold>). (<bold>H–J</bold>) After five-week administration of BrdU in drinking water, SOX6+/BrdU+ cells are identified in adult brain. Scale bars (<bold>B, E, H</bold>) 150 μm; (<bold>C, D, F, G, I, J</bold>) 25 μm. Ctx: cortex, LV: lateral ventricle, SVZ: subventricular zone, P: postnatal day, BrdU: Bromodeoxyuridine.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Loss of Sox6 function ectopically upregulates Neurog2 throughout the forebrain.</title><p>(<bold>A–B</bold>) <italic>In situ</italic> hybridization for <italic>Neurog2</italic> shows very sparse expression in the forebrain of wild-type mice at P6 compared to <italic>Sox6</italic>-/- forebrain (<bold>B</bold>). (<bold>C</bold>) <italic>Neurog2</italic> ISH image at P4 from the Developing Mouse Brain Atlas of the Allen Brain Institute shows <italic>Neurog2</italic> expression in the dentate gyrus of wt mice, similar to the expression at P6 seen in A, A” (<xref ref-type="bibr" rid="bib2">Allen Brain Institute, 2008</xref>) <ext-link ext-link-type="uri" xlink:href="https://developingmouse.brain-map.org/experiment/show/100093831">https://developingmouse.brain-map.org/experiment/show/100093831</ext-link>. (<bold>A’-C’’</bold>) Higher magnification views of boxed regions in (<bold>A–C</bold>) of cortex (<bold>A’, B’, C’</bold>) and hippocampus (<bold>A’’, B’’, C”</bold>). Arrowheads in A” and C” indicate <italic>Neurog2</italic>+ cells in the dentate gyrus of the hippocampus in wild-type mouse brain.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig1-figsupp2-v1.tif"/><permissions><copyright-statement>© 2008, Allen Institute for Brain Science</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Allen Institute for Brain Science</copyright-holder><license><license-p>Images are from the Allen Mouse Brain Atlas, 2008 (<ext-link ext-link-type="uri" xlink:href="https://developingmouse.brain-map.org/">https://developingmouse.brain-map.org/</ext-link>), and are not available under the terms of a Creative Commons Attribution License. Further reproductions of these images should adhere to the Allen Institute's Citation policy (<ext-link ext-link-type="uri" xlink:href="https://alleninstitute.org/legal/citation-policy/">https://alleninstitute.org/legal/citation-policy/</ext-link>)</license-p></license></permissions></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Characterization, FACS isolation, and culture of cortical SOX6+/NG2+ progenitors.</title><p>(<bold>A, B</bold>) Photomicrograph of NG2-DsRed coronal section at P5 showing expression of DsRed by uniformly distributed progenitor cells and pericytes (see also <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4H–L</xref>). Schematic in A depicts a coronal section; boxed region in A identifies the approximate region shown in B. Ctx: cortex. (<bold>C</bold>) Immunostaining of NG2 and SOX10 shows uniform distribution of NG2+ progenitors in cortex at P5. (<bold>D</bold>) Immunostaining confirms expression of NG2 and DsRed by cultured DsRed-Bright cells after FACS purification (4 hr). n=2, biological replicates. (<bold>E</bold>) qPCR of <italic>Gfap</italic>, <italic>Tuj1</italic>, and <italic>Mbp</italic> demonstrates that acutely sorted and cultured DsRed-Bright cells do not contain neurons or astrocytes, and that culture conditions do not promote oligodendrocyte differentiation. n=4, biological replicates, <italic>Actb</italic> normalized data relative to negative population. (<bold>F, G</bold>) Immunofluorescence shows that DsRed-Dim populations contain a mixture of NG2+ cells (with relatively low NG2 expression compared to DsRed-Bright; see <bold>L</bold>) (<bold>F</bold>) and GFAP+/NESTIN+/NG2+ glial progenitors (<bold>G</bold>). (<bold>H</bold>) Quantification of progenitor proliferation in response to PDGF-A, FGF2, and SHH at 5 DIV. (n=1; due to potential ventralization by SHH, only PDGF-A and FGF2 were used in subsequent experiments.) (<bold>I</bold>) Cultured SOX6+/NG2+ cortical progenitors proliferate robustly in response to PDGF-A and FGF2. Cell number increases sevenfold through 7 DIV. n=2, biological replicates. (<bold>J–L</bold>) Representative images of cultured progenitors show proliferation and continued expression of NG2 and Olig2 over time. (<bold>M, N</bold>) Low-magnification immunofluorescence and bright-field images of progenitors in culture show expression of NG2 proteoglycan and maintenance of multipolar morphology through 5 DIV. (<bold>O, P</bold>) Representative high-magnification (40 x) images of progenitors in culture show preservation of characteristic non-overlapping processes by SOX6+/NG2+ progenitors. (<bold>Q</bold>) qPCR shows that serum causes cultured progenitors to decrease expression of the key progenitor genes <italic>Sox6</italic> and <italic>Cspg4</italic> and increase expression of the astroglial marker <italic>Gfap</italic>. n=4, biological replicates, <italic>Actb</italic> normalized data relative to negative population. Scale bars (<bold>C, D, F, G, J, K, L, N</bold>) 100 μm, (<bold>M</bold>) 500 μm, (<bold>O, P</bold>) 10 μm. Data are presented as mean ± SD. ∗∗∗∗<italic>p</italic>&lt;0.0001, ***<italic>p</italic>&lt;0.001, **<italic>p</italic>&lt;0.01, *<italic>p</italic>≥0.05, no statistically significant difference (n.s.); ANOVA Tukey’s post hoc test in (<bold>E</bold>), t-test in (<bold>Q</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>SOX6+/NG2+ progenitors maintain molecular characteristics <italic>in vitro</italic>, and cultures are free of DsRed+ pericytes.</title><p>(<bold>A–E</bold>) Heatmap of the top-500 genes enriched in major cell lineages <xref ref-type="bibr" rid="bib162">Zhang et al., 2014</xref> for acutely sorted DsRed-Negative, -Dim, and -Bright cells, as well as cultured DsRed-Bright cells (5-DIV). Counts are variance-stabilizing transformed (vst) normalized data in log2 scale. (<bold>F</bold>) qPCR of the pericyte markers <italic>Pdgfrb</italic> and <italic>Mcam (CD146</italic>) shows that pericytes are FACS-purified with SOX6+/NG2+ progenitors in DsRed-Bright populations, but they are not present in culture at 5 DIV. Data are presented as mean ± SD, n=4, biological replicates, <italic>Actb</italic> normalized data relative to negative population. (<bold>G–I</bold>) Heatmaps of commonly known pericyte markers (<bold>G</bold>), a conservative list of 241 pericyte-enriched genes (<bold>H</bold>), and an extended list of 785 genes that are enriched in brain mural cells (<bold>I</bold>) <xref ref-type="bibr" rid="bib51">He et al., 2016</xref>, confirming absence of pericytes in culture. See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for a list of genes used in these plots. (<bold>J–L</bold>) qPCR (<bold>J</bold>), microscopy (<bold>K</bold>), and immunocytochemistry (<bold>L</bold>) of DsRed-Bright cells cultured in standard proliferation media with or without serum (see Methods) at 5 DIV showing that pericytes only survive in the presence of serum. qPCR data are presented as mean ± SD, n=4, biological replicates, <italic>Actb</italic> normalized data relative to no serum condition. Scale bars (<bold>K</bold>) 50 μm, (<bold>L</bold>) 100 μm. ∗∗∗∗<italic>p</italic>&lt;0.0001, ***<italic>p</italic>&lt;0.001, **<italic>p</italic>&lt;0.01; ANOVA Tukey’s post hoc test in (<bold>F</bold>), t-test in (<bold>J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig1-figsupp4-v1.tif"/></fig></fig-group><p>We then focused the investigation on SOX6+ cells by immunocytochemistry (ICC) and by using genetically labeled progenitors (NG2-DsRed) (<xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref>). We identify that SOX6+ cells are a subset of NG2-proteoglycan-expressing proliferative cells resident across the CNS (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These data indicate that at least a subset of SOX6+/NG2+ progenitors resident in the neocortex possess some level of dormant neurogenic competence, which might be activated with relatively focused molecular manipulation. Therefore, we targeted SOX6+/NG2+ progenitors for directed differentiation into clinically relevant cortical output neurons, including CSN.</p></sec><sec id="s2-2"><title>Purification and culture of SOX6+/NG2+ cortical progenitors</title><p>We established a culture system of purified SOX6+/NG2+ cortical progenitors to evaluate candidate transcriptional regulators for their ability to direct differentiation of SOX6+/NG2+ progenitors into cortical output neurons <italic>in vitro</italic>, thus enabling rigorous and iterative experimentation under controlled conditions. We used a transgenic NG2-DsRed mouse line (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–C</xref>); <xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref> to isolate DsRed-positive cells by FACS from micro-dissected dorso-lateral neocortex at P2-P6 (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>). Three distinct DsRed populations were identified based on fluorescence intensity: ‘DsRed-Bright’ (2–5%), ‘DsRed-Dim’ (~20%), ‘DsRed-negative’ (~75%) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Quantitative PCR (qPCR) (n=4) and ICC (n=2) revealed that DsRed-Bright cells are progenitors with high expression of <italic>Sox6</italic>, <italic>Cspg4 (NG2</italic>), and <italic>Olig2</italic> (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), whereas DsRed-Dim cells are a heterogeneous population that includes GFAP+ astrocytes, NESTIN+ progenitors, and a subset of NG2+ progenitors (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E–G</xref>). To further investigate these DsRed populations, we performed RNA-seq on acutely sorted DsRed-Bright, DsRed-Dim, and DsRed-negative populations (n=5–6), and evaluated expression of a focused set of 500 genes most enriched in major cortical cell lineages (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="bibr" rid="bib162">Zhang et al., 2014</xref>). Cortical NG2+ progenitor-enriched genes are highly expressed by the DsRed-Bright population (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>), whereas neuronal, astroglial, and microglial genes are depleted (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4B–D</xref>). Together, these data indicate that DsRed-Bright cells are canonical SOX6+/NG2+ progenitors, potentially optimally suited for use in subsequent directed differentiation experiments.</p><p>We FACS-purified DsRed-Bright SOX6+/NG2+ progenitors with stringent gating and cultured them for 5 days (days-in-vitro, DIV) until they reached optimal confluency for transfection (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). To promote the preservation of endogenous progenitor characteristics in culture, we performed a pilot experiment varying morphogen composition to broadly optimize serum-free medium formulation based on previously published protocols (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3H</xref>; <xref ref-type="bibr" rid="bib88">Lyssiotis et al., 2007</xref>). When cultured in this medium, progenitors proliferate robustly in response to the mitogens PDGF-A and FGF2 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3I–N</xref>). They maintain their cardinal molecular hallmarks, including expression of SOX6, NG2, OLIG2, and SOX10 (<xref ref-type="fig" rid="fig1">Figure 1F, I, J</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3J-M</xref>), and conserve characteristic branched morphology with non-overlapping territorial processes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3N–P</xref>; <xref ref-type="bibr" rid="bib61">Hughes et al., 2013</xref>).</p><p>We next investigated the extent of spontaneous oligodendrocyte differentiation from these progenitors in culture, since a substantial subset of broad NG2+ progenitors produces oligodendrocytes <italic>in vivo</italic> (<xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref>). Previous work demonstrated that <italic>Sox6</italic> is expressed by at least some proliferating NG2+ progenitors, and is down-regulated upon differentiation (<xref ref-type="bibr" rid="bib9">Baroti et al., 2016</xref>; <xref ref-type="bibr" rid="bib142">Stolt et al., 2006</xref>). Under our culture conditions, FACS-purified cortical SOX6+/NG2+ progenitors continue to express <italic>Sox6</italic> (<xref ref-type="fig" rid="fig1">Figure 1F, I, J</xref>), indicating maintenance of their progenitor state. ICC for O4 expression (a marker for pre-myelinating oligodendrocytes) revealed that only ~0.15% of these cells express O4 at 3 and 5 DIV (~51 and~49 O4+ cells/cm<sup>2</sup>, respectively). Similarly, qPCR for myelin basic protein (<italic>Mbp</italic>), a canonical oligodendrocyte marker, demonstrated that <italic>Mbp</italic> expression does not increase when cells are cultured for 3 or 5 days, compared to acutely sorted progenitors (n=4) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>). Together, these data indicate that our culture conditions are not permissive for oligodendrocyte differentiation, and that the purified SOX6+/NG2+ progenitors maintain their progenitor state.</p><p>Next, we applied multiple analyses to identify whether there exist contaminant neurons or astrocytes in these cultures of SOX6+/NG2+ progenitors. To identify non-progenitor cells in culture, we immunolabeled for TUJ1 (antibody against TUBB3, a common immature neuronal marker) and GFAP (expressed by astrocytes and some other types of neural progenitors) at 3, 5, and 7 DIV (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). At 3 DIV, among ~12,000 total cells/cm<sup>2</sup>, there were 7 TUJ1+ cells and 3 GFAP+ cells. At 5 DIV, among ~32,000 total cells/cm<sup>2</sup>, there were 11 TUJ1+ cells and 0 GFAP+ cells. At 7 DIV, among ~70,000 total cells/cm<sup>2</sup>, there were 6 TUJ1+ cells and 14 GFAP+ cells (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). These data reveal the exceptional purity (&gt;99.9% pure) of these primary cultures of SOX6+/NG2+ cortical progenitors. Reinforcing these immunocytochemical results, qPCR revealed that neither <italic>Tubb3</italic> nor <italic>Gfap</italic> are detected in these cultures at 5 DIV, nor in acutely sorted DsRed-Bright cells (n=4) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>). In striking contrast, and reinforcing that these culture conditions maintain progenitor competence of SOX6+/NG2+ progenitors, supplementing medium with serum resulted in downregulation of <italic>Sox6</italic> and <italic>NG2</italic> and increased expression of <italic>Gfap</italic> (n=4) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3Q</xref>). Together, these results identify that there is essentially no contamination under these culture conditions at any time point investigated, and that progenitors maintain their molecular and functional characteristics <italic>in vitro</italic>.</p><p>We further investigated the progenitor cultures for potential pericyte contamination, since pericytes express NG2 proteoglycan (<xref ref-type="bibr" rid="bib110">Ozerdem et al., 2001</xref>), so they are DsRed-positive in NG2-DsRed cortex (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A and B</xref>). qPCR for pericyte markers <italic>Pdgfrb</italic> and <italic>Mcam (CD146</italic>) revealed that pericytes are abundant in acutely sorted DsRed-Bright cultures, but are absent in culture at 5 DIV (n=4) (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4F</xref>), indicating that pericytes do not survive in these culture conditions. Validating these results by ICC, there were no PDGFRB+ cells in culture at either 3 or 5 DIV (0 cells/cm<sup>2</sup>, n=2), unless DsRed-Bright cells were cultured in serum-supplemented media (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4J–L</xref>). Together, these results reveal that these culture conditions do not support pericyte survival, and that progenitor cultures are pericyte-free.</p><p>To even further investigate by independent means whether progenitors maintain their <italic>in vivo</italic> molecular features <italic>in vitro</italic>, we performed RNA-seq on these cultures at 5 DIV (n=6), evaluating expression of 500 genes most enriched in the major alternative cell lineages (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="bibr" rid="bib162">Zhang et al., 2014</xref>). The purified SOX6+/NG2+ progenitor cultures express progenitor-enriched genes (<xref ref-type="fig" rid="fig1">Figure 1L</xref>), but, appropriately, do not express neuronal-, astroglial-, microglial-, pericyte-, or vascular-enriched genes (<xref ref-type="fig" rid="fig1">Figure 1M, N</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A–D and G–I</xref>), confirming the ICC and qPCR results. Similarly, oligodendrocyte-enriched genes are not upregulated in culture compared to acutely sorted cells (<xref ref-type="fig" rid="fig1">Figure 1M, N</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4E</xref>). Importantly, gene expression profiles of cultured progenitors were highly consistent and reproducible across biological replicates (n=6) (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A–I</xref>). Together, these data further confirm that cortical SOX6+/NG2+ progenitors maintain their molecular characteristics <italic>in vitro</italic>, enabling establishment of a robust <italic>in vitro</italic> culture system in which to reproducibly manipulate progenitors under controlled conditions.</p></sec><sec id="s2-3"><title>Multi-gene construct ‘NVOF’ induces neuronal differentiation and unipolar pyramidal morphology from SOX6+/NG2+ cortical progenitors</title><p>To direct differentiation of corticospinal neurons from cortical SOX6+/NG2+ progenitors, we designed a tandem construct containing three transcriptional controls (<bold><italic>N</italic></bold><italic>eurog2</italic>, <bold><italic>V</italic></bold><italic>P16:</italic><bold><italic>O</italic></bold><italic>lig2</italic>, and <bold><italic>F</italic></bold><italic>ezf2</italic> – collectively termed ‘<bold>NVOF’</bold>) based on their developmental functions (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>; <xref ref-type="bibr" rid="bib145">Tang et al., 2009</xref>). The expression of the polycistronic construct is driven by the CMV-β-actin (CAG) promoter, with the open reading frames separated by 2A linker sequences (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>; <xref ref-type="bibr" rid="bib145">Tang et al., 2009</xref>), also including a GFP reporter to identify transfected cells.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>NVOF induces mature glutamatergic neurons from SOX6+/NG2+ cortical progenitors <italic>in vitro</italic>.</title><p>(<bold>A–C</bold>) Strategy for directed differentiation of SOX6+/NG2+ progenitors into cortical output neurons (<bold>A</bold>), the NVOF multigene construct (<bold>B</bold>), and the experimental outline (<bold>C</bold>). (<bold>D</bold>) Representative images of control-GFP and NVOF-transfected cells at 1-, 3-, 7-, and 16-days post-transfection (DPT). Unlike control-transfected cells, NVOF-transfected cells lose progenitor morphology at 1 DPT and progressively exhibit complex neuronal morphology, including a primary axon-like process and multiple dendrite–like processes. (<bold>E</bold>) Percentage of control-GFP and NVOF-transfected cells with neuronal morphology and TUJ1 expression (~42% at 3 DPT and ~74% at 7 DPT for NVOF, n=4, &gt;200 cells/n). (<bold>F</bold>) Quantification of primary process length for NVOF-induced neurons at 3 and 7 DPT (n=3,&gt;100 cells/n). (<bold>G</bold>) Representative morphology of NVOF-induced, TUJ1+ neurons at 7 DPT. Note the single axon, dendrite-like structures, and multiple axonal collaterals. (<bold>H</bold>) Representative images of NVOF-induced neurons at 16 DPT showing acquisition of elaborate dendritic morphology and highly intercalated axonal processes. (<bold>I</bold>) High-power representative images of individual NVOF-induced neurons at 16 DPT showing dendritic complexity and a single primary axon-like process for each neuron (red arrows). (<bold>J</bold>) Representative images of <italic>Neurog2</italic>-induced neurons with multiple atypical axon-like processes. (GFP is pseudocolored for enhanced clarity of cell morphology). (<bold>K</bold>) Representative images of <italic>Neurog2</italic>-induced neurons expressing the axonal marker ANKYRIN-G (ANK3) by multiple neurites (n=2). (<bold>L</bold>) Quantification of neurons with single versus multiple axons in <italic>Neurog2</italic>- and NVOF-induced neurons. At 7 DPT, 49 ± 16% of <italic>Neurog2</italic>-induced neurons have multiple, long axon-like processes, whereas a small number of such neurons exist after NVOF induction (9 ± 5%) (n=5, &gt;100 cell). See methods for details. (<bold>M–N</bold>) Representative images of NVOF-induced neurons at 7 DPT showing compartmentalized expression of the somato-dendritic marker MAP2, the somato-axonal marker Neurofilament-M, and the mature neuronal marker, NeuN. (<bold>O</bold>) Quantification of NVOF-induced, TUJ1+ neurons expressing MAP2 at 3 DPT (~48%, n=3, &gt;200 cells) and 7 DPT (~93%, n=4, &gt;200 cells), as well as NeuN at 7 DPT (66 ± 16%, n=4, &gt;100 cells). (<bold>P</bold>) Volcano plot showing upregulation of neuronal genes in NVOF-induced neurons compared to control-transfected cells at 7 DPT (RNA-seq, n=3, biological replicates). (<bold>Q</bold>) Bar graph of RNA-seq data displaying upregulation of neuronal genes and downregulation of progenitor genes in NVOF-induced neurons at 7 DPT. Neurons exclusively upregulate glutamatergic genes, but not genes specific to alternate neuronal identities. Scale bars (<bold>D, G, H, J, M, N</bold>) 100 μm; (<bold>I</bold>) 50 μm. Error bars show standard deviations. ∗∗∗∗<italic>p</italic>&lt;0.0001, ***<italic>p</italic>&lt;0.001, **<italic>p</italic>&lt;0.01, t-test in (<bold>E, F, L</bold>). n.f. (no TUJ1+ cell found).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Expression and function of individual NVOF components.</title><p>(<bold>A</bold>) Representative image of <italic>Neurog2</italic>-GFP-induced neurons showing TUJ1 expression (<bold>A’</bold>). (<bold>B, C</bold>) Representative images of control-GFP versus <italic>VP16:Olig2</italic>-GFP-transfected SOX6+/NG2+ progenitors. Overexpression of <italic>VP16:Olig2</italic> represses T3-mediated differentiation of progenitors into oligodendrocytes, causing transfected cells to acquire morphology of immature neuroblasts (n=3). (<bold>D, E</bold>) Representative images of <italic>Fezf2</italic>-GFP transfected cells. <italic>Fezf2</italic> overexpression in progenitors does not fully support neuronal differentiation, and many cells adopt a ‘chimeric’ morphology with glial-cell-like soma structures and long processes. (n=2). (<bold>F, G</bold>) Representative images of <italic>Ctip2</italic>-GFP transfected cells. <italic>Ctip2</italic> overexpression in SOX6+/NG2+ progenitors induces a striking, TUJ1+/OLIG2- axon-like neurite at 3 DPT, demonstrating inherent plasticity and neuronal competency in SOX6+/NG2+ progenitors. (<bold>H–J</bold>) Immunofluorescence of HEK293T cells transfected with NVOF confirms that GFP, NEUROG2 (<bold>H</bold>), and FEZF2-HA (<bold>I</bold>) are expressed appropriately. Immunocytochemistry for 2A peptides reports expression of GFP, NEUROG2, and VP16:OLIG2 (<bold>J</bold>). Scale bars (<bold>A-G</bold>) 100 μm; (<bold>H-J</bold>) 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>NVOF redirects the axons of later-born upper layer neurons to subcortical targets, similar to deep layer cortical output neurons.</title><p>(<bold>A–D</bold>) Testing NVOF in mouse embryonic dorsal progenitors at E15.5 via <italic>in utero</italic> electroporation. E15.5 embryos were electroporated with control vector (GFP) (<bold>A, B</bold>) and NVOF (<bold>C, D</bold>), and analyzed at P7. Neurons electroporated with control vector project to contralateral cortex (<bold>A’</bold>), but not to subcortical targets (<bold>A’’, A’’’, B</bold>). After NVOF electroporation, many GFP+ axons descend through the internal capsule (<bold>C’’</bold>) toward the thalamus (<bold>C’’’</bold>), and some of these axons reach the cerebral peduncle by P7 (<bold>D</bold>). Some NVOF-electroporated neurons still send axons to contralateral hemisphere through the corpus callosum (<bold>C”</bold>). (<bold>E</bold>) Schematic illustrating that NVOF redirects axons of later-born upper-layer neurons from contralateral targets to subcortical targets, similar to deep-layer cortical output neurons. (n=4) (Asterisk on B marks a blood vessel, not an axon.).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>NVOF-transduced progenitors rapidly lose progenitor identity and acquire cardinal features of mature functional neurons.</title><p>(<bold>A–D</bold>) Representative images of NVOF-transfected progenitors at 3 and 6 DPT showing acquisition of neuronal morphology coupled with TUJ1 expression (filled arrows) and downregulation of the progenitor markers NG2 (a.k.a. CSPG4) and SOX10 (empty arrows). (<bold>E</bold>) Representative low-magnification image of NVOF-induced neurons at 7 DPT. (<bold>E’</bold>) Pseudocolored GFP for better visualization of cell morphology. (<bold>F–J</bold>) NVOF-induced neurons at 7 DPT express the cell adhesion molecule PSA-NCAM (NCAM1) (<bold>F</bold>), which has a punctate distribution at 14 DPT (<bold>G</bold>), and the presynaptic molecules SYNAPSIN (SYN1/2) (<bold>H</bold>), SYNAPTOPHYSIN (SYP) (<bold>I</bold>), and VGLUT1 (<bold>J</bold>), which are key molecular features of glutamatergic neurons. Note the localization of SYNAPSIN and VGLUT1 to filopodial, presumptive presynaptic structures along axonal compartments. (<bold>K</bold>) Representative low-magnification image of NVOF-induced neurons (green, GFP) co-cultured with primary neurons isolated from wild-type forebrain at P0 (red, Tuj1) in astrocyte-conditioned media, showing that NVOF-induced neurons intercalate with primary neurons at 14 DPT. (<bold>L, M</bold>) Representative images of co-culture showing considerable morphological maturation and axon elongation of NVOF-induced neurons. Note dendrite size (filled arrows) and single axons protruding from cell bodies (empty arrows). (<bold>N</bold>) Representative image of an NVOF-induced neuron with highly elongated dendritic structures and abundant SYNAPSIN-positive presynaptic contacts from nearby primary neurons (<bold>N’</bold>). Scale bars (<bold>A, B, C, D, I, J, L, M</bold>) 100 μm; (<bold>E</bold>) 200 μm; (<bold>F, G, H, N</bold>) 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>NVOF induces glutamatergic neurons from SOX6+/NG2+ progenitors with high fidelity and reproducibility.</title><p>(<bold>A, B</bold>) Volcano and heatmap plots of differentially expressed genes between NVOF-induced neurons and cells transfected with control-GFP. (<bold>C</bold>) Volcano plot showing downregulation of progenitor genes in NVOF-induced neurons compared to control-GFP transfected cells at 7 DPT (n=3, biological replicates). (<bold>D</bold>) Gene ontology (GO) term enrichment analysis of genes upregulated in NVOF-induced neurons for biological processes and cellular components. (<bold>E–M</bold>) Representative images of NVOF-induced neurons with negative immunoreactivity for the non-glutamatergic neuronal markers GABA for GABAergic interneurons (<bold>E, E’</bold>), DARPP32 for striatal projection neurons (<bold>G, G’</bold>), 5-HT for serotonergic neurons (<bold>I, I’</bold>), TH for dopaminergic neurons (<bold>K, K’</bold>), and ISL1 for spinal motor neurons (<bold>M, M’</bold>), demonstrating that NVOF-induced neurons appropriately do not co-exhibit multiple neuronal identities. Cultured P2 primary mouse neurons were used as a positive control for immunocytochemistry staining (<bold>F, H, J, L, N</bold>). Scale bars (<bold>E–N</bold>) 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-figsupp4-v1.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 5.</label><caption><title>Synthetic mRNA mediates neuronal induction from SOX6+/NG2+ cortical progenitors.</title><p>(<bold>A, B</bold>) Cultured progenitors are transfected with GFP RNA at higher efficiency (<bold>A</bold>) than GFP DNA (<bold>B</bold>). (<bold>C</bold>) Co-transfection of GFP RNA and tdTomato DNA is highly efficient. (<bold>D, G</bold>) Time course of gene expression in cultured progenitors transfected with GFP RNA shows that GFP expression begins by 6 hr post-transfection (<bold>D</bold>), peaks between 12 and 24 hr (<bold>E, F</bold>), then declines (<bold>G</bold>). (<bold>H, I</bold>) One pulse of <italic>Neurog2</italic> RNA induces morphologically complex, TUJ1+ neurons from SOX6+/NG2+ cortical progenitors (<bold>H</bold>), albeit at a lower efficiency than <italic>Neurog2</italic> or NVOF DNA constructs (<bold>I</bold>). Percentage of TUJ1+, neuron-like cells in cells transfected with GFP control RNA, <italic>Neurog2</italic> RNA, and <italic>Neurog2</italic> DNA relative to the number of TUJ1+ cells after NVOF transfection (<bold>I</bold>). Error bars show standard deviations. ∗∗∗∗<italic>p</italic>&lt;0.0001, **<italic>p</italic>&lt;0.01, *<italic>p</italic>&lt;0.05, t-test. (n=3). (<bold>J</bold>) Co-transfection of <italic>Neurog2</italic> RNA and <italic>Fezf2</italic>-GFP DNA induces TUJ1+ neurons from SOX6+/NG2+ progenitors. Scale bars (<bold>A-J</bold>) 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig2-figsupp5-v1.tif"/></fig></fig-group><p>First, to drive glutamatergic neuronal identity, we selected the pallial proneural transcription factor neurogenin2 (<italic>Neurog2</italic>) (<xref ref-type="bibr" rid="bib133">Schuurmans et al., 2004</xref>; <xref ref-type="bibr" rid="bib92">Mattar et al., 2008</xref>). Previous data showed that forced expression of <italic>Neurog2</italic> reprograms cultured postnatal glia and human ESC/iPSCs into synapse-forming glutamatergic neurons <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib52">Heinrich et al., 2010</xref>; <xref ref-type="bibr" rid="bib161">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Hulme et al., 2022</xref>), and can induce neuron-like cells from postnatal glial cells (<xref ref-type="bibr" rid="bib35">Felske et al., 2023</xref>; <xref ref-type="bibr" rid="bib55">Herrero-Navarro et al., 2021</xref>) and injury-induced reactive glial cells in the adult mouse brain (<xref ref-type="bibr" rid="bib42">Gascón et al., 2016</xref>). We tested <italic>Neurog2</italic> alone in cultured progenitors and found that, in line with previous reports, <italic>Neurog2</italic> is sufficient to induce neurons with long axons <italic>in vitro</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>Second, to overcome the predominant gliogenic potential in NG2+ progenitors, we complemented <italic>Neurog2</italic> with <italic>VP16:Olig2</italic> (VP16 transactivation domain from herpes simplex virus fused to an OLIG2 DNA binding domain) (<xref ref-type="bibr" rid="bib98">Mizuguchi et al., 2001</xref>). This activator form of <italic>Olig2</italic> functions as a dominant negative transcriptional regulator to counteract <italic>Olig2</italic> gliogenic function (<xref ref-type="bibr" rid="bib98">Mizuguchi et al., 2001</xref>; <xref ref-type="bibr" rid="bib106">Novitch et al., 2001</xref>; <xref ref-type="bibr" rid="bib163">Zhou et al., 2001</xref>). <italic>Olig2</italic>, a bHLH transcription factor, is necessary for the specification of a broad population of NG2+ progenitors and for their differentiation into oligodendrocytes (<xref ref-type="bibr" rid="bib78">Li and Richardson, 2016</xref>). In addition, OLIG2 has been shown to antagonize NEUROG2 activity during neurogenesis to maintain progenitors for subsequent gliogenesis during spinal cord development (<xref ref-type="bibr" rid="bib77">Lee et al., 2005</xref>). Misexpression of <italic>Olig2</italic> in the cortex broadly represses proneural and neurogenic genes and increases oligodendrocyte precursor cell numbers (<xref ref-type="bibr" rid="bib80">Liu et al., 2015</xref>). Intriguingly, antagonizing OLIG2 function in reactive glial cells after injury results in a substantial number of immature neurons in the cortical or striatal parenchyma (<xref ref-type="bibr" rid="bib14">Buffo et al., 2005</xref>; <xref ref-type="bibr" rid="bib74">Kronenberg et al., 2010</xref>). To confirm whether <italic>VP16:Olig2</italic> is able to suppress glial differentiation capacity of cortical SOX6+/NG2+ progenitors in our experimental paradigm, we transfected progenitors with either <italic>VP16:Olig2</italic> or control GFP constructs. At 1 DPT, the cultures were treated with thyroid hormone (T3) to induce differentiation of oligodendrocytes. At three days post-T3 treatment, as expected, control cells differentiated into oligodendrocyte-like cells, whereas <italic>VP16:Olig2</italic> transfected progenitors had remarkably turned into neuroblast-like bipolar cells, indicating that VP16:OLIG2 successfully blocks endogenous OLIG2 function (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>).</p><p>Third, to induce cortical output neuronal fate, we selected <italic>Fezf2</italic>, an upstream transcriptional regulator that controls specification and development of cortical output neurons during cortical neurogenesis (<xref ref-type="bibr" rid="bib44">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib21">Chen et al., 2004</xref>; <xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>; <xref ref-type="bibr" rid="bib41">Galazo et al., 2023</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>, see also Discussion). <italic>Fezf2</italic> is capable via single gene over-expression of generating cortical output neuronal fate from alternate cortical progenitors (<xref ref-type="bibr" rid="bib99">Molyneaux et al., 2005</xref>), from progenitors of striatal neurons <italic>in vivo</italic> (<xref ref-type="bibr" rid="bib124">Rouaux and Arlotta, 2010</xref>)<italic>,</italic> and from intracortical projection neurons post-mitotically in the early postnatal brain (<xref ref-type="bibr" rid="bib26">De la Rossa et al., 2013</xref>).</p><p>We first verified expression of individual proteins from the polycistronic construct (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H–J</xref>), then assessed the construct’s functionality in mouse embryonic cortical progenitors <italic>in vivo</italic> (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Previous work has shown that misexpression of <italic>Fezf2</italic> in late-stage embryonic cortical progenitors modifies their fate to cortical output neurons, re-routing the intracortical axonal trajectories of layer II/III neurons to subcortical targets (<xref ref-type="bibr" rid="bib99">Molyneaux et al., 2005</xref>). To investigate whether this FEZF2 function persists in the presence of NEUROG2 and VP16:OLIG2, we electroporated NVOF into embryonic ventricular zone progenitors <italic>in utero</italic> at E15.5, the peak production of upper layer intracortical neurons, and found that forced expression of NVOF induces cortical output identity in electroporated neurons (n=3) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Unlike control GFP-only neurons (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A and B</xref>), many NVOF+ axons descend through the internal capsule, to or past the thalamus (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>), with some extending into the cerebral peduncle (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>). These data demonstrate that the NVOF construct is expressed by electroporated neurons<italic>,</italic> and that <italic>Fezf2</italic> continues to specify cortical output identity when co-expressed with <italic>Neurog2</italic> and <italic>VP16:Olig2</italic>.</p><p>We transfected NVOF into cultured cortical SOX6+/NG2+ progenitors at 4–5 days after FACS purification and analyzed their morphology and expression of cardinal ICC markers of cell type identity over two weeks of differentiation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Progenitors began to lose multipolar morphology within 24 hr (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). By 3 days post-transfection (DPT), many extended a single axon-like neurite (<xref ref-type="fig" rid="fig2">Figure 2D and F</xref>) and expressed the broad neuronal marker TUJ1 (42%, n=3, &gt;200 cells/experiment) (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A and B</xref>). This morphological transformation was coupled with the loss of the progenitor markers NG2 and SOX10 (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A and B</xref>). By 7 DPT, ~73% of NVOF-transfected cells expressed TUJ1, acquired neuronal morphology with dendrite-like features, and extended a single prominent axon-like process (n=4, &gt;200 cells/experiment) (<xref ref-type="fig" rid="fig2">Figure 2D-G</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3C and D</xref>). Consistent with pyramidal neuron morphology, the primary axon-like processes of NVOF-directed neurons underwent significant extension between 3 DPT and 7 DPT, often extending further than 500 μm from the soma (&gt;40%, n=3) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). By 16 DPT, the morphology of these putative neurons became more elaborate; the single long axon-like neurite was maintained, their dendrite-like structures became more tufted, and axon-neurite branches of neighboring cells became intercalated (<xref ref-type="fig" rid="fig2">Figure 2H and I</xref>).</p><p>In striking contrast, progenitors transfected with a control GFP-only construct displayed glial morphology throughout the culturing period, and no GFP+/TUJ1+ cells were present at all (n=4, 250–350 cells/experiment) (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Furthermore, even among non-transfected, GFP-negative cells, only 5 cells/cm<sup>2</sup> out of ~30,000 progenitors/cm<sup>2</sup> were TUJ1+, and these GFP-/TUJ1+ cells did not increase over time (n=4). These results further reinforce the absence of contaminating progenitors with spontaneous neurogenic characteristics in these cultures, and the lack of spontaneous differentiation by cultured cortical SOX6+/NG2+ progenitors.</p><p><italic>Neurog2</italic> is widely used to induce generic excitatory neurons from somatic and pluripotent stem cells (<xref ref-type="bibr" rid="bib52">Heinrich et al., 2010</xref>; <xref ref-type="bibr" rid="bib161">Zhang et al., 2013</xref>). We directly compared <italic>Neurog2</italic>-induced and NVOF-induced neurons to determine whether <italic>Neurog2</italic> might be sufficient for induction of equivalent neuronal differentiation from cultured SOX6+/NG2+ cortical progenitors. We transfected cultured progenitors with either <italic>Neurog2</italic>-GFP or NVOF and analyzed cells at 7 DPT. Though superficially similar in some respects to NVOF-induced neurons (<xref ref-type="fig" rid="fig2">Figure 2J</xref>), <italic>Neurog2</italic> induces multipolar neuronal morphology with many dendrite-like structures and multiple long axon-like processes. While almost all NVOF-induced neurons extend a single primary axon (90%), ~50% of <italic>Neurog2</italic>-induced neurons aberrantly extend multiple axon-like ANKYRIN-G+ processes originating from their cell bodies (<xref ref-type="fig" rid="fig2">Figure 2J–L</xref>) (n=5, &gt;100 cells/n). This aberrant, over-exuberant neuritogenesis by <italic>Neurog2</italic>-induced neurons indicates defective polarization, potentially due to a lack of negative feedback signaling for inhibition of surplus axon formation (<xref ref-type="bibr" rid="bib38">Funahashi et al., 2020</xref>).</p></sec><sec id="s2-4"><title>NVOF-induced neurons exhibit cardinal features of mature functional neurons</title><p>We investigated further whether NVOF-induced, TUJ1+ cells acquire the cardinal molecular hallmarks of mature neurons. At 7 DPT, NVOF-induced neurons express the somato-dendritic marker MAP2 (&gt;90%, n=4, 130–200 cells/n) and the somato-axonal marker NF-M (<xref ref-type="fig" rid="fig2">Figure 2M and O</xref>), indicating clear polarization and dendritic compartmentalization. Dendrite formation was confirmed by high-power imaging at 16 DPT, revealing that the NVOF-induced neurons have dendrite-like processes with filopodial protrusions and a single axon-like primary process lacking dendrite-like structures (<xref ref-type="fig" rid="fig2">Figure 2I</xref>, highlighted with red arrows). Further, at 7 DPT, NVOF-induced neurons express neuronal nuclear antigen (NeuN) (66 ± 16%, n=4, &gt;100 cells/n) (<xref ref-type="fig" rid="fig2">Figure 2N and O</xref>), polysialylated neural cell adhesion molecule (PSA-NCAM or <italic>Ncam1</italic>) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3F and G</xref>), the presynaptic molecule synapsin (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3H</xref>), with some displaying synaptophysin in axonal branches and tips of axonal protrusions (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3I</xref>), and vGLUT1 (vesicular glutamate transporter 1) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3J</xref>), indicating glutamatergic identity. Together, these data indicate that NVOF robustly induces neuronal differentiation and maturation by cortical SOX6+/NG2+ progenitors <italic>in vitro</italic>.</p><p>To determine whether neuronal differentiation from these cortical SOX6+/NG2+ progenitors requires an intermediate proliferative step, we pulsed cultures with BrdU for 15 hr after transfection and labeled GFP+ cells (NVOF-transfected or GFP-only controls) for BrdU by ICC at 3 DPT (n=2). Previous work has reported that cell division is not required for neuronal differentiation from resident glia (<xref ref-type="bibr" rid="bib52">Heinrich et al., 2010</xref>). While a majority of cells transfected with GFP-only were BrdU+, only rare NVOF-transfected cells were BrdU+. This result indicates that NVOF causes rapid cell cycle exit, and that chromatin reorganization during cell division is not required for NVOF-induced neuronal differentiation and maturation from SOX6+/NG2+ progenitors.</p><p>To more broadly investigate the molecular identity and specificity of neurons induced from cortical SOX6+/NG2+ progenitors transfected with NVOF, we performed RNA-seq on control GFP-transfected and NVOF-transfected cells at 7 DPT (n=3) (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A and B</xref>). NVOF-induced neurons have decreased expression of progenitor genes and increased expression of neuronal genes, relative to GFP-transfected cells (<xref ref-type="fig" rid="fig2">Figure 2M</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4C</xref>). Upregulated neuronal genes include proneural transcription factors, neuron-specific cytoskeletal molecules, and molecules that function in synaptic transmission, dendritic specialization, glutamatergic signaling, axon guidance, and neuronal connectivity (<xref ref-type="fig" rid="fig2">Figure 2P, Q</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4D</xref>). <italic>Neurog2</italic> is required for the differentiation of multiple neuronal types across regions of the nervous system and overexpression of <italic>Neurog2</italic> in somatic and stem cells generates neurons with mixed identities (<xref ref-type="bibr" rid="bib62">Hulme et al., 2022</xref>; <xref ref-type="bibr" rid="bib79">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Kempf et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Chouchane et al., 2017</xref>; <xref ref-type="bibr" rid="bib134">Sheta et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Ang et al., 2024</xref>). We, therefore, confirmed that NVOF-induced neurons express exclusively genes typical of glutamatergic neurons, but not genes specific for alternate neuronal types (e.g. GABAergic interneurons, striatal projection neurons, or serotonergic, dopaminergic, hindbrain, or spinal motor neurons) (<xref ref-type="fig" rid="fig2">Figure 2Q</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4E and N</xref>).</p><p>We co-cultured NVOF-transfected cells at 1 DPT with primary forebrain cells from mouse cortex in astrocyte-conditioned media (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3K</xref>) (see Methods) to investigate whether such a potentially permissive and/or instructive environment might even further enhance neuronal differentiation and maturation. It is known that neurons cultured below critical density, or in the absence of glial-derived trophic factors, often survive poorly and/or do not mature (<xref ref-type="bibr" rid="bib65">Kaech and Banker, 2006</xref>; <xref ref-type="bibr" rid="bib113">Pfrieger and Barres, 1997</xref>). Indeed, culture with primary neurons increased morphological maturation of NVOF-induced neurons, resulting in elaborate dendrites with abundant synapses (n=2) (<xref ref-type="fig" rid="fig3">Figure 3A–D</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3L–N</xref>), demonstrating synaptic input from surrounding neurons and functional integration into neuronal networks. Quite notably, the morphology and density of dendritic synapse-like structures in NVOF-induced neurons were essentially indistinguishable from those of primary cortical neurons cultured under identical conditions (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>NVOF-induced neurons are electrically active and have spontaneous synaptic currents.</title><p>(<bold>A–B</bold>) Representative high-magnification images of NVOF-induced neurons at 14 DPT (pseudo-colored GFP) with and without coculture of forebrain primary neurons and astrocyte-conditioned media. (<bold>A’-B’</bold>) Insets showing the boxed areas. Note differences in morphology of presumptive synaptic structures between the two conditions. See methods for details. (<bold>C</bold>) Representative high-magnification image of a primary cortical neuron at 14 DPT (pseudo-colored tdTomato) from <italic>in utero</italic> electroporated wild-type mice as a positive control. (<bold>C’</bold>) Note similarity in morphology of presumptive synaptic structures between primary neurons and NVOF-induced neurons in B’. See methods for details. (<bold>D</bold>) Representative high-magnification image of a SYNAPSIN-positive NVOF-induced neuron co-cultured with forebrain neurons, indicating abundant connections from surrounding neurons. Arrows show the presumptive single primary axon with no synapsin staining. (<bold>E</bold>) A representative NVOF-induced neuron at 10 DPT showing depolarizing steps evoking a train of action potentials (red highlighted trace: step 6, 50 pA). 10 min after break-in, or following a resting Vm stabilization greater than 1 min, cells were injected with 10 current steps ranging from –40 pA to 95 pA in 15 pA increments, for a duration of 500 ms each. (<bold>F</bold>) The first evoked action potential in response to positive current injections for 10 individual cells, overlaid (10 DPT). Waveforms are aligned at threshold for comparison. (<bold>G</bold>) Corresponding dV/dt traces for action potentials shown in F. (<bold>H</bold>) Representative sag current, indicating presence of Ih, induced with a 500 ms current injection of –40 pA (average of 10 sweeps). (<bold>I</bold>) Cell membrane resistance decreases over time (10 DPT, n=10; 16 DPT, n=10), and is substantially lower without NVOF (GFP, n=2). (<bold>J</bold>) Resting membrane voltage for each condition (10 DPT, n=10; 16 DPT, n=10; GFP, n=2). (<bold>K–M</bold>) Action potential threshold, amplitude, and width at 10 DPT (n=10) and 16 DPT (n=10). (<bold>N</bold>) Sag current at 10 DPT (n=9) and 16 DPT (n=8). (<bold>O</bold>) Representative spontaneous outward synaptic currents recorded at –70 mV in NVOF+ cells at 16 DPT. (<bold>P</bold>) Representative spontaneous inward synaptic currents recorded at –70 mV in NVOF-induced neurons at 16 DPT. Scale bars (<bold>A–D</bold>) 50 μm; (<bold>F</bold>) 50 mV; (<bold>G</bold>) 50 mV/ms. For all graphs I-N, open circles are individual cells, filled boxes are mean (<bold>±</bold>) s.e.m.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig3-v1.tif"/></fig><p>To investigate functional properties of NVOF-induced neurons, we performed whole-cell patch-clamp recordings at 10 DPT (without co-culture) and at 16 DPT (with primary neuron co-culture) (<xref ref-type="fig" rid="fig3">Figure 3E–P</xref>). Consistent with their immunocytochemical and morphological characteristics, NVOF-induced neurons possess electrophysiological hallmarks of neurons, including trains of action potentials upon depolarizing steps (<xref ref-type="fig" rid="fig3">Figure 3E–G</xref>), HCN-channel currents (Isag) upon hyperpolarization (<xref ref-type="fig" rid="fig3">Figure 3H</xref>), and spontaneous synaptic currents (<xref ref-type="fig" rid="fig3">Figure 3O and P</xref>). NVOF-induced neurons also mature over time in culture, with overall increases in the action potential threshold (–35.9 mV at 10 DPT versus –30.9 mV at 16 DPT) (<xref ref-type="fig" rid="fig3">Figure 3K</xref>), decreases in action potential width (2.1 ms at 10 DPT versus 1.3 ms at 16 DPT) (<xref ref-type="fig" rid="fig3">Figure 3M</xref>), and increases in Isag (3.4 mV at 10 DPT versus 12.1 mV at 16 DPT) (<xref ref-type="fig" rid="fig3">Figure 3N</xref>). Cortical SOX6+/NG2+ progenitors transfected with the control vector possess membrane resistances and resting voltages that are inconsistent with neuronal identity (<xref ref-type="fig" rid="fig3">Figure 3I and J</xref>).</p></sec><sec id="s2-5"><title>Vector-free induction of neuronal differentiation from cortical SOX6+/NG2+ progenitors with synthetic modified mRNAs</title><p>The results presented above reveal that NVOF-induced neurons express a quite comprehensive set of molecules that indicate faithful neuronal differentiation, and that they possess electrophysiological properties indistinguishable from those of primary neurons. However, previous work reports that sustained expression of <italic>Neurog2</italic> can be deleterious to differentiating cortical neurons (<xref ref-type="bibr" rid="bib16">Cai et al., 2000</xref>). To more closely reproduce the dynamics of developmental expression of <italic>Neurog2</italic>, we aimed to restrict <italic>Neurog2</italic> expression to a short, early time period using synthetic, chemically-modified RNA in which one or more nucleotides are replaced by modified nucleotides. Previous work, in multiple systems, has revealed that synthetic modified mRNA mediates highly efficient, integration-free, transient protein expression <italic>in vitro</italic> and <italic>in vivo</italic> without eliciting an innate immune response (<xref ref-type="bibr" rid="bib126">Sahin et al., 2014</xref>; <xref ref-type="bibr" rid="bib156">Warren et al., 2010</xref>).</p><p>In contrast to the transient expression of <italic>Neurog2</italic> during neurogenesis <italic>in vivo</italic>, cortical output neurons express <italic>Fezf2</italic> throughout development and adulthood (<xref ref-type="bibr" rid="bib99">Molyneaux et al., 2005</xref>). To emulate the distinct kinetics of endogenous developmental expression of <italic>Neurog2</italic> and <italic>Fezf2</italic>, we devised a strategy by which <italic>Neurog2</italic> is transiently expressed via synthetic modified mRNA, and <italic>Fezf2</italic> is expressed on an ongoing basis as a plasmid DNA construct with a constitutively active CAG promoter. We first adapted our transfection protocol to transfect cortical SOX6+/NG2+ progenitors with mRNA at high efficiency (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5A and B</xref>). To test the feasibility of DNA-RNA co-transfection, we co-transfected tdTomato as a plasmid DNA, and GFP as a synthetic modified mRNA (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5C</xref>). ~50% of fluorescent cells were co-transfected with both reporters (n=3). We investigated the dynamics of protein expression, finding that the GFP synthetic modified mRNA displays peak protein levels 12–24 hr post-transfection, then declines (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5D–G</xref>).</p><p>Next, we directly compared the efficacies of a <italic>Neurog2</italic> DNA construct and a <italic>Neurog2</italic> synthetic modified mRNA. Strikingly, confirming the neurogenic competency of cortical SOX6+/NG2+ progenitors, one dose of <italic>Neurog2</italic> synthetic modified mRNA induces robust neurogenesis, albeit with lower efficiency than <italic>Neurog2</italic> DNA or NVOF (n=3) (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5H and I</xref>). We then co-expressed <italic>Neurog2</italic> in synthetic modified mRNA form and <italic>Fezf2</italic> as a plasmid DNA construct. Remarkably, this combination of synthetic modified mRNA plus plasmid DNA produced abundant neurons morphologically indistinguishable from NVOF-induced neurons (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5J</xref>). These results reveal that synthetic modified mRNA transfection can be used to tailor more precise kinetics of developmental genes toward directed differentiation of neuronal subtypes.</p></sec><sec id="s2-6"><title>NVOF-induced neurons acquire molecular hallmarks of cortical output neuron identity <italic>in vitro</italic></title><p>We progressively focused our investigations to evaluate whether NVOF-induced neurons <italic>in vitro</italic> express cardinal molecular hallmarks of endogenous cortical output neurons, with a particular focus on the major output neuron subgroup of subcerebral projection neurons (SCPN, comprising neuronal subtypes that project to brainstem and spinal cord). Results reveal that ~58% of NVOF-induced neurons at 7 DPT express BCL11b/CTIP2, a transcription factor that regulates outgrowth, guidance, and fasciculation of SCPN/CSN axons (<xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>) (n=6, ave 177 cells/experiment) (<xref ref-type="fig" rid="fig4">Figure 4A, G and H</xref>), whereas no control GFP-only cells express CTIP2 (n=2, ave 207 cells/experiment). NVOF-induced neurons also express PCP4 (Purkinje cell protein 4), a calmodulin-binding protein reproducibly expressed by SCPN/CSN (<xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>) (~83% at 7 DPT, n=4, ave 131 cells/experiment) (<xref ref-type="fig" rid="fig4">Figure 4B, G and H</xref>). Importantly, the number of CTIP2+ NVOF-induced neurons continued to increase over time, indicating continued subtype differentiation after 7 DPT (<xref ref-type="fig" rid="fig4">Figure 4I</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>NVOF-induced neurons exhibit molecular hallmarks of corticospinal neurons <italic>in vitro</italic>.</title><p>(<bold>A–F</bold>) Representative immunocytochemistry images of NVOF-induced neurons expressing the subcerebral projection neuron (SCPN) transcriptional controls CTIP2 (<bold>A</bold>) and PCP4 (<bold>B</bold>), the corticothalamic projection neuron (CThPN) transcriptional controls FOG2 (<bold>C</bold>) and FOXP2 (<bold>D</bold>), but not the callosal projection neuron (CPN) molecular controls SATB2 (<bold>E</bold>) and CUX1 (<bold>F</bold>). Scale bars (<bold>A–F</bold>) 100 μm. (<bold>G</bold>) Percentage of NVOF-induced, TUJ1+ neurons expressing CTIP2 (56 ± 20%, n=5), PCP4 (77 ± 14%, n=3), FOG2 (81 ± 13%, n=3), and SATB2 (0%, n=3). Error bars show standard deviations. (<bold>H</bold>) Violin plot shows mean intensities of CTIP2, PCP4, and FOG2 fluorescence signals in nuclei of NVOF-induced neurons. Plotted values are mean nuclear intensity of individual neurons normalized to the average intensity of the three lowest-expressing neurons. Red line shows median expression, and dark gray lines show quartile expressions. (<bold>I</bold>) Bar plot showing percentages of CTIP2-negative, -dim, and -bright neurons at 1-, 3-, 7-, and 12-DPT (n=1). (<bold>J, K</bold>) Volcano plots and heatmaps of neurons transfected with control GFP and NVOF 7 DPT, displaying the 862 genes enriched in SCPN primary neurons compared to control-transfected cells. See methods for details. (<bold>L</bold>) Bar plot of RNA-seq data showing upregulation of SCPN (purple) and CThPN (blue) marker genes, and no activation or downregulation of CPN (green) genes by NVOF-induced neurons relative to neurons transfected with control GFP at 7 DPT.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig4-v1.tif"/></fig><p>Next, we investigated NVOF-induced neurons for expression of corticothalamic projection (CThPN) neuron-enriched molecular controls. Intriguingly, most NVOF-induced neurons express FOG2 (ZFPM2) (~79% at 7 DPT, n=4, ave 132 cells/experiment) (<xref ref-type="fig" rid="fig4">Figure 4C, G and H</xref>), a critical regulator of CThPN axonal targeting and diversity (<xref ref-type="bibr" rid="bib40">Galazo et al., 2016</xref>). However, FOXP2, a transcriptional control required for CThPN specification (<xref ref-type="bibr" rid="bib59">Hisaoka et al., 2010</xref>), is expressed heterogeneously by NVOF-induced neurons, with minimal to no expression by many neurons (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These data indicate that NVOF-induced neurons acquire broad cortical output neuronal identity, but refinement of subtype identity (SCPN vs. CThPN) is incomplete, suggesting that additional controls are required for complete subtype refinement.</p><p>We also investigated the possibility of subtype ‘confusion’ during directed differentiation by examining whether NVOF-induced neurons also or alternatively express cardinal molecular markers of callosal projection neurons (CPN) or other intra-cortical projection neurons. If identified, this would indicate either immature differentiation or mixed/hybrid identity that is commonly observed with ES/iPSC-derived neurons (<xref ref-type="bibr" rid="bib125">Sadegh and Macklis, 2014</xref>). Quite notably and appropriately, NVOF-induced neurons do not express SATB2 (0% at 7 DPT, n=4, ~130 cells/n) (<xref ref-type="fig" rid="fig4">Figure 4E and G</xref>) or CUX1 (n=3) (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), molecular controls that are expressed by CPN and other intracortical projection neurons.</p><p>Reinforcing and extending these ICC results, RNA-seq reveals that NVOF-induced neurons express many SCPN/CSN-enriched genes (<xref ref-type="fig" rid="fig4">Figure 4K</xref>) (see methods), including key molecules with central functions in subtype specification of SCPN/CSN (<xref ref-type="fig" rid="fig4">Figure 4L</xref>), along with some CThPN-enriched genes (e.g. <italic>Tbr1</italic>, <italic>Fog2</italic>, and <italic>Foxp2</italic>) (<xref ref-type="fig" rid="fig4">Figure 4L</xref>). In accordance with the ICC results, RNA-seq reveals that NVOF-induced neurons have no or minimal expression of genes specific to CPN or other intracortical projection neurons, including <italic>Satb2</italic>, <italic>Cux1</italic>, and <italic>Cux2</italic> (<xref ref-type="fig" rid="fig4">Figure 4L</xref>). Together, these results indicate that NVOF-induced neurons acquire cortical output neuron identity, primarily of SCPN/CSN, but with some CThPN features, without fully refining molecular identity between these subtypes of cortical output neurons (see Discussion).</p><p>We directly compared expression of key subtype-specific molecular controls between NVOF-induced and <italic>Neurog2</italic>-induced neurons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). While <italic>Neurog2</italic>-induced neurons approximate elements of NVOF induction, with some expression of cortical output neuron markers CTIP2, PCP4, and FOG2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), and not the CPN and other intracortical neuronal molecules, such as SATB2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>) and CUX1 (data not shown) by ICC, NVOF induction generated more neurons expressing CTIP2, PCP4, and FOG2, with higher average expression (n=&gt;3 for each marker) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>), indicating substantially enhanced subtype-specific differentiation by <italic>Fezf2</italic>. Reinforcing the interpretation from aberrant multipolar morphology of <italic>Neurog2</italic>-induced neurons that <italic>Neurog2</italic> alone induces ‘confused’ and unresolved differentiation (<xref ref-type="fig" rid="fig2">Figure 2J–L</xref>), <italic>Neurog2</italic>-induced neurons simultaneously express CTIP1 (BCL11a), a CPN molecular control and antagonist of CTIP2 (<xref ref-type="bibr" rid="bib45">Greig et al., 2016</xref>; <xref ref-type="bibr" rid="bib158">Woodworth et al., 2016</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–D</xref>). During cortical development, CTIP1 is initially expressed broadly by postmitotic neurons, but later, through its cross-repressive interaction with CTIP2, its expression resolves to CPN and CThPN, but not SCPN/CSN, at E17. Continued expression of CTIP1 by <italic>Neurog2</italic>-induced neurons further indicates incomplete and unresolved subtype differentiation.</p><p>To comprehensively and directly characterize subtype identities induced by NVOF compared with FACS-purified primary SCPN/CSN or the morphologically and molecularly ‘hybrid’ <italic>Neurog2</italic>-induced neurons, we performed RNA-seq on FACS-purified GFP+ neurons generated by NVOF or <italic>Neurog2</italic> at 7 DPT (n=3), and on FACS-purified SCPN/CSN or CPN from P2 mice (n=3) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Pearson correlation analysis for genes enriched in SCPN compared to CPN reveals that NVOF-induced neurons are substantially more similar to primary SCPN/CSN (<italic>R</italic>=0.87) than are <italic>Neurog2</italic>-induced neurons (<italic>R</italic>=0.77) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Even more strikingly, NVOF induces higher expression of many SCPN/CSN genes relative to <italic>Neurog2</italic> alone (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), while <italic>Neurog2</italic> simultaneously and aberrantly activates many typically CPN-specific genes that are expressed at E15 in mouse, the peak period of CPN birth and specification (<xref ref-type="fig" rid="fig5">Figure 5C</xref>; <xref ref-type="bibr" rid="bib100">Molyneaux et al., 2015</xref>). In particular, in line with the prior ICC results, NVOF-induced neurons express SCPN/CSN genes with known key functions in subtype-specific development of SCPN/CSN at higher levels (e.g. <italic>Ctip2</italic> and <italic>Ephb1</italic>, both essential for SCPN/CSN axon guidance) (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>; <xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>; <xref ref-type="bibr" rid="bib82">Lodato et al., 2014</xref>). NVOF-induced neurons express <italic>Lumican</italic> and <italic>Crim1</italic>, recently identified to be expressed highly selectively by bulbo-cervical and thoraco-lumbar CSN, respectively, and to regulate their segmentally specific axon targeting (<xref ref-type="bibr" rid="bib129">Sahni et al., 2021b</xref>; <xref ref-type="bibr" rid="bib128">Sahni et al., 2021a</xref>; <xref ref-type="bibr" rid="bib63">Itoh et al., 2023</xref>). In striking contrast, <italic>Neurog2</italic>-induced neurons express many cardinal CPN genes at higher levels (e.g. <italic>Epha3</italic> and <italic>Satb2</italic>, which both regulate CPN connectivity) (<xref ref-type="bibr" rid="bib1">Alcamo et al., 2008</xref>; <xref ref-type="bibr" rid="bib103">Nishikimi et al., 2011</xref>; <xref ref-type="fig" rid="fig5">Figure 5D and E</xref>), further reinforcing that <italic>Neurog2</italic> alone is insufficient for appropriate and resolved differentiation of SOX6+/NG2+ progenitors to cortical output identity.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Unlike NVOF-induced neurons, <italic>Neurog2</italic>-induced neurons exhibit unresolved subtype-specific molecular features.</title><p>(<bold>A</bold>) Pearson correlation analysis shows high similarity between NVOF-induced neurons at 7 DPT and primary subcerebral projection neuron (SCPN) at P2 (R: 0.87). Compared to NVOF, <italic>Neurog2</italic> induction (7 DPT) leads to decreased similarity with primary SCPN at P2 (R: 0.77). Data points are log2 fold differences of gene expression at 7 DPT by NVOF- or <italic>Neurog2</italic>-induced neurons (on X-axis) and by SCPN (on Y-axis) compared to progenitors transfected with control GFP. (<bold>B</bold>) Volcano plot showing fold differences of SCPN-enriched genes between NVOF- and <italic>Neurog2</italic>-induced neurons. (<bold>C</bold>) Volcano plot showing fold differences of CPN-enriched genes between NVOF- and <italic>Neurog2</italic>-induced neurons. (<bold>D, E</bold>) Direct comparison of NVOF- versus <italic>Neurog2</italic>-induced neurons at 7 DPT for select developmental genes with key roles in specification and differentiation of SCPN, CPN, and CThPN. Scatter plot (<bold>D</bold>) and bar graph (<bold>E</bold>) shows fold differences in gene expression.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>Neurog2</italic> is not sufficient to induce molecular hallmarks of cortical output neurons.</title><p>(<bold>A</bold>) Percentage of <italic>Neurog2</italic>- and NVOF-induced neurons expressing CTIP2, PCP4, FOG2, SATB2, and CTIP1 at 7 DPT. (<bold>B</bold>) Quantification of mean fluorescence intensity for CTIP2 (n=~700), PCP4 (n=~450), FOG2 (n=~450), and CTIP1 (n=~150) in <italic>Neurog2</italic>- and NVOF-induced neurons at 7 DPT. Plotted values are mean nuclear intensity of individual neurons normalized to the average intensity of the three lowest-expressing neurons. (<bold>C, D</bold>) Representative images of CTIP1 expression by <italic>Neurog2</italic>- (<bold>C</bold>) and NVOF-induced neurons (<bold>D</bold>). Scale bar (<bold>C, D</bold>) 100 μm. Error bars show standard deviations. ∗∗∗∗<italic>p</italic>&lt;0.0001, t-test in (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100340-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Together, these results highlight that optimized directed differentiation is achieved by emulating normal developmental steps of sequential subtype specification of neocortical neurons regulated by interactions between broad proneural programs and lineage-specific transcription factors with dynamic temporal expression and cross-regulatory activities.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In the work presented here, we first FACS-purify and characterize a subpopulation of postnatal cortical progenitors that are molecularly related to early developmental cortical projection neuron-specific progenitors. We next identify that developmental transcriptional controls can direct the differentiation of SOX6+/NG2+ cortical progenitors into CSN-like neurons <italic>in vitro</italic>. <italic>Fezf2</italic>, a molecular control over SCPN/CSN development, and transcriptional regulators <italic>Neurog2</italic> and <italic>VP16-Olig2</italic> (together, ‘NVOF’) are able to activate a dormant neurogenic program and overcome the default postnatal gliogenic differentiation program of these cortical progenitors. This directed differentiation generates neurons with a glutamatergic neuronal identity and specific morphologic, molecular, and electrophysiologic features of cortical output neurons resembling corticospinal/subcerebral projection neurons. Our results reveal that NVOF-directed neurons acquire the key molecular features of mature glutamatergic neurons (e.g. expression of NeuN, vGLUT1, CAMK2A, SYN1, SHANK1, and ionotropic and metabotropic glutamate receptors), a cortical projection neuron-like morphology with a single long NF-M+ primary axon and a MAP2+ apical dendrite-like process, the expression of molecular controls specific for SCPN/CSN (e.g. BCL11B/CTIP2, CRYM, EPHB1, and PCP4), and, importantly, do not express molecular markers of alternate fates (e.g. SATB2, BCL11A/CTIP1, CUX1, GABA, DARPP32, TH, 5HT, ISL1). We identify that these critical specifics of differentiation are not reproduced by commonly employed <italic>Neurog2</italic>-driven differentiation. Together, our work indicates that directed differentiation via combinatorial and complementary action of central developmental transcriptional controls enables previously inaccessible specificity in generating defined neuronal subtypes for cellular regeneration or disease modeling of degenerated or damaged neuronal circuitry.</p><sec id="s3-1"><title>In contrast to <italic>Neurog2</italic>-only activation, NVOF-directed neurons acquire multimodal CSN identity</title><p>The neurons differentiated by NVOF closely resemble <italic>bona fide</italic> corticospinal neurons. Direct transcriptomic comparison with primary SCPN/CSN reveals that NVOF-directed neurons express a large number of SCPN/CSN-enriched genes (<xref ref-type="fig" rid="fig4">Figure 4J and K</xref>), with close similarity to SCPN/CSN (<italic>R</italic>=0.87) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), and their unipolar somatodendritic-axonal morphology also closely resembles that of purified CSN (<xref ref-type="bibr" rid="bib109">Ozdinler and Macklis, 2006</xref>). In contrast to <italic>Neurog2-</italic>induced neurons, NVOF-directed neurons express multiple genes that typically identify CSN specifically. These include the general indicator <italic>Crymu,</italic> as well as <italic>Lumican</italic> and <italic>Crim1</italic>, expressed highly selectively by bulbo-cervical and thoraco-lumbar CSN, respectively, and regulate their segmentally specific axon targeting (<xref ref-type="bibr" rid="bib129">Sahni et al., 2021b</xref>; <xref ref-type="bibr" rid="bib128">Sahni et al., 2021a</xref>; <xref ref-type="bibr" rid="bib63">Itoh et al., 2023</xref>). Quite importantly, NVOF-directed neurons do not display substantial enrichment of key CPN-specific molecular controls (<xref ref-type="fig" rid="fig5">Figure 5C–E</xref>), indicating that they do not acquire ‘mixed,’ ‘confused’ identity. This is all in stark contrast to <italic>Neurog2</italic>-only induced neurons, which display aberrant multipolar morphology, mixed transcriptomic signatures, and substantial co-expression of what are normally developmentally exclusionary differentiation regulators and CPN+SCPN molecular signatures.</p><p>While <italic>Neurog2</italic> is expressed dynamically in cortical progenitors during generation of major neuronal subtypes (<xref ref-type="bibr" rid="bib13">Britz et al., 2006</xref>), <italic>Neurog2</italic> knockout does not show significant perturbations to the expression of molecular hallmarks of these neurons (<xref ref-type="bibr" rid="bib49">Hand and Polleux, 2011</xref>; <xref ref-type="bibr" rid="bib27">Dennis et al., 2017</xref>). <italic>Neurog2</italic> misexpression by electroporation during the production of superficial layers does not induce characteristic molecular features of deep layer neurons, although a subset of axons of the transfected neurons are re-directed to the ventral telencephalon (<xref ref-type="bibr" rid="bib27">Dennis et al., 2017</xref>). Conversely, genetic deletion of <italic>Neurog2</italic> or shRNA knockdown of <italic>Neurog2</italic> from superficial layer intracortical neurons results in variable defects of midline crossing as well as misrouting of callosal axons toward aberrant cortical and subcortical targets (<xref ref-type="bibr" rid="bib49">Hand and Polleux, 2011</xref>). Together, these data suggest that <italic>Neurog2</italic> has only a limited lineage-instructive role over specification of cortical output neurons.</p><p><italic>Neurog2</italic> is also expressed by progenitors of spinal motor neurons, sensory neurons, and dopaminergic neurons in the mammalian brain, and regulates their specification and differentiation (<xref ref-type="bibr" rid="bib62">Hulme et al., 2022</xref>). Therefore, it is conceivable that <italic>Neurog2</italic> expression will induce a subset of its genomic targets depending on the starting cell population, culture conditions, or <italic>in vivo</italic> context. In agreement with this hypothesis, recent reports have identified mixed subtype features in neurons generated from ES/iPS cells by <italic>Neurog2</italic> alone (<xref ref-type="bibr" rid="bib79">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Ang et al., 2024</xref>; <xref ref-type="bibr" rid="bib22">Chen et al., 2020</xref>). Several approaches, including pre-patterning of progenitors, combinatorial expression of a cocktail of transcription factors, temporal control of <italic>Neurog2</italic> expression, induction of signaling pathways with small molecules, and co-culture with astrocytes, have been successfully used to sharpen cell fate specification (<xref ref-type="bibr" rid="bib79">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Ang et al., 2024</xref>; <xref ref-type="bibr" rid="bib22">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib122">Rosa et al., 2020</xref>). Consistent with these results, our NVOF transcriptional regulator combination robustly generates cortical output neuron-like cells compared to <italic>Neurog2</italic> alone.</p><p>Intriguingly, even though NVOF-directed neurons acquire both type-specific identity of cortical output neurons, and highly specific indicators of CSN identity, they do not fully resolve the subtype-specific identities of purely subcerebral vs. corticothalamic (CThPN) neurons. They express <italic>Fog2</italic> and <italic>Tbr1</italic>, markers of corticothalamic neurons that are not normally expressed by most mature SCPN/CSN. SCPN and CThPN together comprise cortical output neurons. SCPN and CThPN are located in deep cortical layers V and VI, respectively, and both subtypes send their axons away from cortex via the internal capsule. Not only do these two subtypes share predominant portions of the molecular developmental programs regulating their specification, post-mitotic differentiation, and axon guidance, but approximately 5% are dual SCPN-CThPN that express both high-level <italic>Bcl11b</italic>/<italic>Ctip2</italic> and <italic>Fog2</italic>, and that send dual projections to both thalamus and subcerebral targets (<xref ref-type="bibr" rid="bib40">Galazo et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Galazo et al., 2023</xref>). These dual-projecting neurons are thought to ‘share’ cortical output information with multiple targets for sensorimotor integration. It is possible that the neurons generated here by NVOF-directed differentiation are dual SCPN-CThPN. Recent results identify that the non-DNA-binding transcriptional co-repressor TLE4 forms a complex with transcription factor FEZF2 to epigenetically regulate <italic>Fezf2</italic> expression levels and thus the balance between SCPN and CThPN molecular and projection identity at least through the first postnatal week in mouse (<xref ref-type="bibr" rid="bib41">Galazo et al., 2023</xref>). This delineation between SCPN and CThPN follows multiple earlier regulatory steps, e.g., the control by the transcription factor SOX5 over sequential generation of CThPN and SCPN by progressively de-repressing <italic>Fezf2</italic> expression. Thus, resolution between SCPN and CThPN subtypes normally occurs progressively through late differentiation <italic>in vivo</italic>.</p><p>More broadly, differential expression of key controls in terms of both their levels and timing of expression, in addition to combinatorial co-expression with other key regulators, delineates differentiation of cortical projection neurons into progressively distinct subtypes with distinct targets and functional circuitry (<xref ref-type="bibr" rid="bib44">Greig et al., 2013</xref>; <xref ref-type="bibr" rid="bib111">Ozkan et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Greig et al., 2016</xref>; <xref ref-type="bibr" rid="bib158">Woodworth et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Galazo et al., 2016</xref>; <xref ref-type="bibr" rid="bib94">McKenna et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Han et al., 2011</xref>; <xref ref-type="bibr" rid="bib76">Lai et al., 2008</xref>). For example, <italic>Fezf2</italic> and <italic>Ctip2</italic> are expressed more highly by SCPN/CSN relative to CThPN, but both subtypes are severely affected by loss of <italic>Fezf2</italic> function (<xref ref-type="bibr" rid="bib99">Molyneaux et al., 2005</xref>; <xref ref-type="bibr" rid="bib58">Hirata et al., 2004</xref>). In this normal developmental context, the partially unresolved state of NVOF-directed neurons might represent a mid-developmental stage of subtype identity acquisition, since early during normal development many molecular controls are expressed broadly, and their expression progressively resolves over time to produce more highly subtype-restricted expression in postnatal cortex (<xref ref-type="bibr" rid="bib8">Azim et al., 2009b</xref>; <xref ref-type="bibr" rid="bib19">Cederquist et al., 2013</xref>). Consistent with this interpretation, the observed increase of <italic>Ctip2</italic> expression over time by NVOF-directed neurons (<xref ref-type="fig" rid="fig4">Figure 4I</xref>) suggests ongoing subtype identity refinement.</p><p>An additional factor in the incomplete delineation of NVOF-directed neurons into SCPN/CSN might be the constitutive expression of <italic>Neurog2. Neurog2</italic> expression is normally dynamically regulated in neural progenitors (<xref ref-type="bibr" rid="bib136">Shimojo et al., 2011</xref>). In addition to its well-established role in activation of proneural genes, <italic>Neurog2</italic> might activate some neuronal subtype-specific genes, such as <italic>Fog2</italic> and <italic>Ctip2</italic> (<xref ref-type="bibr" rid="bib92">Mattar et al., 2008</xref>; <xref ref-type="bibr" rid="bib72">Kovach et al., 2013</xref>). In this context, co-expression of <italic>Fog2</italic> and <italic>Ctip2</italic> by NVOF-directed neurons might be due, at least in part, to constitutive <italic>Neurog2</italic> expression. To begin to overcome this issue, we applied synthetic modified RNA to enable fine-tuning of both level and temporal dynamics of expression of <italic>Neurog2</italic> and observed robust neuronal induction. The regulation of both level and temporal dynamics of expression during normal development suggests that level- and temporal-controlled expression of <italic>Neurog2</italic> coupled with sustained expression of <italic>Fezf2</italic> (<italic>Fezf2</italic> is expressed constitutively by SCPN/CSN <italic>in vivo</italic>) might enable more refined differentiation of SCPN/CSN from SOX6+/NG2+ progenitors.</p><p>Yet another contributing factor to the lack of full SCPN-CThPN delineation of NVOF-directed neurons might be that the basic neuronal induction medium lacks critical extrinsic factors (e.g. diffusible morphogens and growth factors) required for full neuronal maturation and identity refinement. We and others have reported similar but more severe ‘stalling’ of developmental maturation of ES cell-derived cortical-like neurons under standard culture conditions (<xref ref-type="bibr" rid="bib125">Sadegh and Macklis, 2014</xref>). Supporting this hypothesis, co-culture of NVOF-directed neurons with primary cortical cells (including glia), and in the presence of astrocyte-conditioned medium, improves their survival and both morphological and electrophysiological maturation (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Taken together, independent regulation over both level and temporal dynamics of individual transcription factor expression, along with culture in optimized induction medium, might likely generate neurons with even further refined identities and distinction between closely related subtypes.</p></sec><sec id="s3-2"><title>SOX6+/NG2+ progenitors are a subset of cortical ‘NG2 progenitors’ with distinct molecular and functional features</title><p>The broad group of cells often collectively characterized by shared expression of NG2 proteoglycan constitute ~2–3% of neural cells in adult rodent cortex, and are the primary proliferative cell group from early postnatal stages through adulthood and in the aged CNS (<xref ref-type="bibr" rid="bib25">Dawson et al., 2003</xref>; <xref ref-type="bibr" rid="bib60">Huang et al., 2020</xref>). Recent work reveals that this broad group of ‘NG2 progenitors’ is not a homogeneous population; rather, it consists of at least several subpopulations with distinct molecular, cellular, and functional properties (<xref ref-type="bibr" rid="bib155">Viganò and Dimou, 2016</xref>; <xref ref-type="bibr" rid="bib20">Chamling et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Fang et al., 2023</xref>; <xref ref-type="bibr" rid="bib91">Marisca et al., 2020</xref>; <xref ref-type="bibr" rid="bib139">Spitzer et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Sánchez-González et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Janeckova et al., 2024</xref>; <xref ref-type="bibr" rid="bib71">Kirdajova et al., 2021</xref>; <xref ref-type="bibr" rid="bib153">Tsoa et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Hilscher et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Floriddia et al., 2020</xref>). While some NG2-expressing progenitors generate oligodendrocytes throughout life, most of them do not differentiate and remain proliferative in the cortex (<xref ref-type="bibr" rid="bib61">Hughes et al., 2013</xref>; <xref ref-type="bibr" rid="bib131">Sánchez-González et al., 2020</xref>). A subset of these cells generates protoplasmic astrocytes in the ventral forebrain and spinal cord (<xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref>; <xref ref-type="bibr" rid="bib165">Zhu et al., 2008b</xref>), and a smaller subset has been reported to generate neurons in the piriform cortex (<xref ref-type="bibr" rid="bib119">Rivers et al., 2008</xref>; <xref ref-type="bibr" rid="bib46">Guo et al., 2010</xref>) and dorsolateral cortex (<xref ref-type="bibr" rid="bib64">Janeckova et al., 2024</xref>).</p><p>During development, diverse sets of NG2-expressing progenitors arise from anatomically and molecularly distinct dorsal and ventral proliferative zones in sequential waves (<xref ref-type="bibr" rid="bib81">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Kessaris et al., 2006</xref>). A substantial proportion of the NG2-expressing progenitors in the cortex (~80% in postnatal rodents) share a common lineage with cortical projection neurons in mice (<xref ref-type="bibr" rid="bib151">Tripathi et al., 2011</xref>) and are thus exposed to the same morphogen gradients and epigenetic landscaping. This shared origin and molecular history provides a strong developmental basis for understanding mechanistically why these SOX6+/NG2+ cortical progenitors that originate from the dorsal (pallial) cortical proliferative zone might be especially competent for directed differentiation into cortical projection neurons, and cortical output neurons in particular.</p><p>Of particular note with regard to potential regenerative applications, repopulation of degenerated or injured neurons in particular, SOX6+/NG2+ progenitors, like NG2-expressing progenitors more broadly, are widely distributed in cortex in a tiled manner. Furthermore, progenitors lost due to differentiation or cell death are replenished by cell division and migration of neighboring progenitors (<xref ref-type="bibr" rid="bib61">Hughes et al., 2013</xref>; <xref ref-type="bibr" rid="bib152">Trotter et al., 2010</xref>). Thus, SOX6+/NG2+ progenitors are already positioned local to sites of existing neuron degeneration or other pathology, thus theoretically avoiding the need for long-distance migration and appropriate positioning that would be necessary for transplanted exogenous progenitors, induced neurons, or spatially restricted adult neuronal progenitors from adult neurogenic regions, such as the anterior subventricular zone or hippocampal dentate gyrus. This broad, tiled distribution adds substantially to their potential for cellular repopulation and regenerative approaches.</p></sec><sec id="s3-3"><title>Cortical SOX6+/NG2+ progenitors are developmentally poised to generate projection neurons</title><p>Our finding that loss of <italic>Sox6</italic> de-represses the proneural gene <italic>Neurog2</italic> strongly indicates that <italic>Sox6</italic> continues to function importantly in regulation of proneural genes in cortical progenitors postnatally, and that SOX6+/NG2+ progenitors actively suppress neurogenic potential. Our observation of <italic>Neurog2</italic> de-repression in the absence of <italic>Sox6</italic> function suggests that downregulation of <italic>Sox6</italic> might be considered as an additional or an alternate molecular regulator for future directed differentiation experiments. Reinforcing this interpretation, even transient expression of <italic>Neurog2</italic> alone via a single dose of synthetic modified mRNA is sufficient to induce TUJ1+ neurons (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5H</xref>), and, upon NVOF expression, substantial numbers of progenitors lose progenitor features and acquire unipolar neuronal morphology by 3 days post-transfection (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Furthermore, and quite remarkably, over-expression of the SCPN/CSN-molecular control <italic>Ctip2</italic> (which has no known proneural function) in SOX6+/NG2+ progenitors is sufficient to induce unipolar neuronal morphology, TUJ1 expression, and down-regulation of glial genes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F and G</xref>). Together, these results indicate that SOX6+/NG2+ progenitors have substantial competence to differentiate into neurons and that they are at a relatively advanced stage of progenitor fate acquisition.</p><p>Directed differentiation of type- or subtype-specific neurons from a developmentally related population of local progenitors might encounter fewer epigenetic blocks than with stem cell or less closely related progenitor populations, thus resulting in improved functional differentiation of type- or subtype-specific neurons (<xref ref-type="bibr" rid="bib55">Herrero-Navarro et al., 2021</xref>). Recent studies have documented that residual transcriptional, epigenetic, and chromatin domain signatures specific to cells of origin persist during derivation of iPSCs, e.g., especially during early passages (<xref ref-type="bibr" rid="bib114">Polo et al., 2010</xref>; <xref ref-type="bibr" rid="bib10">Beagan et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Krijger et al., 2016</xref>). Such bias and/or blockade is likely to be suboptimal for differentiation of functional type- or subtype-specific neurons, and thus for either functional regeneration or reliable modeling of pathology. Circumstantially supporting this view of persistent effects of cellular origin, reprogramming of fibroblasts to neuronal lineage occurs at a much lower efficiency and more slowly compared to reprogramming of cultured postnatal astrocytes (<xref ref-type="bibr" rid="bib102">Ninkovic and Götz, 2015</xref>), or to our results reported here. Intriguingly, we find that cortical SOX6+/NG2+ progenitors transfected with the single factor <italic>Fezf2</italic> acquire a hybrid morphology, preserving glia-like cell body morphology while developing a neuron-like, single, long primary neurite (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>). These results suggest incomplete and heterogeneous neuronal induction. Since <italic>Fezf2</italic> has no known proneuronal function, and since it functions centrally in specification and differentiation of cortical output neurons with long axons, it is possible that some of the <italic>Fezf2</italic>’s target genes and their regulatory domains remain epigenetically accessible in cortical SOX6+/NG2+ progenitors. This partial, seemingly hybrid, differentiation driven by <italic>Fezf2</italic> alone further reinforces both the competency of SOX6+/NG2+ progenitors to differentiate relatively efficiently into cortical output projection neurons and the need for multi-component regulation to guide cortical output projection neuron differentiation while suppressing alternative fates and enhancing cell type distinction.</p></sec><sec id="s3-4"><title>Summary</title><p>The work reported here substantially and uniquely advances the goal of induction of neurogenesis and directed differentiation of subtype-specific neurons from endogenous adult progenitors. We first identify the SOX6+/NG2+ cortical progenitor population and employ genetic access to pure cultures of these progenitors. We then develop NVOF, a first-generation multi-component transcriptional regulatory construct, that induces cortical output neuron-directed differentiation while suppressing the otherwise default glial differentiation pathway. We next identify that NVOF-directed neurons derived from SOX6+/NG2+ cortical progenitors differentiate with remarkable fidelity to <italic>bona fide in vivo</italic> cortical output neurons with appropriate morphological, molecular, deep transcriptomic, and electrophysiological characteristics. Furthermore, these neurons do not display characteristics of alternative neuron types, most notably not even of closely related non-output-neuron cortical projection neurons. This sharp subtype delineation is in striking contrast to previously developed approaches (e.g. fibroblast or iPSC-derived iNs, or glial-derived neuron-like cells) that generate much more ‘generic’ neuron-like cells with mixed molecular identity, multipolarity, and often continued expression of some genes residual from the cells of origin, further confusing the output cellular identity (<xref ref-type="bibr" rid="bib6">Autar et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Cao et al., 2017</xref>; <xref ref-type="bibr" rid="bib97">Miskinyte et al., 2017</xref>; <xref ref-type="bibr" rid="bib70">Kim et al., 2010</xref>). Instead, SOX6+/NG2+ cortical progenitor-derived neurons closely resemble corticospinal/subcerebral projection neurons with some hybrid corticothalamic molecular markers (the two dominant and developmentally closely related subtypes of the specialized cortical output neurons), reminiscent of the ~5% population of CSN/SCPN <italic>in vivo</italic> with hybrid corticothalamic molecular and projection features. Together, this developmentally based directed differentiation from developmentally appropriate adult cortical progenitors sets a precedent and foundation for future optimizations of combinatorial levels, order, temporal dynamics, and subcellular localizations of an appropriate set of molecular controls over subtype-specific neuronal differentiation for <italic>in vitro</italic> mechanistic and therapeutic disease modeling, and toward regenerative neuronal repopulation and circuit repair.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">CD1 wild-type</td><td align="left" valign="bottom">Charles River Laboratories (Wilmington, MA)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used for all baseline and crossbreeding experiments</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">NG2.DsRed.BAC</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock# 008241; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:008241">IMSR_JAX:008241</ext-link></td><td align="left" valign="bottom">Generated by <xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref>; <xref ref-type="bibr" rid="bib165">Zhu et al., 2008b</xref>; used for isolation of NG2+ progenitors</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Sox6 knockout</td><td align="left" valign="bottom">Gift from V. Lefebvre (Cleveland Clinic)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Maintained on C57BL/6 and outcrossed into CD1 background</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">NG2-DsRed+ progenitors</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">FACS purification from NG2.DsRed transgenic mice.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BrdU</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">B5002</td><td align="left" valign="bottom">(50 µg/mg/injection or 1.5 mg/mL in drinking water)</td></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">pCBIG plasmid (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Gift from C. Lois (Caltech)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CMV/β-actin promoter-driven plasmid for expression constructs</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">NVOF construct (GFP-Neurog2-VP16:Olig2-Fezf2-HA)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Created by cloning coding sequences into pCBIG vector with 2A linkers</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pORFin / pORFinB</td><td align="left" valign="bottom">D. Rossi Lab (Boston Children’s Hospital)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Vectors used for synthetic mRNA cloning and <italic>in vitro</italic> transcription</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Kynurenic acid</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">K3375</td><td align="left" valign="bottom">Used in dissection and dissociation medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DL-2-amino-5-phosphonopentanoic acid (APV)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A5282</td><td align="left" valign="bottom">Used in dissection and dissociation medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DL-Cysteine hydrochloride</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C9768</td><td align="left" valign="bottom">Used in enzymatic dissociation medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Papain</td><td align="left" valign="bottom">Worthington</td><td align="left" valign="bottom">LS003126</td><td align="left" valign="bottom">Used in cortical dissociation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DNAse I</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D5025</td><td align="left" valign="bottom">Used in enzymatic digestion for dissociation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Poly-D-lysine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P0899</td><td align="left" valign="bottom">Substrate coating for cell culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Laminin</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">23017015</td><td align="left" valign="bottom">Used in cell culture substrate coating</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Poly-L-ornithine</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">A-004-C</td><td align="left" valign="bottom">Used for coating cover glasses</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fugene 6</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Transfection reagent for DNA and RNA</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PDGF-A</td><td align="left" valign="bottom">Peprotech</td><td align="left" valign="bottom">315–17</td><td align="left" valign="bottom">10 ng/mL in growth medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FGF2</td><td align="left" valign="bottom">Peprotech</td><td align="left" valign="bottom">450–33</td><td align="left" valign="bottom">10–20 ng/mL in growth medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EGF</td><td align="left" valign="bottom">Peprotech</td><td align="left" valign="bottom">315–09</td><td align="left" valign="bottom">20 ng/mL in growth medium</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI stain</td><td align="left" valign="bottom">SouthernBiotech</td><td align="left" valign="bottom">0100–20</td><td align="left" valign="bottom">Used for nuclear staining</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Alexa Fluor 555-conjugated Cholera Toxin</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">C22843</td><td align="left" valign="bottom">Retrograde labeling of neurons</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Superscript IV First-Strand Synthesis System</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">18090050</td><td align="left" valign="bottom">Used for cDNA synthesis</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Random Hexamers</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">SO142</td><td align="left" valign="bottom">Used for cDNA priming</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">iTaq Universal Sybr Green Supermix</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used for qPCR</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy Plus Mini Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">74134</td><td align="left" valign="bottom">RNA isolation with gDNA elimination step</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Kapa mRNA HyperPrep Kit</td><td align="left" valign="bottom">Roche (formerly Kapa Biosystems)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used for library prep (14 cycles, PolyA enrichment)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Kapa qPCR Library Quantification Kit</td><td align="left" valign="bottom">Kapa Biosystems</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Library quantification prior to sequencing</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ANK3 (ANKYRIN-G) (Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-12719; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_626674">AB_626674</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BrdU (Rat monoclonal)</td><td align="left" valign="bottom">AbD Serotec</td><td align="left" valign="bottom">OBT0030; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2313756">AB_2313756</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CSPG4 (NG2) (Rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">AB5320; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_91789">AB_91789</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CTIP2 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab28448; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1140055">AB_1140055</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CTIP2 (Rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab18465; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2064130">AB_2064130</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CUX1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-13024; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2261231">AB_2261231</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-DARPP32 (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">2306 S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_823479">AB_823479</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FOG2 (Rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-10755; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2218978">AB_2218978</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FOXP2 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab16064; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2314424">AB_2314424</ext-link></td><td align="left" valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GABA (Mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A0310; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_476667">AB_476667</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFAP (Mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G3893; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_477010">AB_477010</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFAP (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G9269; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_477035">AB_477035</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A10262; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2534023">AB_2534023</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (Rabbit polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A11122; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_221569">AB_221569</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HA (Mouse monoclonal)</td><td align="left" valign="bottom">Covance</td><td align="left" valign="bottom">MMS-101R; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_291262">AB_291262</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ISL1 (Mouse monoclonal)</td><td align="left" valign="bottom">Novus</td><td align="left" valign="bottom">H00003670; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_539948">AB_539948</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MAP2 (Mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">M1406; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_477171">AB_477171</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NESTIN (Chicken polyclonal)</td><td align="left" valign="bottom">Novus</td><td align="left" valign="bottom">NB100-1604; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2282642">AB_2282642</ext-link></td><td align="left" valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NeuN (Mouse monoclonal)</td><td align="left" valign="bottom">Chemicon</td><td align="left" valign="bottom">MAB377; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2298772">AB_2298772</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NF-M (Rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">AB1987; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_91201">AB_91201</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NEUROG2 (Mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">MAB3314; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2149520">AB_2149520</ext-link></td><td align="left" valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-OLIG2 (Goat polyclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">AF2418; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2157554">AB_2157554</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RFP (Rat monoclonal)</td><td align="left" valign="bottom">Antibodies-online</td><td align="left" valign="bottom">ABIN334653; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10795839">AB_10795839</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PCP4 (Rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">14705–1-AP; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2878075">AB_2878075</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PDGFRB (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">3169; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2878075">AB_2878075</ext-link></td><td align="left" valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PSA-NCAM (Mouse monoclonal)</td><td align="left" valign="bottom">Chemicon</td><td align="left" valign="bottom">MAB5324; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_95211">AB_95211</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SATB2 (Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab51502; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_882455">AB_882455</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SATB2 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab34735; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2301417">AB_2301417</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SOX6 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab30455; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1143033">AB_1143033</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SOX10 (Goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-17342; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2195374">AB_2195374</ext-link></td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SYNAPSIN (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">106 002; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_887804">AB_887804</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SYNAPTOPHYSIN (Mouse monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">MAB5258; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2313839">AB_2313839</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TH (Rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">AB152; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_390204">AB_390204</ext-link></td><td align="left" valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TUBB3 (Tuj1) (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">T2200; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_262133">AB_262133</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TUBB3 (Tuj1) (Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">MMS-435P; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2313773">AB_2313773</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-vGLUT1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">135 302; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_887877">AB_887877</ext-link></td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-2A peptide (Rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">ABS31; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_11214282">AB_11214282</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-5HT (Rabbit polyclonal)</td><td align="left" valign="bottom">Immunostar</td><td align="left" valign="bottom">20080; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_572263">AB_572263</ext-link></td><td align="left" valign="bottom">(1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa-Fluor-conjugated Secondary Antibodies (various hosts)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom"/><td align="left" valign="bottom">(1:1000); Used for ICC</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Positive Control tissue samples</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used to validate ICC</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Nikon NIS Elements</td><td align="left" valign="bottom">Nikon</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014329">SCR_014329</ext-link></td><td align="left" valign="bottom">Image acquisition and quantification</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 8</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom">Statistical analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio (v1.3.959)</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_000432">SCR_000432</ext-link></td><td align="left" valign="bottom">Data analysis and visualization</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FASTQC</td><td align="left" valign="bottom">Babraham Institute</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014583">SCR_014583</ext-link></td><td align="left" valign="bottom">Sequencing quality control</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Dobin et al., 2013</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015899">SCR_015899</ext-link></td><td align="left" valign="bottom">Alignment of RNA-seq reads</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib85">Love et al., 2014</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015687">SCR_015687</ext-link></td><td align="left" valign="bottom">Differential expression analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">PANTHER database</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib95">Mi et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_004869">SCR_004869</ext-link></td><td align="left" valign="bottom">GO enrichment analysis</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Nanoject II</td><td align="left" valign="bottom">Drummond</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Retrograde labeling of neurons</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Vevo 770 ultrasound backscatter microscopy system</td><td align="left" valign="bottom">VisualSonics</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Retrograde labeling of neurons</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">FACSAria II Cell sorter</td><td align="left" valign="bottom">Becton Dickinson</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Isolation of NG2-DsRed+progenitors</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Aspirator Tube for electroporation</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">A5177</td><td align="left" valign="bottom">Plasmid <italic>in utero</italic> electroporation</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">CUY21edit Electroporator</td><td align="left" valign="bottom">Bex Co. Ltd</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Plasmid <italic>in utero</italic> electroporations</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>All mouse studies were approved by the Harvard University IACUC and were performed in accordance with institutional and federal guidelines. The date of vaginal plug detection was designated embryonic day (E) 0.5, and the day of birth as postnatal day (P) 0. Wild-type CD1 mice were purchased from Charles River Laboratories (Wilmington, MA). The NG2.DsRed.BAC mouse line was generated by Nishiyama and colleagues (<xref ref-type="bibr" rid="bib164">Zhu et al., 2008a</xref>) and was procured from Jackson Laboratories (stock number: 008241). <italic>Sox6</italic> knockout mouse was the generous gift of V. Lefebvre (Cleveland Clinic) (<xref ref-type="bibr" rid="bib137">Smits et al., 2001</xref>) and was maintained on a C57BL/6 background and separately crossed into an outbred CD1 background. Most <italic>Sox6</italic> knockout embryos on a c57 background die perinatally (<xref ref-type="bibr" rid="bib7">Azim et al., 2009a</xref>), while outcrossing into the CD1 background resulted in live <italic>Sox6</italic> knockout pups. These pups survived for several days, developed poor body condition, and died by about P14. Male and female pups were included in all retrolabeling, FACS purification, and culture experiments. All mice were maintained in standard housing conditions on a 12 hr light/dark cycle with food and water <italic>ad libitum</italic>. A maximum of four adult animals were housed per cage.</p><p>All mouse studies were approved by the Harvard University IACUC (protocol numbers HU IACUC # 11-19-4 and HU IACUC ID # 11-22-2) and were performed in accordance with institutional and federal guidelines.</p></sec><sec id="s4-2"><title>BrdU labeling</title><p>To cumulatively label dividing cells in the cortex at P7 and P28, BrdU (Sigma, B5002) was injected intraperitoneally from P3 to P7 or from P23 to P28 (50 µg/mg/injection). To cumulatively label slowly dividing and/or quiescent populations in adult brain, BrdU was added to drinking water for 4–6 weeks (1.5 mg/mL). Brains were collected at corresponding ages and processed for BrdU immunocytochemistry.</p></sec><sec id="s4-3"><title>Plasmids</title><p>CMV/β-actin promoter-driven plasmid pCBIG (derived from CBIG, a gift from C. Lois, Caltech) was used to drive expression of IRES-GFP (control), single factors (<italic>Ctip2</italic>, <italic>Neurog2</italic>, <italic>VP16:Olig2</italic>, <italic>Fezf2-HA</italic>, and tdTomato) or NVOF construct. The NVOF construct was created by cloning GFP, <italic>Neurog2</italic>, <italic>VP16-Olig2</italic>, and <italic>Fezf2-HA</italic> coding sequences separated by 2A linker sequences into a pCBIG vector (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In this system, genes linked to each other via viral 2A sites are transcribed as a single mRNA, but are translated into individual polypeptides (<xref ref-type="bibr" rid="bib145">Tang et al., 2009</xref>; <xref ref-type="bibr" rid="bib29">Donnelly et al., 2001</xref>; <xref ref-type="bibr" rid="bib144">Szymczak et al., 2004</xref>). For synthetic modified mRNA synthesis, GFP, RFP, <italic>Fezf2-HA</italic>, and <italic>Neurog2</italic> open reading frames were cloned into pORFin or pORFinB vectors (from D. Rossi Lab, HSCRB and Boston Children’s Hospital). pORFin vectors had the appropriate 5’ and 3’ UTR sequences flanking the cloning sites, and an upstream T7 promoter for <italic>in vitro</italic> transcription. RNA was synthesized in accordance with a published protocol (<xref ref-type="bibr" rid="bib90">Mandal and Rossi, 2013</xref>).</p></sec><sec id="s4-4"><title>Purification and culture of cortical SOX6+/NG2+ progenitors</title><p>Heterozygous offspring pups (P2-P5) from the NG2-DsRed male and wild-type CD1 female crosses were used for FACS experiments. Pups were screened for red fluorescence under a dissecting microscope (Nikon, SMZ-1500) and anesthetized on ice. Brains were dissected, and meninges were removed in ice-cold Hank’s buffered salt solution (HBSS) (Gibco, 14025092). Neocortices were micro-dissected in ice-cold dissociation medium (pH 7.35), composed of 20 mM glucose (Sigma, G6152), 0.8 mM kynurenic acid (Sigma, K3375), 0.05 mM DL-2-amino-5-phosphonopentanoic acid (APV) (Sigma, A5282), 100 U/ml penicillin - 100 µg/ml streptomycin (Gibco, 15140122), 0.09 M Na<sub>2</sub>SO<sub>4</sub>, 0.03 M K<sub>2</sub>SO<sub>4</sub>, and 0.014 M MgCl<sub>2</sub> (pH 7.35±0.02). Dissected cortices were enzymatically digested in dissociation medium containing 0.16 mg/ml DL-Cysteine hydrochloride (Sigma, C9768), 10 U/ml papain (Worthington, LS003126), and 30 U/ml DNAse I (Sigma, D5025) at 37 °C for 30 min, rinsed two times with ice-cold OptiMEM (Gibco, 51985034), and supplemented with 20 mM glucose, 0.4 mM kynurenic acid, and 0.025 mM APV to protect against glutamate-induced neurotoxicity (<xref ref-type="bibr" rid="bib18">Catapano et al., 2001</xref>). Digested cortices were mechanically dissociated by gentle trituration using fire-polished glass Pasteur pipets to create a single-cell suspension. Dissociated cells were centrifuged at 100 g for 5 min at 4 °C, resuspended (5–10×10<sup>6</sup> cell/ml) in OptiMEM with supplements, and filtered through a 35 μm cell strainer (Corning, 352235). All chemicals were purchased from Sigma-Aldrich unless stated otherwise.</p><p>Cells were purified based on DsRed fluorescence intensity using a BD FACSAria II cell sorter in four-way purity mode (85 μm nozzle). DsRed-positive cells from the NG2.DsRed BAC-transgenic mouse cortex consisted of two distinct populations: bright and dim. After qPCR and immunocytochemical characterization of both populations, only the bright population, which yielded 200–300K cells/brain, was purified for induced neurogenesis experiments. A previously published protocol was adapted to maintain cells in a proliferative progenitor state (<xref ref-type="bibr" rid="bib101">Najm et al., 2013</xref>). Purified cells were sorted into and cultured in growth medium, composed of DMEM/F12 with GlutaMAX (Gibco, 10565018), 15 mM HEPES (Gibco, 15630106), B27 without vitamin A (Gibco, 12587–010), N2-max (R&amp;D Systems, AR009), 100 U/ml penicillin - 100 μg/ml streptomycin (Gibco, 15140122), 10 ng/ml PDGF-A (Peprotech, 315–17), and 20 ng/ml FGF2 (Peprotech, 450–33). Half of the medium in each well was replaced every other day. Cells were seeded (~10 K cells/cm<sup>2</sup>) on either 50–100 μg/ml poly-D-lysine (Sigma, P0899) plus laminin (Thermo, 23017015), or 0.01% poly-L-ornithine (Millipore, A-004-C) plus laminin-coated cover glasses (Fisher, 12-545-81) in 24-well plates for microscopy experiments (Corning, 353047), or without cover glass in 6-well plates for RNA experiments (Corning, 353047). Transfection was performed at ~5 DIV after half-replacing the medium with fresh proliferation medium using Fugene 6 (Promega) with the following ratio: per 6-well plate, 600 μl DMEM/F12 medium (w/o supplements), 30 μl transfection reagent, and 8 μg of DNA was mixed, incubated for 15–30 min, and directly added into each well (~100 μl/well), yielding ~10% transfection rate at 24 hr. The same Fugene 6 transfection reagent was used for synthetic RNA transfections (20 μl media, 1.2 μl transfection reagent, and 0.2 μg RNA for each well of the 24-well plate). On the day following transfection, growth medium was replaced with neuronal induction medium, composed of a 1:1 mixture of DMEM/F12 and Neurobasal-A (Gibco, 10888022), GlutaMAX (Gibco, 35050061), 15 mM HEPES, B27 with vitamin A (Gibco, 17504044), N2 (Gibco, 17502048), and 100 U/ml penicillin - 100 μg/ml streptomycin (Gibco, 15140122). Medium was half-replaced every third day after transfection until fixation.</p></sec><sec id="s4-5"><title>Retrograde labeling and FACS purification of SCPN and CPN</title><p>Retrograde labeling experiments were adapted from previously published procedures (<xref ref-type="bibr" rid="bib4">Arlotta et al., 2005</xref>). Briefly, pups were anesthetized by hypothermia at P0/P1, and SCPN and CPN were retrolabeled from their corresponding axonal projections by pressure injection (Nanoject II, Drummond) of Alexa Fluor 555-conjugated cholera toxin, subunit B (CTB) (Invitrogen, C22843) (6–7 injections, 23 nl/injection, 2 μg/ul) using pulled and beveled glass micropipettes with a tip diameter of 30–50 μm. SCPN were labeled from the cerebral peduncle, and CPN were labeled from contralateral corpus callosum close to the midline (3–4 rostrocaudal levels). Injections were performed in deeply anesthetized pups using a Vevo 770 ultrasound backscatter microscopy system (VisualSonics). Brains were collected at P2 for FACS purification, and retrograde labeling success was verified under a fluorescence-equipped dissecting microscope (SMZ-1500; Nikon). Cells were purified with stringent fluorescence gating using a BD FACSAria II cell sorter (85 μm nozzle) in four-way purity mode.</p></sec><sec id="s4-6"><title><italic>In utero</italic> electroporation</title><p>Timed pregnant CD1 dams were anesthetized with isoflurane, and an incision was made in the abdomen. The uterine horns were exposed and gently positioned on a sterile piece of gauze. 1.0 μg/μl of plasmid DNA was mixed with 0.005% Fast Green in sterile PBS and injected <italic>in utero</italic> into one lateral ventricle of each embryonic brain. The injections were performed with beveled glass micropipettes (tip diameter of 30–60 μm) via mouth pipetting with an aspirator tube assembly (Sigma, A5177). Plasmid electroporations were performed by placing a positive electrode (tweezer electrodes, 5 mm diameter) above the cortex and a negative electrode behind the head, and applying five pulses of current at 40 V for 50 milliseconds per pulse with 1 s intervals between pulses (CUY21Edit Electroporator, Bex Co. Ltd.). Brains were collected at P7 for NVOF misexpression analysis and at P0-P1 for primary neuron culture.</p></sec><sec id="s4-7"><title>Astrocyte-conditioned media</title><p>Production of astrocyte-conditioned media was based on the published protocol for primary culture of postnatal cortical astrocytes (<xref ref-type="bibr" rid="bib53">Heinrich et al., 2011</xref>). Briefly, cerebral cortices were micro-dissected from wild-type P5-P7 CD1 pups, gently dissociated without enzymatic digestion using fire-polished glass Pasteur pipets, and centrifuged at 100 g for 5 min at 4 °C. Dissociated cells were seeded in T25 flasks and cultured in astrocyte growth medium DMEM/F12 with GlutaMAX (Gibco, 10565018), 10% fetal calf serum (Seradigm, 97068–091), 5% horse serum (Invitrogen, 26050070), B27 (with vitamin A), 100 U/ml penicillin – 100 μg/ml streptomycin (Gibco, 15140122), 10 ng/ml EGF (Peprotech, 315–09), and 10 ng/ml FGF2 (Peprotech, 450–33). Medium was fully changed 24 hr post-culturing, and half of the medium was replaced three days post-culturing. Culture fidelity was verified by morphology and GFAP expression of the differentiated cells. To obtain astrocyte-conditioned media, astrocytes were passaged at ~5 DIV using trypsin (Gibco, 25200056), centrifuged at 100 g for 5 min at room temperature, diluted 1:4, re-seeded in T75 flasks containing astrocyte growth medium, and cultured for 24 hr. Growth medium was subsequently replaced with neuronal induction medium (described above). The conditioned medium was collected at days 10, and 20, and aliquots were stored at –80 °C.</p></sec><sec id="s4-8"><title>NVOF-induced and primary neuron co-culture</title><p>To co-culture induced neurons with primary neurons, primary forebrain neurons were obtained from P0-P1 CD1 wild-type pups using the dissociation protocol described above, and directly added onto progenitor cell cultures at 24 hr after transfection (25 K/cm<sup>2</sup>). One-half of the medium was replaced with fresh astrocyte-conditioned media every third day. For dendritic morphology comparison, cortical projection neurons were labeled via <italic>in utero</italic> electroporation (at E14.5) of a tdTomato reporter plasmid driven by CMV-beta-actin promoter. Neurons were dissociated at P0-P1, cultured in 24-well plates with cover glass (50 K cell/cm<sup>2</sup>), and cultured in parallel with induced neurons using the same neuronal media that is described above.</p></sec><sec id="s4-9"><title>Histology and immunocytochemistry</title><p>Immunocytochemistry (ICC) for tissue sections was performed following standard protocols. Briefly, mice were transcardially perfused with PBS then 4% PFA, dissected, and post-fixed overnight at 4 °C in 4% paraformaldehyde. Brains were embedded in 4% low melting temperature agar (Sigma-Aldrich) and sectioned at 50 μm on a vibrating microtome (Leica). Fixed tissues were stored in PBS with 0.025% sodium azide. Floating sections were blocked with 0.3% BSA (wt/vol) (Sigma, A3059), 0.3% Triton X-100 (Sigma, T8787), and 0.025% sodium azide (Sigma, S2002) in PBS for 30 min. Primary antibodies were diluted in the same blocking solution and incubated with sections for 4 hr at room temperature, or overnight at 4 °C. Sections were rinsed three times with PBS for 10 min and incubated with appropriate secondary antibodies diluted in blocking solution for 2–3 hr at room temperature. Sections were rinsed three times with PBS, and mounted using Fluoromount with DAPI (SouthernBiotech, 0100–20) for image acquisition. ICC for BrdU was preceded by 2 hr of treatment with 2 N HCl at room temperature for antigen retrieval.</p><p>ICC for cultured cells was performed by first fixing cells in 4% paraformaldehyde at room temperature for 10 min, rinsing three times with PBS, and storing in PBS with 0.025% sodium azide at 4 °C. Cells were blocked in the blocking solution for 15 min, incubated with primary antibodies for 2 hr, rinsed with PBS three times for 5 min, incubated with secondary antibodies for 45 min, rinsed with PBS three times for 5 min (all reactions at room temperature), and mounted using Fluoromount with DAPI.</p><p>The following primary antibodies and dilutions were used: mouse anti-ANK3 (ANKYRIN-G), 1:250 (Santa Cruz, sc-12719); rat anti-BrdU, 1:500 (AbD Serotec, OBT0030); rabbit anti-CSPG4 (NG2), 1:500 (Millipore, AB5320); rabbit anti-CTIP2, 1:500 (Abcam, ab28448); rat anti-CTIP2, 1:250 (Abcam, ab18465); rabbit anti-CUX1, 1:200 (Santa Cruz Biotechnology, sc-13024); rabbit anti-DARPP32, 1:250 (Cell Signaling Technology, 2306 S); rabbit anti-FOG2, 1:250 (Santa Cruz Biotechnology, sc-10755); rabbit anti-FOXP2, 1:2000 (Abcam, AB16064); mouse anti-GABA, 1:200 (Sigma, A0310); mouse anti-GFAP, 1:1000 (Sigma, G3893); rabbit anti-GFAP, 1:1000 (Sigma, G9269); chicken anti-GFP, 1:1000 (Invitrogen, A10262); rabbit anti-GFP, 1:1000 (Invitrogen, A11122); mouse anti-HA, 1:1000 (Covance, MMS-101R); mouse anti-ISL1, 1:250 (Novus, H00003670); mouse anti-MAP2, 1:500 (Sigma, M1406); chicken anti-NESTIN, 1:2000 (Novus, NB100-1604); mouse anti-NeuN, 1:500 (Chemicon, MAB377); rabbit anti-NF-M, 1:200 (Millipore, AB1987); mouse anti-NEUROG2, 1:100 (R&amp;D Systems; MAB3314); goat anti-OLIG2, 1:200 (R&amp;D Systems, AF2418); rat anti-RFP, 1:500 (antibodies-online, ABIN334653); rabbit anti-PCP4, 1:500 (Proteintech, 14705–1-AP); rabbit anti-PDGFRB, 1:100 (Cell Signaling, 3169); mouse anti-PSA-NCAM, 1:200 (Chemicon, MAB5324); mouse anti-SATB2, 1:200 (Abcam, ab51502); rabbit anti-SATB2, 1:500 (Abcam, ab34735); rabbit anti-SOX6, 1:500 (Abcam, AB30455); goat anti-SOX10, 1:200 (Santa Cruz, sc-17342); rabbit anti-SYNAPSIN, 1:500 (Synaptic Systems, 106002); mouse anti-SYNAPTOPHYSIN, 1:500 (Millipore, MAB5258); rabbit anti-TH, 1:250 (Millipore, AB152); rabbit anti-TUBB3 (TUJ1), 1:1000 (Sigma, T2200); mouse anti-TUBB3 (TUJ1), 1:1000 (Biolegend, MMS-435P), rabbit anti-vGLUT1, 1:500 (Synaptic Systems, 135302); rabbit anti-2A-peptide, 1:1000 (Millipore, ABS31), rabbit anti-5HT, 1:3000 (Immunostar, 20080). Alexa Fluor-conjugated secondary antibodies (Invitrogen) were used at a dilution of 1:1000. Positive controls were included in all ICC experiments with negative results. All ICC experiments utilized different batches of FACS-purified cells from independent litters to yield a minimum of three true biological replicates. Primary data were analyzed by one investigator (AO), then confirmed by a second independent investigator (HP).</p></sec><sec id="s4-10"><title>Image acquisition, quantification, and statistical analysis</title><p>Wide-field image acquisition was performed with a Nikon 90i epifluorescence microscope equipped with a Clara DR-328G cooled CCD digital camera (Andor Technology) running NIS Elements software (Nikon). Brightfield images were acquired using a Nikon ECLIPSE Ts2R-FL inverted microscope. For optimal data visualization, images were adjusted for contrast, brightness, and size in Adobe Photoshop and Illustrator (2019). Identical procedures were applied across different experimental conditions. For cell quantifications, a cover glass area of ~50 mm<sup>2</sup> (7×7 tile) was imaged using a 10x objective. The acquired image was binned as 1 mm<sup>2</sup> boxes, individual boxes were randomly selected, and all GFP+ cells in each selected box were quantified using NIS-elements software (Nikon). To quantify the immunofluorescence intensity of target molecules, nuclei were identified via DAPI, and the average intensity of the outlined nuclear area was measured on Nikon-NIS. The following criteria were used to mark neurons with multiple axons: If the second longest neurite originating from the cell soma was at least half the length of the longest neurite, that cell was marked as multipolar. A minimum of four independent biological replicates were used for each experimental condition across the study unless otherwise mentioned in the text. Microsoft Excel, RStudio (version 1.3.959), and GraphPad Prism 8 were used for data analysis, plotting graphs, and statistics. Statistical details of the experiments can be found in the figure legends. Significance is based on the p value indicated on the graphs as * p % 0.05, ** p % 0.01, ***p % 0.001, ****p % 0.0001.</p></sec><sec id="s4-11"><title>Electrophysiology</title><p>Electrophysiological recordings were performed at 20–25°C on an Olympus BX51WI microscope. Cells were bathed in artificial cerebral spinal fluid (ACSF) containing 119 mM NaCl, 2.5 mM KCl, 4 mM CaCl<sub>2</sub>, 4 mM MgSO<sub>4</sub>, 1 mM NaH<sub>2</sub>PO<sub>4</sub>, 26.2 mM NaHCO<sub>3</sub>, and 11 mM glucose. ACSF was continuously saturated with 95% O<sub>2</sub>/5% CO<sub>2</sub>. Intracellular recordings were obtained using glass micropipettes filled with an internal solution containing 136 mM KMeSO<sub>3</sub>, 17.8 mM HEPES, 0.6 mM MgCl<sub>2</sub>, 1 mM EGTA, 4 mM Mg-ATP, and 0.3 mM Na-GTP. Traces were collected using a Multiclamp 700B amplifier (Molecular Devices), filtered with a 2 kHz Bessel filter, digitized at 50 kHz using a Digidata 1440 A digitizer (Molecular Devices), stored using Clampex 10 (Molecular Devices), and analyzed off-line via customized procedures written in Igor Pro (WaveMetrics). Series resistance was monitored throughout the experiment. Cells at DPI/DIV 15–16 were identified visually by fluorescence. Action potentials were evoked by injection of current steps, ranging from –140 pA to 400 pA in 60 pA increments, with a duration of 600 ms. Action potential parameters were quantified for the first action potential evoked at the lowest current injection that resulted in an action potential. The threshold potential was defined as the voltage at which dV/dt of the action potential waveform reached 10% of its maximum value, relative to a dV/dt baseline taken 10 ms before the peak. Action potential amplitude was defined as the difference between the threshold value (in mV) and the maximum voltage of the action potential. Width was measured at half-maximum amplitude. Sag current was measured during a –140 pA step current for a duration of 600 ms.</p></sec><sec id="s4-12"><title>RNA sequencing</title><p>A minimum of three independent biological replicates was used for each experimental group (i.e. mouse litters, cell culture batches, FACS purifications, etc. were different for each biological replicate). RNA isolation was performed using a Qiagen RNeasy Plus Mini Kit with the gDNA elimination step. FACS-purified cells were collected directly into RLT Plus buffer with β-mercaptoethanol. RNA concentration, purity, and integrity were measured by a Nanodrop (Thermo Fisher), an Agilent TapeStation 2200, and an Agilent Bioanalyzer 2100. Only high-quality RNA samples were used for library preparation. For the 32 samples used in this study, the minimum RNA integrity number (RIN) was 8, the average was 9.7, and the median was 10.</p><p>Library preparation and sequencing were performed by the Bauer Core Facility at Harvard University. RNA was fragmented at 94 °C for 6 min with a final size range of 200–300 bp. The library was prepared from 50 ng total input RNA per sample using a Kapa mRNA HyperPrep kit (14 cycles) with PolyA enrichment (stranded via dUTP addition, and first-strand preserved). Unique dual 8 bp adapters (1.5 μM) (IDT for Illumina) were used for indexing. The library quality and concentration were confirmed by an Agilent TapeStation 2200 and a Kapa qPCR library quantification kit. The pooled samples were run on Illumina NextSeq High flow cells (75 bp, paired-end reading). Sequencing quality was assessed by FASTQC (version 0.11.9). STAR-aligned counts were used for quality control metrics (<xref ref-type="bibr" rid="bib141">Steinbaugh et al., 2018</xref>).</p><p>The quasi-aligned counts from Salmon with default options were used to perform downstream gene expression analyses (<xref ref-type="bibr" rid="bib112">Patro et al., 2017</xref>). Transcript-level count matrices were produced via the Bioconductor package ‘tximport’ (<xref ref-type="bibr" rid="bib138">Soneson et al., 2015</xref>). Ensembl gene IDs were generated using the GRCm38 reference genome (Ensembl v98). DESeq2 was used to perform differential expression analyses (<xref ref-type="bibr" rid="bib85">Love et al., 2014</xref>). Low count genes (total reads &lt;10) were pre-filtered before DESeq2 functions. Gene names and other information were annotated using the Bioconductor package ‘AnnotationDbi.’ Variance-stabilizing transformed (vst) normalized counts (log2 scale) were used for data visualization (<xref ref-type="bibr" rid="bib86">Love et al., 2016</xref>). The code used to perform subsequent analyses of the sequencing data was an adaptation of standard R packages. Gene ontology (GO) enrichment analysis was performed using the PANTHER online database (<xref ref-type="bibr" rid="bib148">The Gene Ontology Consortium, 2019</xref>; <xref ref-type="bibr" rid="bib5">Ashburner et al., 2000</xref>). Raw FASTQ files and processed counts are available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/IODOK1">https://doi.org/10.7910/DVN/IODOK1</ext-link>.</p></sec><sec id="s4-13"><title>Quantitative PCR</title><p>cDNA was prepared using the Superscript IV first-strand synthesis system (Thermo, 18090050) and random hexamers (Thermo, SO142) following the manufacturer’s standard protocol. Random hexamers were used for amplification. qPCR was performed using the iTaq Universal Sybr Green Supermix (Bio-Rad) on a Bio-Rad CFX96 thermal cycler following standard procedures. For all qPCR primers used in this study, reaction efficiency was calculated by standard curve analysis, and only primers with high efficiency (90–105%) were used. See <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for the primer list. Four independent biological replicates were used for each experimental group in all qPCR experiments.</p></sec><sec id="s4-14"><title>Materials availability statement</title><p>The NVOF construct used in this study can be requested from the laboratory of the corresponding author, Jeffrey D. Macklis (jeffrey_macklis@harvard.edu). The map and sequence of this construct is provided in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing, Writing – original draft</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mouse studies were approved by the Harvard University IACUC (protocol numbers HU IACUC # 11-19-4 and HU IACUC ID # 11-22-2) and were performed in accordance with institutional and federal guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Transcript counts for top-500 genes enriched in major cell lineages (<xref ref-type="bibr" rid="bib162">Zhang et al., 2014</xref>) and mural cells (<xref ref-type="bibr" rid="bib51">He et al., 2016</xref>) for acutely sorted DsRed-Negative, -Dim, and -Bright cells, as well as cultured DsRed-Bright cells (5-DIV).</title><p>Counts are variance-stabilizing transformed (vst) normalized data in log2 scale.</p></caption><media xlink:href="elife-100340-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>List of primer sets used in qPCR experiment.</title></caption><media xlink:href="elife-100340-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>The map and sequence of the NVOF construct.</title></caption><media xlink:href="elife-100340-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100340-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Raw FASTQ files and processed counts are available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7910/DVN/IODOK1">https://doi.org/10.7910/DVN/IODOK1</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Ozkan</surname><given-names>A</given-names></name><name><surname>Padnabhan</surname><given-names>H</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors</data-title><source>Harvard Dataverse</source><pub-id pub-id-type="doi">10.7910/DVN/IODOK1</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by NINDS grants NS045523, DP1 NS106665, and NS049553, by the Emily and Robert Pearlstein Fund for Nervous System Repair, and by the Max and Anne Wien Professor of Life Sciences fund (to JDM). AO was partially supported by a fellowship from the Suna and Inan Kirac Foundation. HP was partially supported by an International Brain Research Organization Fellowship and a McKnight Brain Research Institute/Regeneration Project Fellowship. We thank Jessica Kim, Jessica Wooten, Ioana Florea, and Ryan Humphries for technical assistance; David Dombkowski at MGH and Girijesh Buruzula, Joyce LaVecchio, and Silvia Ionescu at HSCRB for their help with FACS purification; Andrew Thompson for help with the cloning; Vibhu Sahni and Maria Galazo for assistance with retrograde labeling of SCPN/CSN and scientific discussions; Wataru Ebina for help with synthetic modified RNA experiments; Pratibha Tripathi for advice on astrocyte culture; and other members of the Macklis Laboratory for helpful suggestions and critical reading of the manuscript. This work is dedicated to the memory and intellectual curiosity of Byron Wien.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcamo</surname><given-names>EA</given-names></name><name><surname>Chirivella</surname><given-names>L</given-names></name><name><surname>Dautzenberg</surname><given-names>M</given-names></name><name><surname>Dobreva</surname><given-names>G</given-names></name><name><surname>Fariñas</surname><given-names>I</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Satb2 regulates callosal projection neuron identity in the developing cerebral cortex</article-title><source>Neuron</source><volume>57</volume><fpage>364</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.012</pub-id><pub-id pub-id-type="pmid">18255030</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="data"><person-group person-group-type="author"><collab>Allen Brain Institute</collab></person-group><year iso-8601-date="2008">2008</year><data-title>Neurog2 - rp_091201_01_b09 - coronal</data-title><source>Allen Developing Mouse Brain Atlas</source><ext-link ext-link-type="uri" xlink:href="https://developingmouse.brain-map.org/experiment/show/100093831">https://developingmouse.brain-map.org/experiment/show/100093831</ext-link></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>CE</given-names></name><name><surname>Olmos</surname><given-names>VH</given-names></name><name><surname>Vodehnal</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>QY</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Narayanaswamy</surname><given-names>A</given-names></name><name><surname>Mall</surname><given-names>M</given-names></name><name><surname>Chesnov</surname><given-names>K</given-names></name><name><surname>Dominicus</surname><given-names>CS</given-names></name><name><surname>Südhof</surname><given-names>T</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2308401121</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2308401121</pub-id><pub-id pub-id-type="pmid">38446849</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arlotta</surname><given-names>P</given-names></name><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Inoue</surname><given-names>J</given-names></name><name><surname>Kominami</surname><given-names>R</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo</article-title><source>Neuron</source><volume>45</volume><fpage>207</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.036</pub-id><pub-id pub-id-type="pmid">15664173</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Harris</surname><given-names>MA</given-names></name><name><surname>Hill</surname><given-names>DP</given-names></name><name><surname>Issel-Tarver</surname><given-names>L</given-names></name><name><surname>Kasarskis</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>Matese</surname><given-names>JC</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name><name><surname>Ringwald</surname><given-names>M</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Gene Ontology: tool for the unification of biology</article-title><source>Nature Genetics</source><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Autar</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Rumsey</surname><given-names>JW</given-names></name><name><surname>Long</surname><given-names>CJ</given-names></name><name><surname>Akanda</surname><given-names>N</given-names></name><name><surname>Jackson</surname><given-names>M</given-names></name><name><surname>Narasimhan</surname><given-names>NS</given-names></name><name><surname>Caneus</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>D</given-names></name><name><surname>Hickman</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disorders</article-title><source>Stem Cell Reports</source><volume>17</volume><fpage>96</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2021.11.009</pub-id><pub-id pub-id-type="pmid">34942087</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azim</surname><given-names>E</given-names></name><name><surname>Jabaudon</surname><given-names>D</given-names></name><name><surname>Fame</surname><given-names>RM</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1238</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1038/nn.2387</pub-id><pub-id pub-id-type="pmid">19657336</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azim</surname><given-names>E</given-names></name><name><surname>Shnider</surname><given-names>SJ</given-names></name><name><surname>Cederquist</surname><given-names>GY</given-names></name><name><surname>Sohur</surname><given-names>US</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Lmo4 and Clim1 progressively delineate cortical projection neuron subtypes during development</article-title><source>Cerebral Cortex</source><volume>19 Suppl 1</volume><fpage>i62</fpage><lpage>i69</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhp030</pub-id><pub-id pub-id-type="pmid">19366868</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baroti</surname><given-names>T</given-names></name><name><surname>Zimmermann</surname><given-names>Y</given-names></name><name><surname>Schillinger</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Lommes</surname><given-names>P</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Stolt</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcription factors Sox5 and Sox6 exert direct and indirect influences on oligodendroglial migration in spinal cord and forebrain</article-title><source>Glia</source><volume>64</volume><fpage>122</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1002/glia.22919</pub-id><pub-id pub-id-type="pmid">26345464</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beagan</surname><given-names>JA</given-names></name><name><surname>Gilgenast</surname><given-names>TG</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Plona</surname><given-names>Z</given-names></name><name><surname>Norton</surname><given-names>HK</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Hsu</surname><given-names>SC</given-names></name><name><surname>Shields</surname><given-names>EJ</given-names></name><name><surname>Lyu</surname><given-names>X</given-names></name><name><surname>Apostolou</surname><given-names>E</given-names></name><name><surname>Hochedlinger</surname><given-names>K</given-names></name><name><surname>Corces</surname><given-names>VG</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Phillips-Cremins</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Local genome topology can exhibit an incompletely rewired 3D-folding state during somatic cell reprogramming</article-title><source>Cell Stem Cell</source><volume>18</volume><fpage>611</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.04.004</pub-id><pub-id pub-id-type="pmid">27152443</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>AM</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adult mammalian neural stem cells and neurogenesis: five decades later</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.09.003</pub-id><pub-id pub-id-type="pmid">26431181</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brill</surname><given-names>MS</given-names></name><name><surname>Ninkovic</surname><given-names>J</given-names></name><name><surname>Winpenny</surname><given-names>E</given-names></name><name><surname>Hodge</surname><given-names>RD</given-names></name><name><surname>Ozen</surname><given-names>I</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Lepier</surname><given-names>A</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Erdelyi</surname><given-names>F</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name><name><surname>Parras</surname><given-names>C</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name><name><surname>Raineteau</surname><given-names>O</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Adult generation of glutamatergic olfactory bulb interneurons</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1524</fpage><lpage>1533</lpage><pub-id pub-id-type="doi">10.1038/nn.2416</pub-id><pub-id pub-id-type="pmid">19881504</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britz</surname><given-names>O</given-names></name><name><surname>Mattar</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Langevin</surname><given-names>LM</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A role for proneural genes in the maturation of cortical progenitor cells</article-title><source>Cerebral Cortex</source><volume>16</volume><fpage>i138</fpage><lpage>i151</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhj168</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffo</surname><given-names>A</given-names></name><name><surname>Vosko</surname><given-names>MR</given-names></name><name><surname>Ertürk</surname><given-names>D</given-names></name><name><surname>Hamann</surname><given-names>GF</given-names></name><name><surname>Jucker</surname><given-names>M</given-names></name><name><surname>Rowitch</surname><given-names>D</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Expression pattern of the transcription factor Olig2 in response to brain injuries: Implications for neuronal repair</article-title><source>PNAS</source><volume>102</volume><fpage>18183</fpage><lpage>18188</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506535102</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahoy</surname><given-names>JD</given-names></name><name><surname>Emery</surname><given-names>B</given-names></name><name><surname>Kaushal</surname><given-names>A</given-names></name><name><surname>Foo</surname><given-names>LC</given-names></name><name><surname>Zamanian</surname><given-names>JL</given-names></name><name><surname>Christopherson</surname><given-names>KS</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Lubischer</surname><given-names>JL</given-names></name><name><surname>Krieg</surname><given-names>PA</given-names></name><name><surname>Krupenko</surname><given-names>SA</given-names></name><name><surname>Thompson</surname><given-names>WJ</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4178-07.2008</pub-id><pub-id pub-id-type="pmid">18171944</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Morrow</surname><given-names>EM</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Misexpression of basic helix-loop-helix genes in the murine cerebral cortex affects cell fate choices and neuronal survival</article-title><source>Development</source><volume>127</volume><fpage>3021</fpage><lpage>3030</lpage><pub-id pub-id-type="doi">10.1242/dev.127.14.3021</pub-id><pub-id pub-id-type="pmid">10862740</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>SY</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>KH</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhanced derivation of human pluripotent stem cell-derived cortical glutamatergic neurons by a small molecule</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>3282</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-03519-w</pub-id><pub-id pub-id-type="pmid">28607372</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catapano</surname><given-names>LA</given-names></name><name><surname>Arnold</surname><given-names>MW</given-names></name><name><surname>Perez</surname><given-names>FA</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Specific neurotrophic factors support the survival of cortical projection neurons at distinct stages of development</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>8863</fpage><lpage>8872</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-22-08863.2001</pub-id><pub-id pub-id-type="pmid">11698598</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederquist</surname><given-names>GY</given-names></name><name><surname>Azim</surname><given-names>E</given-names></name><name><surname>Shnider</surname><given-names>SJ</given-names></name><name><surname>Padmanabhan</surname><given-names>H</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lmo4 establishes rostral motor cortex projection neuron subtype diversity</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>6321</fpage><lpage>6332</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5140-12.2013</pub-id><pub-id pub-id-type="pmid">23575831</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamling</surname><given-names>X</given-names></name><name><surname>Kallman</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>W</given-names></name><name><surname>Berlinicke</surname><given-names>CA</given-names></name><name><surname>Mertz</surname><given-names>JL</given-names></name><name><surname>Devkota</surname><given-names>P</given-names></name><name><surname>Pantoja</surname><given-names>IEM</given-names></name><name><surname>Smith</surname><given-names>MD</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Kaushik</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Whartenby</surname><given-names>KA</given-names></name><name><surname>Calabresi</surname><given-names>PA</given-names></name><name><surname>Mao</surname><given-names>HQ</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>TH</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>652</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-20892-3</pub-id><pub-id pub-id-type="pmid">33510160</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Magavi</surname><given-names>SSP</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice</article-title><source>PNAS</source><volume>101</volume><fpage>16357</fpage><lpage>16362</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406795101</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Maimaitili</surname><given-names>M</given-names></name><name><surname>Habekost</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>KP</given-names></name><name><surname>Mermet-Joret</surname><given-names>N</given-names></name><name><surname>Nabavi</surname><given-names>S</given-names></name><name><surname>Febbraro</surname><given-names>F</given-names></name><name><surname>Denham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rapid generation of regionally specified CNS neurons by sequential patterning and conversion of human induced pluripotent stem cells</article-title><source>Stem Cell Research</source><volume>48</volume><elocation-id>101945</elocation-id><pub-id pub-id-type="doi">10.1016/j.scr.2020.101945</pub-id><pub-id pub-id-type="pmid">32791483</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouchane</surname><given-names>M</given-names></name><name><surname>Melo de Farias</surname><given-names>AR</given-names></name><name><surname>Moura</surname><given-names>DMS</given-names></name><name><surname>Hilscher</surname><given-names>MM</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Leão</surname><given-names>RN</given-names></name><name><surname>Costa</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lineage reprogramming of astroglial cells from different origins into distinct neuronal subtypes</article-title><source>Stem Cell Reports</source><volume>9</volume><fpage>162</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.05.009</pub-id><pub-id pub-id-type="pmid">28602612</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czupryn</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>YD</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>McNay</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>MP</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice</article-title><source>Science</source><volume>334</volume><fpage>1133</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1126/science.1209870</pub-id><pub-id pub-id-type="pmid">22116886</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>MRL</given-names></name><name><surname>Polito</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>JM</given-names></name><name><surname>Reynolds</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS</article-title><source>Molecular and Cellular Neurosciences</source><volume>24</volume><fpage>476</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/s1044-7431(03)00210-0</pub-id><pub-id pub-id-type="pmid">14572468</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De la Rossa</surname><given-names>A</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Golding</surname><given-names>B</given-names></name><name><surname>Vitali</surname><given-names>I</given-names></name><name><surname>Moss</surname><given-names>J</given-names></name><name><surname>Toni</surname><given-names>N</given-names></name><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Jabaudon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/nn.3299</pub-id><pub-id pub-id-type="pmid">23292682</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>DJ</given-names></name><name><surname>Wilkinson</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Dixit</surname><given-names>R</given-names></name><name><surname>Adnani</surname><given-names>L</given-names></name><name><surname>Balakrishnan</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Kovach</surname><given-names>C</given-names></name><name><surname>Gruenig</surname><given-names>N</given-names></name><name><surname>Kurrasch</surname><given-names>DM</given-names></name><name><surname>Dyck</surname><given-names>RH</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>Neurog2</italic> and <italic>Ascl1</italic> together regulate a postmitotic derepression circuit to govern laminar fate specification in the murine neocortex</article-title><source>PNAS</source><volume>114</volume><fpage>E4934</fpage><lpage>E4943</lpage><pub-id pub-id-type="doi">10.1073/pnas.1701495114</pub-id><pub-id pub-id-type="pmid">28584103</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>MLL</given-names></name><name><surname>Luke</surname><given-names>G</given-names></name><name><surname>Mehrotra</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hughes</surname><given-names>LE</given-names></name><name><surname>Gani</surname><given-names>D</given-names></name><name><surname>Ryan</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of the aphthovirus 2A/2B polyprotein “cleavage” mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal “skip”</article-title><source>The Journal of General Virology</source><volume>82</volume><fpage>1013</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-82-5-1013</pub-id><pub-id pub-id-type="pmid">11297676</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Durak</surname><given-names>O</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Tillman</surname><given-names>DE</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Wettstein</surname><given-names>MR</given-names></name><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Addison</surname><given-names>TA</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>ASD Gene <italic>Bcl11a</italic> Regulates Subcellular RNA Localization, Associative Circuitry, and Social Behavior</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.10.06.511159</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsherbiny</surname><given-names>A</given-names></name><name><surname>Dobreva</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Epigenetic memory of cell fate commitment</article-title><source>Current Opinion in Cell Biology</source><volume>69</volume><fpage>80</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2020.12.014</pub-id><pub-id pub-id-type="pmid">33535129</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espuny-Camacho</surname><given-names>I</given-names></name><name><surname>Michelsen</surname><given-names>KA</given-names></name><name><surname>Gall</surname><given-names>D</given-names></name><name><surname>Linaro</surname><given-names>D</given-names></name><name><surname>Hasche</surname><given-names>A</given-names></name><name><surname>Bonnefont</surname><given-names>J</given-names></name><name><surname>Bali</surname><given-names>C</given-names></name><name><surname>Orduz</surname><given-names>D</given-names></name><name><surname>Bilheu</surname><given-names>A</given-names></name><name><surname>Herpoel</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>N</given-names></name><name><surname>Gaspard</surname><given-names>N</given-names></name><name><surname>Péron</surname><given-names>S</given-names></name><name><surname>Schiffmann</surname><given-names>SN</given-names></name><name><surname>Giugliano</surname><given-names>M</given-names></name><name><surname>Gaillard</surname><given-names>A</given-names></name><name><surname>Vanderhaeghen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo</article-title><source>Neuron</source><volume>77</volume><fpage>440</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.011</pub-id><pub-id pub-id-type="pmid">23395372</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>LP</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Meyer</surname><given-names>E</given-names></name><name><surname>Welle</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Scheller</surname><given-names>A</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A subset of OPCs do not express Olig2 during development which can be increased in the adult by brain injuries and complex motor learning</article-title><source>Glia</source><volume>71</volume><fpage>415</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1002/glia.24284</pub-id><pub-id pub-id-type="pmid">36308278</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feliciano</surname><given-names>DM</given-names></name><name><surname>Bordey</surname><given-names>A</given-names></name><name><surname>Bonfanti</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Noncanonical sites of adult neurogenesis in the mammalian brain</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a018846</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a018846</pub-id><pub-id pub-id-type="pmid">26384869</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felske</surname><given-names>T</given-names></name><name><surname>Tocco</surname><given-names>C</given-names></name><name><surname>Péron</surname><given-names>S</given-names></name><name><surname>Harb</surname><given-names>K</given-names></name><name><surname>Alfano</surname><given-names>C</given-names></name><name><surname>Galante</surname><given-names>C</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities</article-title><source>PLOS Biology</source><volume>21</volume><elocation-id>e3002237</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002237</pub-id><pub-id pub-id-type="pmid">37552690</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Rudy</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms of inhibition within the telencephalon: “where the wild things are”</article-title><source>Annual Review of Neuroscience</source><volume>34</volume><fpage>535</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113717</pub-id><pub-id pub-id-type="pmid">21469958</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floriddia</surname><given-names>EM</given-names></name><name><surname>Lourenço</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Hilscher</surname><given-names>MM</given-names></name><name><surname>Kukanja</surname><given-names>P</given-names></name><name><surname>Gonçalves Dos Santos</surname><given-names>JP</given-names></name><name><surname>Altınkök</surname><given-names>M</given-names></name><name><surname>Yokota</surname><given-names>C</given-names></name><name><surname>Llorens-Bobadilla</surname><given-names>E</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Grãos</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>LO</given-names></name><name><surname>Frisén</surname><given-names>J</given-names></name><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5860</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19453-x</pub-id><pub-id pub-id-type="pmid">33203872</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funahashi</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Advances in defining signaling networks for the establishment of neuronal polarity</article-title><source>Current Opinion in Cell Biology</source><volume>63</volume><fpage>76</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2019.12.009</pub-id><pub-id pub-id-type="pmid">32018218</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Adult neurogenesis in mammals</article-title><source>Science</source><volume>364</volume><fpage>827</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1126/science.aav6885</pub-id><pub-id pub-id-type="pmid">31147506</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galazo</surname><given-names>MJ</given-names></name><name><surname>Emsley</surname><given-names>JG</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Corticothalamic projection neuron development beyond subtype specification: Fog2 and intersectional controls regulate intraclass neuronal diversity</article-title><source>Neuron</source><volume>91</volume><fpage>90</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.024</pub-id><pub-id pub-id-type="pmid">27321927</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galazo</surname><given-names>MJ</given-names></name><name><surname>Sweetser</surname><given-names>DA</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Tle4 controls both developmental acquisition and early post-natal maturation of corticothalamic projection neuron identity</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>112957</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112957</pub-id><pub-id pub-id-type="pmid">37561632</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Murenu</surname><given-names>E</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name><name><surname>Ortega</surname><given-names>F</given-names></name><name><surname>Russo</surname><given-names>GL</given-names></name><name><surname>Petrik</surname><given-names>D</given-names></name><name><surname>Deshpande</surname><given-names>A</given-names></name><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Karow</surname><given-names>M</given-names></name><name><surname>Robertson</surname><given-names>SP</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Beckers</surname><given-names>J</given-names></name><name><surname>Irmler</surname><given-names>M</given-names></name><name><surname>Berndt</surname><given-names>C</given-names></name><name><surname>Angeli</surname><given-names>JPF</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification and successful negotiation of a metabolic checkpoint in direct neuronal reprogramming</article-title><source>Cell Stem Cell</source><volume>18</volume><fpage>396</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.12.003</pub-id><pub-id pub-id-type="pmid">26748418</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grande</surname><given-names>A</given-names></name><name><surname>Sumiyoshi</surname><given-names>K</given-names></name><name><surname>López-Juárez</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Sakthivel</surname><given-names>B</given-names></name><name><surname>Aronow</surname><given-names>B</given-names></name><name><surname>Campbell</surname><given-names>K</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Environmental impact on direct neuronal reprogramming in vivo in the adult brain</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>2373</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3373</pub-id><pub-id pub-id-type="pmid">23974433</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Woodworth</surname><given-names>MB</given-names></name><name><surname>Galazo</surname><given-names>MJ</given-names></name><name><surname>Padmanabhan</surname><given-names>H</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular logic of neocortical projection neuron specification, development and diversity</article-title><source>Nature Reviews. Neuroscience</source><volume>14</volume><fpage>755</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/nrn3586</pub-id><pub-id pub-id-type="pmid">24105342</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Woodworth</surname><given-names>MB</given-names></name><name><surname>Greppi</surname><given-names>C</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ctip1 controls acquisition of sensory area identity and establishment of sensory input fields in the developing neocortex</article-title><source>Neuron</source><volume>90</volume><fpage>261</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.008</pub-id><pub-id pub-id-type="pmid">27100196</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Horiuchi</surname><given-names>M</given-names></name><name><surname>Miers</surname><given-names>L</given-names></name><name><surname>Vaccarino</surname><given-names>F</given-names></name><name><surname>Pleasure</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>12036</fpage><lpage>12049</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1360-10.2010</pub-id><pub-id pub-id-type="pmid">20826667</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hains</surname><given-names>BC</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury</article-title><source>The Journal of Comparative Neurology</source><volume>462</volume><fpage>328</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1002/cne.10733</pub-id><pub-id pub-id-type="pmid">12794736</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Kwan</surname><given-names>KY</given-names></name><name><surname>Shim</surname><given-names>S</given-names></name><name><surname>Lam</surname><given-names>MMS</given-names></name><name><surname>Shin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract</article-title><source>PNAS</source><volume>108</volume><fpage>3041</fpage><lpage>3046</lpage><pub-id pub-id-type="doi">10.1073/pnas.1016723108</pub-id><pub-id pub-id-type="pmid">21285371</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hand</surname><given-names>R</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neurogenin2 regulates the initial axon guidance of cortical pyramidal neurons projecting medially to the corpus callosum</article-title><source>Neural Development</source><volume>6</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-6-30</pub-id><pub-id pub-id-type="pmid">21864333</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>KD</given-names></name><name><surname>Shepherd</surname><given-names>GMG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The neocortical circuit: themes and variations</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>170</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/nn.3917</pub-id><pub-id pub-id-type="pmid">25622573</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>Vanlandewijck</surname><given-names>M</given-names></name><name><surname>Raschperger</surname><given-names>E</given-names></name><name><surname>Andaloussi Mäe</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>B</given-names></name><name><surname>Lebouvier</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Hofmann</surname><given-names>J</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Analysis of the brain mural cell transcriptome</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>35108</elocation-id><pub-id pub-id-type="doi">10.1038/srep35108</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Blum</surname><given-names>R</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name><name><surname>Tripathi</surname><given-names>P</given-names></name><name><surname>Sánchez</surname><given-names>R</given-names></name><name><surname>Tiedt</surname><given-names>S</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Directing astroglia from the cerebral cortex into subtype specific functional neurons</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000373</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000373</pub-id><pub-id pub-id-type="pmid">20502524</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name><name><surname>Lepier</surname><given-names>A</given-names></name><name><surname>Sanchez</surname><given-names>R</given-names></name><name><surname>Simon-Ebert</surname><given-names>T</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex</article-title><source>Nature Protocols</source><volume>6</volume><fpage>214</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/nprot.2010.188</pub-id><pub-id pub-id-type="pmid">21293461</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Bergami</surname><given-names>M</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Lepier</surname><given-names>A</given-names></name><name><surname>Viganò</surname><given-names>F</given-names></name><name><surname>Dimou</surname><given-names>L</given-names></name><name><surname>Sutor</surname><given-names>B</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex</article-title><source>Stem Cell Reports</source><volume>3</volume><fpage>1000</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.10.007</pub-id><pub-id pub-id-type="pmid">25458895</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrero-Navarro</surname><given-names>Á</given-names></name><name><surname>Puche-Aroca</surname><given-names>L</given-names></name><name><surname>Moreno-Juan</surname><given-names>V</given-names></name><name><surname>Sempere-Ferràndez</surname><given-names>A</given-names></name><name><surname>Espinosa</surname><given-names>A</given-names></name><name><surname>Susín</surname><given-names>R</given-names></name><name><surname>Torres-Masjoan</surname><given-names>L</given-names></name><name><surname>Leyva-Díaz</surname><given-names>E</given-names></name><name><surname>Karow</surname><given-names>M</given-names></name><name><surname>Figueres-Oñate</surname><given-names>M</given-names></name><name><surname>López-Mascaraque</surname><given-names>L</given-names></name><name><surname>López-Atalaya</surname><given-names>JP</given-names></name><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>López-Bendito</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Astrocytes and neurons share region-specific transcriptional signatures that confer regional identity to neuronal reprogramming</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabe8978</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abe8978</pub-id><pub-id pub-id-type="pmid">33827819</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevner</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>From radial glia to pyramidal-projection neuron: transcription factor cascades in cerebral cortex development</article-title><source>Molecular Neurobiology</source><volume>33</volume><fpage>33</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1385/MN:33:1:033</pub-id><pub-id pub-id-type="pmid">16388109</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilscher</surname><given-names>MM</given-names></name><name><surname>Langseth</surname><given-names>CM</given-names></name><name><surname>Kukanja</surname><given-names>P</given-names></name><name><surname>Yokota</surname><given-names>C</given-names></name><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes</article-title><source>BMC Biology</source><volume>20</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-022-01325-z</pub-id><pub-id pub-id-type="pmid">35610641</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>T</given-names></name><name><surname>Suda</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Narimatsu</surname><given-names>M</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><name><surname>Hibi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Zinc finger gene fez-like functions in the formation of subplate neurons and thalamocortical axons</article-title><source>Developmental Dynamics</source><volume>230</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20068</pub-id><pub-id pub-id-type="pmid">15188439</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hisaoka</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Senba</surname><given-names>E</given-names></name><name><surname>Morikawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The forkhead transcription factors, Foxp1 and Foxp2, identify different subpopulations of projection neurons in the mouse cerebral cortex</article-title><source>Neuroscience</source><volume>166</volume><fpage>551</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.12.055</pub-id><pub-id pub-id-type="pmid">20040367</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Velmeshev</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Rottkamp</surname><given-names>CA</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Origins and proliferative states of human oligodendrocyte precursor cells</article-title><source>Cell</source><volume>182</volume><fpage>594</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.027</pub-id><pub-id pub-id-type="pmid">32679030</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>EG</given-names></name><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Fukaya</surname><given-names>M</given-names></name><name><surname>Bergles</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nn.3390</pub-id><pub-id pub-id-type="pmid">23624515</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulme</surname><given-names>AJ</given-names></name><name><surname>Maksour</surname><given-names>S</given-names></name><name><surname>St-Clair Glover</surname><given-names>M</given-names></name><name><surname>Miellet</surname><given-names>S</given-names></name><name><surname>Dottori</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation</article-title><source>Stem Cell Reports</source><volume>17</volume><fpage>14</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2021.11.015</pub-id><pub-id pub-id-type="pmid">34971564</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Sahni</surname><given-names>V</given-names></name><name><surname>Shnider</surname><given-names>SJ</given-names></name><name><surname>McKee</surname><given-names>H</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Inter-axonal molecular crosstalk via Lumican proteoglycan sculpts murine cervical corticospinal innervation by distinct subpopulations</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>112182</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112182</pub-id><pub-id pub-id-type="pmid">36934325</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janeckova</surname><given-names>L</given-names></name><name><surname>Knotek</surname><given-names>T</given-names></name><name><surname>Kriska</surname><given-names>J</given-names></name><name><surname>Hermanova</surname><given-names>Z</given-names></name><name><surname>Kirdajova</surname><given-names>D</given-names></name><name><surname>Kubovciak</surname><given-names>J</given-names></name><name><surname>Berkova</surname><given-names>L</given-names></name><name><surname>Tureckova</surname><given-names>J</given-names></name><name><surname>Camacho Garcia</surname><given-names>S</given-names></name><name><surname>Galuskova</surname><given-names>K</given-names></name><name><surname>Kolar</surname><given-names>M</given-names></name><name><surname>Anderova</surname><given-names>M</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Astrocyte-like subpopulation of NG2 glia in the adult mouse cortex exhibits characteristics of neural progenitor cells</article-title><source>Glia</source><volume>72</volume><fpage>245</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1002/glia.24471</pub-id><pub-id pub-id-type="pmid">37772368</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>S</given-names></name><name><surname>Banker</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Culturing hippocampal neurons</article-title><source>Nature Protocols</source><volume>1</volume><fpage>2406</fpage><lpage>2415</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.356</pub-id><pub-id pub-id-type="pmid">17406484</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempermann</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neurogenesis in the adult hippocampus</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a018812</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a018812</pub-id><pub-id pub-id-type="pmid">26330519</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempermann</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Adult neurogenesis: An evolutionary perspective</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>8</volume><elocation-id>a018986</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a018986</pub-id><pub-id pub-id-type="pmid">26684183</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempf</surname><given-names>J</given-names></name><name><surname>Knelles</surname><given-names>K</given-names></name><name><surname>Hersbach</surname><given-names>BA</given-names></name><name><surname>Petrik</surname><given-names>D</given-names></name><name><surname>Riedemann</surname><given-names>T</given-names></name><name><surname>Bednarova</surname><given-names>V</given-names></name><name><surname>Janjic</surname><given-names>A</given-names></name><name><surname>Simon-Ebert</surname><given-names>T</given-names></name><name><surname>Enard</surname><given-names>W</given-names></name><name><surname>Smialowski</surname><given-names>P</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Heterogeneity of neurons reprogrammed from spinal cord astrocytes by the proneural factors Ascl1 and Neurogenin2</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109409</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109409</pub-id><pub-id pub-id-type="pmid">34289357</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Fogarty</surname><given-names>M</given-names></name><name><surname>Iannarelli</surname><given-names>P</given-names></name><name><surname>Grist</surname><given-names>M</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/nn1620</pub-id><pub-id pub-id-type="pmid">16388308</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Doi</surname><given-names>A</given-names></name><name><surname>Wen</surname><given-names>B</given-names></name><name><surname>Ng</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Cahan</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Aryee</surname><given-names>MJ</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Ehrlich</surname><given-names>LIR</given-names></name><name><surname>Yabuuchi</surname><given-names>A</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Cunniff</surname><given-names>KC</given-names></name><name><surname>Hongguang</surname><given-names>H</given-names></name><name><surname>McKinney-Freeman</surname><given-names>S</given-names></name><name><surname>Naveiras</surname><given-names>O</given-names></name><name><surname>Yoon</surname><given-names>TJ</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Jung</surname><given-names>N</given-names></name><name><surname>Seita</surname><given-names>J</given-names></name><name><surname>Hanna</surname><given-names>J</given-names></name><name><surname>Murakami</surname><given-names>P</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Feinberg</surname><given-names>AP</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Epigenetic memory in induced pluripotent stem cells</article-title><source>Nature</source><volume>467</volume><fpage>285</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/nature09342</pub-id><pub-id pub-id-type="pmid">20644535</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirdajova</surname><given-names>D</given-names></name><name><surname>Valihrach</surname><given-names>L</given-names></name><name><surname>Valny</surname><given-names>M</given-names></name><name><surname>Kriska</surname><given-names>J</given-names></name><name><surname>Krocianova</surname><given-names>D</given-names></name><name><surname>Benesova</surname><given-names>S</given-names></name><name><surname>Abaffy</surname><given-names>P</given-names></name><name><surname>Zucha</surname><given-names>D</given-names></name><name><surname>Klassen</surname><given-names>R</given-names></name><name><surname>Kolenicova</surname><given-names>D</given-names></name><name><surname>Honsa</surname><given-names>P</given-names></name><name><surname>Kubista</surname><given-names>M</given-names></name><name><surname>Anderova</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transient astrocyte-like NG2 glia subpopulation emerges solely following permanent brain ischemia</article-title><source>Glia</source><volume>69</volume><fpage>2658</fpage><lpage>2681</lpage><pub-id pub-id-type="doi">10.1002/glia.24064</pub-id><pub-id pub-id-type="pmid">34314531</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovach</surname><given-names>C</given-names></name><name><surname>Dixit</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Mattar</surname><given-names>P</given-names></name><name><surname>Wilkinson</surname><given-names>G</given-names></name><name><surname>Elsen</surname><given-names>GE</given-names></name><name><surname>Kurrasch</surname><given-names>DM</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neurog2 simultaneously activates and represses alternative gene expression programs in the developing neocortex</article-title><source>Cerebral Cortex</source><volume>23</volume><fpage>1884</fpage><lpage>1900</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhs176</pub-id><pub-id pub-id-type="pmid">22735158</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krijger</surname><given-names>PHL</given-names></name><name><surname>Di Stefano</surname><given-names>B</given-names></name><name><surname>de Wit</surname><given-names>E</given-names></name><name><surname>Limone</surname><given-names>F</given-names></name><name><surname>van Oevelen</surname><given-names>C</given-names></name><name><surname>de Laat</surname><given-names>W</given-names></name><name><surname>Graf</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell-of-origin-specific 3D genome structure acquired during somatic cell reprogramming</article-title><source>Cell Stem Cell</source><volume>18</volume><fpage>597</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.01.007</pub-id><pub-id pub-id-type="pmid">26971819</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronenberg</surname><given-names>G</given-names></name><name><surname>Gertz</surname><given-names>K</given-names></name><name><surname>Cheung</surname><given-names>G</given-names></name><name><surname>Buffo</surname><given-names>A</given-names></name><name><surname>Kettenmann</surname><given-names>H</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Endres</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Modulation of fate determinants Olig2 and Pax6 in resident glia evokes spiking neuroblasts in a model of mild brain ischemia</article-title><source>Stroke</source><volume>41</volume><fpage>2944</fpage><lpage>2949</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.110.583039</pub-id><pub-id pub-id-type="pmid">21051674</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>HG</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><name><surname>Kempermann</surname><given-names>G</given-names></name><name><surname>Thal</surname><given-names>LJ</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain</article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>5820</fpage><lpage>5829</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-15-05820.1997</pub-id><pub-id pub-id-type="pmid">9221780</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>T</given-names></name><name><surname>Jabaudon</surname><given-names>D</given-names></name><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Azim</surname><given-names>E</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name><name><surname>Menezes</surname><given-names>JRL</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>SOX5 controls the sequential generation of distinct corticofugal neuron subtypes</article-title><source>Neuron</source><volume>57</volume><fpage>232</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.023</pub-id><pub-id pub-id-type="pmid">18215621</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Ruiz</surname><given-names>EC</given-names></name><name><surname>Pfaff</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>282</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1101/gad.1257105</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Evolution of the CNS myelin gene regulatory program</article-title><source>Brain Research</source><volume>1641</volume><fpage>111</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.10.013</pub-id><pub-id pub-id-type="pmid">26474911</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H-C</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Ebert</surname><given-names>S</given-names></name><name><surname>Schörnig</surname><given-names>M</given-names></name><name><surname>Santel</surname><given-names>M</given-names></name><name><surname>Nikolova</surname><given-names>MT</given-names></name><name><surname>Weigert</surname><given-names>A</given-names></name><name><surname>Hevers</surname><given-names>W</given-names></name><name><surname>Kasri</surname><given-names>NN</given-names></name><name><surname>Taverna</surname><given-names>E</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Treutlein</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>NGN2 induces diverse neuron types from human pluripotency</article-title><source>Stem Cell Reports</source><volume>16</volume><fpage>2118</fpage><lpage>2127</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2021.07.006</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Mandrycky</surname><given-names>N</given-names></name><name><surname>McNabb</surname><given-names>CT</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Fuchs</surname><given-names>PN</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Sheen</surname><given-names>V</given-names></name><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Mao</surname><given-names>M</given-names></name><name><surname>Richard Lu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region</article-title><source>Neurobiology of Disease</source><volume>77</volume><fpage>106</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2015.02.021</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In vivo clonal analysis reveals development heterogeneity of oligodendrocyte precursor cells derived from distinct germinal zones</article-title><source>Advanced Science</source><volume>8</volume><elocation-id>e2102274</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202102274</pub-id><pub-id pub-id-type="pmid">34396711</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodato</surname><given-names>S</given-names></name><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Zuccaro</surname><given-names>E</given-names></name><name><surname>Goff</surname><given-names>LA</given-names></name><name><surname>Chen</surname><given-names>H-H</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Meleski</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>E</given-names></name><name><surname>Mahony</surname><given-names>S</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Gifford</surname><given-names>DK</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>1046</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1038/nn.3757</pub-id><pub-id pub-id-type="pmid">24997765</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodato</surname><given-names>S</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Generating neuronal diversity in the mammalian cerebral cortex</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>31</volume><fpage>699</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100814-125353</pub-id><pub-id pub-id-type="pmid">26359774</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lois</surname><given-names>C</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia</article-title><source>PNAS</source><volume>90</volume><fpage>2074</fpage><lpage>2077</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.5.2074</pub-id><pub-id pub-id-type="pmid">8446631</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>V</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RNA-Seq workflow: gene-level exploratory analysis and differential expression</article-title><source>F1000Research</source><volume>4</volume><elocation-id>1070</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7035.2</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>JH</given-names></name><name><surname>Hansen</surname><given-names>DV</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Development and evolution of the human neocortex</article-title><source>Cell</source><volume>146</volume><fpage>18</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.06.030</pub-id><pub-id pub-id-type="pmid">21729779</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssiotis</surname><given-names>CA</given-names></name><name><surname>Walker</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Schultz</surname><given-names>PG</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells</article-title><source>PNAS</source><volume>104</volume><fpage>14982</fpage><lpage>14987</lpage><pub-id pub-id-type="doi">10.1073/pnas.0707044104</pub-id><pub-id pub-id-type="pmid">17855562</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magavi</surname><given-names>SS</given-names></name><name><surname>Leavitt</surname><given-names>BR</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Induction of neurogenesis in the neocortex of adult mice</article-title><source>Nature</source><volume>405</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1038/35016083</pub-id><pub-id pub-id-type="pmid">10879536</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>PK</given-names></name><name><surname>Rossi</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Reprogramming human fibroblasts to pluripotency using modified mRNA</article-title><source>Nature Protocols</source><volume>8</volume><fpage>568</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.019</pub-id><pub-id pub-id-type="pmid">23429718</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marisca</surname><given-names>R</given-names></name><name><surname>Hoche</surname><given-names>T</given-names></name><name><surname>Agirre</surname><given-names>E</given-names></name><name><surname>Hoodless</surname><given-names>LJ</given-names></name><name><surname>Barkey</surname><given-names>W</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functionally distinct subgroups of oligodendrocyte precursor cells integrate neural activity and execute myelin formation</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0581-2</pub-id><pub-id pub-id-type="pmid">32066987</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattar</surname><given-names>P</given-names></name><name><surname>Langevin</surname><given-names>LM</given-names></name><name><surname>Markham</surname><given-names>K</given-names></name><name><surname>Klenin</surname><given-names>N</given-names></name><name><surname>Shivji</surname><given-names>S</given-names></name><name><surname>Zinyk</surname><given-names>D</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Basic helix-loop-helix transcription factors cooperate to specify a cortical projection neuron identity</article-title><source>Molecular and Cellular Biology</source><volume>28</volume><fpage>1456</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1128/MCB.01510-07</pub-id><pub-id pub-id-type="pmid">18160702</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattugini</surname><given-names>N</given-names></name><name><surname>Bocchi</surname><given-names>R</given-names></name><name><surname>Scheuss</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>GL</given-names></name><name><surname>Torper</surname><given-names>O</given-names></name><name><surname>Lao</surname><given-names>CL</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inducing different neuronal subtypes from astrocytes in the injured mouse cerebral cortex</article-title><source>Neuron</source><volume>103</volume><fpage>1086</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.08.009</pub-id><pub-id pub-id-type="pmid">31488328</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>WL</given-names></name><name><surname>Betancourt</surname><given-names>J</given-names></name><name><surname>Larkin</surname><given-names>KA</given-names></name><name><surname>Abrams</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>549</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4131-10.2011</pub-id><pub-id pub-id-type="pmid">21228164</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Mills</surname><given-names>C</given-names></name><name><surname>Albou</surname><given-names>LP</given-names></name><name><surname>Mushayamaha</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D394</fpage><lpage>D403</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1106</pub-id><pub-id pub-id-type="pmid">33290554</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michelsen</surname><given-names>KA</given-names></name><name><surname>Acosta-Verdugo</surname><given-names>S</given-names></name><name><surname>Benoit-Marand</surname><given-names>M</given-names></name><name><surname>Espuny-Camacho</surname><given-names>I</given-names></name><name><surname>Gaspard</surname><given-names>N</given-names></name><name><surname>Saha</surname><given-names>B</given-names></name><name><surname>Gaillard</surname><given-names>A</given-names></name><name><surname>Vanderhaeghen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Area-specific reestablishment of damaged circuits in the adult cerebral cortex by cortical neurons derived from mouse embryonic stem cells</article-title><source>Neuron</source><volume>85</volume><fpage>982</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.02.001</pub-id><pub-id pub-id-type="pmid">25741724</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miskinyte</surname><given-names>G</given-names></name><name><surname>Devaraju</surname><given-names>K</given-names></name><name><surname>Grønning Hansen</surname><given-names>M</given-names></name><name><surname>Monni</surname><given-names>E</given-names></name><name><surname>Tornero</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>NB</given-names></name><name><surname>Bengzon</surname><given-names>J</given-names></name><name><surname>Ahlenius</surname><given-names>H</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks</article-title><source>Stem Cell Research &amp; Therapy</source><volume>8</volume><elocation-id>207</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-017-0658-3</pub-id><pub-id pub-id-type="pmid">28962665</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuguchi</surname><given-names>R</given-names></name><name><surname>Sugimori</surname><given-names>M</given-names></name><name><surname>Takebayashi</surname><given-names>H</given-names></name><name><surname>Kosako</surname><given-names>H</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Nabeshima</surname><given-names>Y</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons</article-title><source>Neuron</source><volume>31</volume><fpage>757</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00413-5</pub-id><pub-id pub-id-type="pmid">11567615</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name><name><surname>Hirata</surname><given-names>T</given-names></name><name><surname>Hibi</surname><given-names>M</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fezl is required for the birth and specification of corticospinal motor neurons</article-title><source>Neuron</source><volume>47</volume><fpage>817</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.030</pub-id><pub-id pub-id-type="pmid">16157277</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Goff</surname><given-names>LA</given-names></name><name><surname>Brettler</surname><given-names>AC</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Hrvatin</surname><given-names>S</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>DeCoN: genome-wide analysis of in vivo transcriptional dynamics during pyramidal neuron fate selection in neocortex</article-title><source>Neuron</source><volume>85</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.024</pub-id><pub-id pub-id-type="pmid">25556833</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najm</surname><given-names>FJ</given-names></name><name><surname>Lager</surname><given-names>AM</given-names></name><name><surname>Zaremba</surname><given-names>A</given-names></name><name><surname>Wyatt</surname><given-names>K</given-names></name><name><surname>Caprariello</surname><given-names>AV</given-names></name><name><surname>Factor</surname><given-names>DC</given-names></name><name><surname>Karl</surname><given-names>RT</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>RH</given-names></name><name><surname>Tesar</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>426</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1038/nbt.2561</pub-id><pub-id pub-id-type="pmid">23584611</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ninkovic</surname><given-names>J</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>How to make neurons--thoughts on the molecular logic of neurogenesis in the central nervous system</article-title><source>Cell and Tissue Research</source><volume>359</volume><fpage>5</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s00441-014-2048-9</pub-id><pub-id pub-id-type="pmid">25416507</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikimi</surname><given-names>M</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Tabata</surname><given-names>H</given-names></name><name><surname>Torii</surname><given-names>K</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Segregation and pathfinding of callosal axons through EphA3 signaling</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>16251</fpage><lpage>16260</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3303-11.2011</pub-id><pub-id pub-id-type="pmid">22072676</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DK</given-names></name><name><surname>Bachoo</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vivo reprogramming of astrocytes to neuroblasts in the adult brain</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>1164</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1038/ncb2843</pub-id><pub-id pub-id-type="pmid">24056302</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nord</surname><given-names>AS</given-names></name><name><surname>Pattabiraman</surname><given-names>K</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genomic perspectives of transcriptional regulation in forebrain development</article-title><source>Neuron</source><volume>85</volume><fpage>27</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.11.011</pub-id><pub-id pub-id-type="pmid">25569346</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novitch</surname><given-names>BG</given-names></name><name><surname>Chen</surname><given-names>AI</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2</article-title><source>Neuron</source><volume>31</volume><fpage>773</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00407-x</pub-id><pub-id pub-id-type="pmid">11567616</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohira</surname><given-names>K</given-names></name><name><surname>Furuta</surname><given-names>T</given-names></name><name><surname>Hioki</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>KC</given-names></name><name><surname>Kuramoto</surname><given-names>E</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Funatsu</surname><given-names>N</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Oishi</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ischemia-induced neurogenesis of neocortical layer 1 progenitor cells</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/nn.2473</pub-id><pub-id pub-id-type="pmid">20037576</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>DDM</given-names></name><name><surname>Chou</surname><given-names>S-J</given-names></name><name><surname>Sahara</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Area patterning of the mammalian cortex</article-title><source>Neuron</source><volume>56</volume><fpage>252</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.010</pub-id><pub-id pub-id-type="pmid">17964244</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdinler</surname><given-names>PH</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>IGF-I specifically enhances axon outgrowth of corticospinal motor neurons</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>1371</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1038/nn1789</pub-id><pub-id pub-id-type="pmid">17057708</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozerdem</surname><given-names>U</given-names></name><name><surname>Grako</surname><given-names>KA</given-names></name><name><surname>Dahlin-Huppe</surname><given-names>K</given-names></name><name><surname>Monosov</surname><given-names>E</given-names></name><name><surname>Stallcup</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis</article-title><source>Developmental Dynamics</source><volume>222</volume><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1002/dvdy.1200</pub-id><pub-id pub-id-type="pmid">11668599</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ozkan</surname><given-names>A</given-names></name><name><surname>MacDonald</surname><given-names>JL</given-names></name><name><surname>Fame</surname><given-names>RM</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name><name><surname>Durak</surname><given-names>O</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Specification of cortical projection neurons</chapter-title><person-group person-group-type="editor"><name><surname>Ozkan</surname><given-names>A</given-names></name></person-group><source>Patterning and Cell Type Specification in the Developing CNS and PNS</source><publisher-name>Elsevier</publisher-name><fpage>427</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-814405-3.00019-9</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patro</surname><given-names>R</given-names></name><name><surname>Duggal</surname><given-names>G</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Kingsford</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title><source>Nature Methods</source><volume>14</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id><pub-id pub-id-type="pmid">28263959</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfrieger</surname><given-names>FW</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Synaptic efficacy enhanced by glial cells in vitro</article-title><source>Science</source><volume>277</volume><fpage>1684</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1126/science.277.5332.1684</pub-id><pub-id pub-id-type="pmid">9287225</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polo</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Figueroa</surname><given-names>ME</given-names></name><name><surname>Kulalert</surname><given-names>W</given-names></name><name><surname>Eminli</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>KY</given-names></name><name><surname>Apostolou</surname><given-names>E</given-names></name><name><surname>Stadtfeld</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shioda</surname><given-names>T</given-names></name><name><surname>Natesan</surname><given-names>S</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name><name><surname>Melnick</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>T</given-names></name><name><surname>Hochedlinger</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>848</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1038/nbt.1667</pub-id><pub-id pub-id-type="pmid">20644536</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>Z</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Maimon</surname><given-names>R</given-names></name><name><surname>Dowdy</surname><given-names>SF</given-names></name><name><surname>Devaraj</surname><given-names>NK</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Fu</surname><given-names>XD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reversing a model of Parkinson’s disease with <italic>in situ</italic> converted nigral neurons</article-title><source>Nature</source><volume>582</volume><fpage>550</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2388-4</pub-id><pub-id pub-id-type="pmid">32581380</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ramón y Cajal</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1995">1995</year><source>Histology of the Nervous System of Man and Vertebrates</source><publisher-name>Oxford University Press</publisher-name><pub-id pub-id-type="doi">10.1093/oso/9780195074017.001.0001</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>BA</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system</article-title><source>Science</source><volume>255</volume><fpage>1707</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1126/science.1553558</pub-id><pub-id pub-id-type="pmid">1553558</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietze</surname><given-names>RL</given-names></name><name><surname>Valcanis</surname><given-names>H</given-names></name><name><surname>Brooker</surname><given-names>GF</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Bartlett</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Purification of a pluripotent neural stem cell from the adult mouse brain</article-title><source>Nature</source><volume>412</volume><fpage>736</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1038/35089085</pub-id><pub-id pub-id-type="pmid">11507641</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivers</surname><given-names>LE</given-names></name><name><surname>Young</surname><given-names>KM</given-names></name><name><surname>Rizzi</surname><given-names>M</given-names></name><name><surname>Jamen</surname><given-names>F</given-names></name><name><surname>Psachoulia</surname><given-names>K</given-names></name><name><surname>Wade</surname><given-names>A</given-names></name><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice</article-title><source>Nature Neuroscience</source><volume>11</volume><fpage>1392</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1038/nn.2220</pub-id><pub-id pub-id-type="pmid">18849983</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivetti di Val Cervo</surname><given-names>P</given-names></name><name><surname>Romanov</surname><given-names>RA</given-names></name><name><surname>Spigolon</surname><given-names>G</given-names></name><name><surname>Masini</surname><given-names>D</given-names></name><name><surname>Martín-Montañez</surname><given-names>E</given-names></name><name><surname>Toledo</surname><given-names>EM</given-names></name><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Feyder</surname><given-names>M</given-names></name><name><surname>Pifl</surname><given-names>C</given-names></name><name><surname>Ng</surname><given-names>YH</given-names></name><name><surname>Sánchez</surname><given-names>SP</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Harkany</surname><given-names>T</given-names></name><name><surname>Fisone</surname><given-names>G</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson’s disease model</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>444</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/nbt.3835</pub-id><pub-id pub-id-type="pmid">28398344</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessler</surname><given-names>R</given-names></name><name><surname>Smallwood</surname><given-names>SA</given-names></name><name><surname>Veenvliet</surname><given-names>JV</given-names></name><name><surname>Pechlivanoglou</surname><given-names>P</given-names></name><name><surname>Peng</surname><given-names>S-P</given-names></name><name><surname>Chakrabarty</surname><given-names>K</given-names></name><name><surname>Groot-Koerkamp</surname><given-names>MJA</given-names></name><name><surname>Pasterkamp</surname><given-names>RJ</given-names></name><name><surname>Wesseling</surname><given-names>E</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Boddeke</surname><given-names>E</given-names></name><name><surname>Smidt</surname><given-names>MP</given-names></name><name><surname>Copray</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons</article-title><source>Stem Cell Reports</source><volume>2</volume><fpage>520</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.03.001</pub-id><pub-id pub-id-type="pmid">24749075</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>F</given-names></name><name><surname>Dhingra</surname><given-names>A</given-names></name><name><surname>Uysal</surname><given-names>B</given-names></name><name><surname>Mendis</surname><given-names>GDC</given-names></name><name><surname>Loeffler</surname><given-names>H</given-names></name><name><surname>Elsen</surname><given-names>G</given-names></name><name><surname>Mueller</surname><given-names>S</given-names></name><name><surname>Schwarz</surname><given-names>N</given-names></name><name><surname>Castillo-Lizardo</surname><given-names>M</given-names></name><name><surname>Cuddy</surname><given-names>C</given-names></name><name><surname>Becker</surname><given-names>F</given-names></name><name><surname>Heutink</surname><given-names>P</given-names></name><name><surname>Reid</surname><given-names>CA</given-names></name><name><surname>Petrou</surname><given-names>S</given-names></name><name><surname>Lerche</surname><given-names>H</given-names></name><name><surname>Maljevic</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>In vitro differentiated human stem cell-derived neurons reproduce synaptic synchronicity arising during neurodevelopment</article-title><source>Stem Cell Reports</source><volume>15</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2020.05.015</pub-id><pub-id pub-id-type="pmid">32559460</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rösler</surname><given-names>KM</given-names></name><name><surname>Truffert</surname><given-names>A</given-names></name><name><surname>Hess</surname><given-names>CW</given-names></name><name><surname>Magistris</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Quantification of upper motor neuron loss in amyotrophic lateral sclerosis</article-title><source>Clinical Neurophysiology</source><volume>111</volume><fpage>2208</fpage><lpage>2218</lpage><pub-id pub-id-type="doi">10.1016/s1388-2457(00)00481-8</pub-id><pub-id pub-id-type="pmid">11090774</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouaux</surname><given-names>C</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fezf2 directs the differentiation of corticofugal neurons from striatal progenitors in vivo</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>1345</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1038/nn.2658</pub-id><pub-id pub-id-type="pmid">20953195</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadegh</surname><given-names>C</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Established monolayer differentiation of mouse embryonic stem cells generates heterogeneous neocortical-like neurons stalled at a stage equivalent to midcorticogenesis</article-title><source>The Journal of Comparative Neurology</source><volume>522</volume><fpage>2691</fpage><lpage>2706</lpage><pub-id pub-id-type="doi">10.1002/cne.23576</pub-id><pub-id pub-id-type="pmid">24610556</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname><given-names>U</given-names></name><name><surname>Karikó</surname><given-names>K</given-names></name><name><surname>Türeci</surname><given-names>Ö</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mRNA-based therapeutics--developing a new class of drugs</article-title><source>Nature Reviews. Drug Discovery</source><volume>13</volume><fpage>759</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1038/nrd4278</pub-id><pub-id pub-id-type="pmid">25233993</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sahni</surname><given-names>V</given-names></name><name><surname>Engmann</surname><given-names>A</given-names></name><name><surname>Ozkan</surname><given-names>A</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Motor cortex connections</chapter-title><person-group person-group-type="editor"><name><surname>Sahni</surname><given-names>V</given-names></name></person-group><source>Neural Circuit and Cognitive Development</source><publisher-name>Elsevier</publisher-name><fpage>167</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-814411-4.00008-1</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahni</surname><given-names>V</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Shnider</surname><given-names>SJ</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Crim1 and Kelch-like 14 exert complementary dual-directional developmental control over segmentally specific corticospinal axon projection targeting</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>109842</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109842</pub-id><pub-id pub-id-type="pmid">34686337</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahni</surname><given-names>V</given-names></name><name><surname>Shnider</surname><given-names>SJ</given-names></name><name><surname>Jabaudon</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>JHT</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Corticospinal neuron subpopulation-specific developmental genes prospectively indicate mature segmentally specific axon projection targeting</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>109843</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109843</pub-id><pub-id pub-id-type="pmid">34686320</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sances</surname><given-names>S</given-names></name><name><surname>Bruijn</surname><given-names>LI</given-names></name><name><surname>Chandran</surname><given-names>S</given-names></name><name><surname>Eggan</surname><given-names>K</given-names></name><name><surname>Ho</surname><given-names>R</given-names></name><name><surname>Klim</surname><given-names>JR</given-names></name><name><surname>Livesey</surname><given-names>MR</given-names></name><name><surname>Lowry</surname><given-names>E</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name><name><surname>Rushton</surname><given-names>D</given-names></name><name><surname>Sadegh</surname><given-names>C</given-names></name><name><surname>Sareen</surname><given-names>D</given-names></name><name><surname>Wichterle</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>SC</given-names></name><name><surname>Svendsen</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Modeling ALS with motor neurons derived from human induced pluripotent stem cells</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>542</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1038/nn.4273</pub-id><pub-id pub-id-type="pmid">27021939</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez-González</surname><given-names>R</given-names></name><name><surname>Bribián</surname><given-names>A</given-names></name><name><surname>López-Mascaraque</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell fate potential of NG2 progenitors</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>9876</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66753-9</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration</article-title><source>Neuron</source><volume>71</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.06.031</pub-id><pub-id pub-id-type="pmid">21745636</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuurmans</surname><given-names>C</given-names></name><name><surname>Armant</surname><given-names>O</given-names></name><name><surname>Nieto</surname><given-names>M</given-names></name><name><surname>Stenman</surname><given-names>JM</given-names></name><name><surname>Britz</surname><given-names>O</given-names></name><name><surname>Klenin</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Langevin</surname><given-names>L-M</given-names></name><name><surname>Seibt</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Cunningham</surname><given-names>JM</given-names></name><name><surname>Dyck</surname><given-names>R</given-names></name><name><surname>Walsh</surname><given-names>C</given-names></name><name><surname>Campbell</surname><given-names>K</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>2892</fpage><lpage>2902</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600278</pub-id><pub-id pub-id-type="pmid">15229646</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheta</surname><given-names>R</given-names></name><name><surname>Teixeira</surname><given-names>M</given-names></name><name><surname>Idi</surname><given-names>W</given-names></name><name><surname>Pierre</surname><given-names>M</given-names></name><name><surname>de Rus Jacquet</surname><given-names>A</given-names></name><name><surname>Emond</surname><given-names>V</given-names></name><name><surname>Zorca</surname><given-names>CE</given-names></name><name><surname>Vanderperre</surname><given-names>B</given-names></name><name><surname>Durcan</surname><given-names>TM</given-names></name><name><surname>Fon</surname><given-names>EA</given-names></name><name><surname>Calon</surname><given-names>F</given-names></name><name><surname>Chahine</surname><given-names>M</given-names></name><name><surname>Oueslati</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>17176</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-22158-4</pub-id><pub-id pub-id-type="pmid">36229560</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Gulden</surname><given-names>FO</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>From trans to cis: transcriptional regulatory networks in neocortical development</article-title><source>Trends in Genetics</source><volume>31</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2014.12.004</pub-id><pub-id pub-id-type="pmid">25624274</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojo</surname><given-names>H</given-names></name><name><surname>Ohtsuka</surname><given-names>T</given-names></name><name><surname>Kageyama</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dynamic expression of notch signaling genes in neural stem/progenitor cells</article-title><source>Frontiers in Neuroscience</source><volume>5</volume><elocation-id>e00078</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2011.00078</pub-id><pub-id pub-id-type="pmid">21716644</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smits</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Mandel</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>de Crombrugghe</surname><given-names>B</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The transcription factors L-Sox5 and Sox6 are essential for cartilage formation</article-title><source>Developmental Cell</source><volume>1</volume><fpage>277</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(01)00003-x</pub-id><pub-id pub-id-type="pmid">11702786</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Research</source><volume>4</volume><elocation-id>1521</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>SO</given-names></name><name><surname>Sitnikov</surname><given-names>S</given-names></name><name><surname>Kamen</surname><given-names>Y</given-names></name><name><surname>Evans</surname><given-names>KA</given-names></name><name><surname>Kronenberg-Versteeg</surname><given-names>D</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>de Faria</surname><given-names>O</given-names></name><name><surname>Agathou</surname><given-names>S</given-names></name><name><surname>Káradóttir</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Oligodendrocyte progenitor cells become regionally diverse and heterogeneous with age</article-title><source>Neuron</source><volume>101</volume><fpage>459</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.020</pub-id><pub-id pub-id-type="pmid">30654924</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>K</given-names></name><name><surname>Leone</surname><given-names>DP</given-names></name><name><surname>Bateson</surname><given-names>RK</given-names></name><name><surname>Dobreva</surname><given-names>G</given-names></name><name><surname>Kohwi</surname><given-names>Y</given-names></name><name><surname>Kohwi-Shigematsu</surname><given-names>T</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A network of genetic repression and derepression specifies projection fates in the developing neocortex</article-title><source>PNAS</source><volume>109</volume><fpage>19071</fpage><lpage>19078</lpage><pub-id pub-id-type="doi">10.1073/pnas.1216793109</pub-id><pub-id pub-id-type="pmid">23144223</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbaugh</surname><given-names>MJ</given-names></name><name><surname>Pantano</surname><given-names>L</given-names></name><name><surname>Kirchner</surname><given-names>RD</given-names></name><name><surname>Barrera</surname><given-names>V</given-names></name><name><surname>Chapman</surname><given-names>BA</given-names></name><name><surname>Piper</surname><given-names>ME</given-names></name><name><surname>Mistry</surname><given-names>M</given-names></name><name><surname>Khetani</surname><given-names>RS</given-names></name><name><surname>Rutherford</surname><given-names>KD</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Hutchinson</surname><given-names>JN</given-names></name><name><surname>Ho Sui</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>bcbioRNASeq: R package for bcbio RNA-seq analysis</article-title><source>F1000Research</source><volume>6</volume><elocation-id>1976</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.12093.2</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolt</surname><given-names>CC</given-names></name><name><surname>Schlierf</surname><given-names>A</given-names></name><name><surname>Lommes</surname><given-names>P</given-names></name><name><surname>Hillgärtner</surname><given-names>S</given-names></name><name><surname>Werner</surname><given-names>T</given-names></name><name><surname>Kosian</surname><given-names>T</given-names></name><name><surname>Sock</surname><given-names>E</given-names></name><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function</article-title><source>Developmental Cell</source><volume>11</volume><fpage>697</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.08.011</pub-id><pub-id pub-id-type="pmid">17084361</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugino</surname><given-names>K</given-names></name><name><surname>Hempel</surname><given-names>CM</given-names></name><name><surname>Miller</surname><given-names>MN</given-names></name><name><surname>Hattox</surname><given-names>AM</given-names></name><name><surname>Shapiro</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Nelson</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular taxonomy of major neuronal classes in the adult mouse forebrain</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1038/nn1618</pub-id><pub-id pub-id-type="pmid">16369481</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymczak</surname><given-names>AL</given-names></name><name><surname>Workman</surname><given-names>CJ</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Vignali</surname><given-names>KM</given-names></name><name><surname>Dilioglou</surname><given-names>S</given-names></name><name><surname>Vanin</surname><given-names>EF</given-names></name><name><surname>Vignali</surname><given-names>DAA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Correction of multi-gene deficiency in vivo using a single “self-cleaving” 2A peptide-based retroviral vector</article-title><source>Nature Biotechnology</source><volume>22</volume><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1038/nbt957</pub-id><pub-id pub-id-type="pmid">15064769</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Ehrlich</surname><given-names>I</given-names></name><name><surname>Wolff</surname><given-names>SBE</given-names></name><name><surname>Michalski</surname><given-names>A-M</given-names></name><name><surname>Wölfl</surname><given-names>S</given-names></name><name><surname>Hasan</surname><given-names>MT</given-names></name><name><surname>Lüthi</surname><given-names>A</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>8621</fpage><lpage>8629</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0359-09.2009</pub-id><pub-id pub-id-type="pmid">19587267</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Graybuck</surname><given-names>LT</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Bertagnolli</surname><given-names>D</given-names></name><name><surname>Goldy</surname><given-names>J</given-names></name><name><surname>Garren</surname><given-names>E</given-names></name><name><surname>Economo</surname><given-names>MN</given-names></name><name><surname>Viswanathan</surname><given-names>S</given-names></name><name><surname>Penn</surname><given-names>O</given-names></name><name><surname>Bakken</surname><given-names>T</given-names></name><name><surname>Menon</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Fong</surname><given-names>O</given-names></name><name><surname>Hirokawa</surname><given-names>KE</given-names></name><name><surname>Lathia</surname><given-names>K</given-names></name><name><surname>Rimorin</surname><given-names>C</given-names></name><name><surname>Tieu</surname><given-names>M</given-names></name><name><surname>Larsen</surname><given-names>R</given-names></name><name><surname>Casper</surname><given-names>T</given-names></name><name><surname>Barkan</surname><given-names>E</given-names></name><name><surname>Kroll</surname><given-names>M</given-names></name><name><surname>Parry</surname><given-names>S</given-names></name><name><surname>Shapovalova</surname><given-names>NV</given-names></name><name><surname>Hirschstein</surname><given-names>D</given-names></name><name><surname>Pendergraft</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>HA</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Szafer</surname><given-names>A</given-names></name><name><surname>Dee</surname><given-names>N</given-names></name><name><surname>Groblewski</surname><given-names>P</given-names></name><name><surname>Wickersham</surname><given-names>I</given-names></name><name><surname>Cetin</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>JA</given-names></name><name><surname>Levi</surname><given-names>BP</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Daigle</surname><given-names>TL</given-names></name><name><surname>Looger</surname><given-names>L</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>J</given-names></name><name><surname>Lein</surname><given-names>E</given-names></name><name><surname>Hawrylycz</surname><given-names>M</given-names></name><name><surname>Svoboda</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Shared and distinct transcriptomic cell types across neocortical areas</article-title><source>Nature</source><volume>563</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0654-5</pub-id><pub-id pub-id-type="pmid">30382198</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taverna</surname><given-names>E</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>465</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155801</pub-id><pub-id pub-id-type="pmid">25000993</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Gene Ontology Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>The gene ontology resource: 20 years and still GOing strong</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D330</fpage><lpage>D338</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1055</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torper</surname><given-names>O</given-names></name><name><surname>Ottosson</surname><given-names>DR</given-names></name><name><surname>Pereira</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>S</given-names></name><name><surname>Cardoso</surname><given-names>T</given-names></name><name><surname>Grealish</surname><given-names>S</given-names></name><name><surname>Parmar</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vivo reprogramming of striatal NG2 Glia into functional neurons that integrate into local host circuitry</article-title><source>Cell Reports</source><volume>12</volume><fpage>474</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.040</pub-id><pub-id pub-id-type="pmid">26166567</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treutlein</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>QY</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Mall</surname><given-names>M</given-names></name><name><surname>Koh</surname><given-names>W</given-names></name><name><surname>Shariati</surname><given-names>SAM</given-names></name><name><surname>Sim</surname><given-names>S</given-names></name><name><surname>Neff</surname><given-names>NF</given-names></name><name><surname>Skotheim</surname><given-names>JM</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq</article-title><source>Nature</source><volume>534</volume><fpage>391</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/nature18323</pub-id><pub-id pub-id-type="pmid">27281220</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>RB</given-names></name><name><surname>Clarke</surname><given-names>LE</given-names></name><name><surname>Burzomato</surname><given-names>V</given-names></name><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>PN</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>6809</fpage><lpage>6819</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6474-10.2011</pub-id><pub-id pub-id-type="pmid">21543611</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotter</surname><given-names>J</given-names></name><name><surname>Karram</surname><given-names>K</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NG2 cells: Properties, progeny and origin</article-title><source>Brain Research Reviews</source><volume>63</volume><fpage>72</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2009.12.006</pub-id><pub-id pub-id-type="pmid">20043946</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoa</surname><given-names>RW</given-names></name><name><surname>Coskun</surname><given-names>V</given-names></name><name><surname>Ho</surname><given-names>CK</given-names></name><name><surname>de Vellis</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>YE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain</article-title><source>PNAS</source><volume>111</volume><fpage>7444</fpage><lpage>7449</lpage><pub-id pub-id-type="doi">10.1073/pnas.1400422111</pub-id><pub-id pub-id-type="pmid">24799701</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Veeraraghavan</surname><given-names>P</given-names></name><name><surname>Engmann</surname><given-names>AK</given-names></name><name><surname>Hatch</surname><given-names>JJ</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Addison</surname><given-names>T</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Dynamic subtype- and context-specific subcellular RNA regulation in growth cones of developing neurons of the cerebral cortex</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.09.24.559186</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viganò</surname><given-names>F</given-names></name><name><surname>Dimou</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The heterogeneous nature of NG2-glia</article-title><source>Brain Research</source><volume>1638</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.09.012</pub-id><pub-id pub-id-type="pmid">26388262</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>L</given-names></name><name><surname>Manos</surname><given-names>PD</given-names></name><name><surname>Ahfeldt</surname><given-names>T</given-names></name><name><surname>Loh</surname><given-names>Y-H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Lau</surname><given-names>F</given-names></name><name><surname>Ebina</surname><given-names>W</given-names></name><name><surname>Mandal</surname><given-names>PK</given-names></name><name><surname>Smith</surname><given-names>ZD</given-names></name><name><surname>Meissner</surname><given-names>A</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name><name><surname>Brack</surname><given-names>AS</given-names></name><name><surname>Collins</surname><given-names>JJ</given-names></name><name><surname>Cowan</surname><given-names>C</given-names></name><name><surname>Schlaeger</surname><given-names>TM</given-names></name><name><surname>Rossi</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA</article-title><source>Cell Stem Cell</source><volume>7</volume><fpage>618</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.08.012</pub-id><pub-id pub-id-type="pmid">20888316</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodworth</surname><given-names>MB</given-names></name><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>SnapShot: cortical development</article-title><source>Cell</source><volume>151</volume><elocation-id>918.e1</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2012.10.004</pub-id><pub-id pub-id-type="pmid">23141546</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodworth</surname><given-names>MB</given-names></name><name><surname>Greig</surname><given-names>LC</given-names></name><name><surname>Liu</surname><given-names>KX</given-names></name><name><surname>Ippolito</surname><given-names>GC</given-names></name><name><surname>Tucker</surname><given-names>HO</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ctip1 regulates the balance between specification of distinct projection neuron subtypes in deep cortical layers</article-title><source>Cell Reports</source><volume>15</volume><fpage>999</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.064</pub-id><pub-id pub-id-type="pmid">27117402</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Parry</surname><given-names>M</given-names></name><name><surname>Hou</surname><given-names>XY</given-names></name><name><surname>Liu</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cain</surname><given-names>R</given-names></name><name><surname>Pei</surname><given-names>ZF</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Guo</surname><given-names>ZY</given-names></name><name><surname>Abhijeet</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s disease</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1105</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14855-3</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuttke</surname><given-names>TV</given-names></name><name><surname>Markopoulos</surname><given-names>F</given-names></name><name><surname>Padmanabhan</surname><given-names>H</given-names></name><name><surname>Wheeler</surname><given-names>AP</given-names></name><name><surname>Murthy</surname><given-names>VN</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Developmentally primed cortical neurons maintain fidelity of differentiation and establish appropriate functional connectivity after transplantation</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>517</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0098-0</pub-id><pub-id pub-id-type="pmid">29507412</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pak</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Ahlenius</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chanda</surname><given-names>S</given-names></name><name><surname>Marro</surname><given-names>S</given-names></name><name><surname>Patzke</surname><given-names>C</given-names></name><name><surname>Acuna</surname><given-names>C</given-names></name><name><surname>Covy</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Danko</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rapid single-step induction of functional neurons from human pluripotent stem cells</article-title><source>Neuron</source><volume>78</volume><fpage>785</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.029</pub-id><pub-id pub-id-type="pmid">23764284</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sloan</surname><given-names>SA</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Scholze</surname><given-names>AR</given-names></name><name><surname>O’Keeffe</surname><given-names>S</given-names></name><name><surname>Phatnani</surname><given-names>HP</given-names></name><name><surname>Guarnieri</surname><given-names>P</given-names></name><name><surname>Caneda</surname><given-names>C</given-names></name><name><surname>Ruderisch</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>11929</fpage><lpage>11947</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id><pub-id pub-id-type="pmid">25186741</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Choi</surname><given-names>G</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2</article-title><source>Neuron</source><volume>31</volume><fpage>791</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00414-7</pub-id><pub-id pub-id-type="pmid">11567617</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Bergles</surname><given-names>DE</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008a</year><article-title>NG2 cells generate both oligodendrocytes and gray matter astrocytes</article-title><source>Development</source><volume>135</volume><fpage>145</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1242/dev.004895</pub-id><pub-id pub-id-type="pmid">18045844</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Hill</surname><given-names>RA</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008b</year><article-title>NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord</article-title><source>Neuron Glia Biology</source><volume>4</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1017/S1740925X09000015</pub-id><pub-id pub-id-type="pmid">19006598</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100340.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Corbin</surname><given-names>Joshua</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Children's National Hospital</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>This study presents <bold>fundamental</bold> new findings introducing a new approach for the reprogramming of brain glial cells to corticospinal neurons. The data is highly <bold>compelling</bold>, with multiple lines of evidence demonstrating the success of this new assay. These exciting findings set the stage for future studies of the potential of these reprogrammed cells to form functional connections <italic>in vivo</italic> and their utility in clinical conditions where corticospinal neurons are compromised.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100340.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript by Ozcan et al., presents compelling evidence demonstrating the latent potential of glial precursors of the adult cerebral cortex for neuronal reprogramming. The findings substantially advance our understanding of the potential of endogenous cells in the adult brain to be reprogrammed. Moreover, they describe a molecular cocktail that directs reprogramming toward corticospinal neurons (CSN).</p><p>Strengths:</p><p>Experimentally, the work is compelling and beautifully designed. The work provides a characterization of endogenous progenitors, genetic strategies to isolate them, and proof of concept of exploiting these progenitors' potential to produce a specific desired neuronal type with &quot;a la carte&quot; combination of transcription factors.</p><p>Weaknesses:</p><p>This study demonstrates reprogramming <italic>in vitro</italic>. Future research will need to assess how these reprogrammed corticospinal neurons integrate and function under physiological conditions and in models of trauma or neurodegeneration.</p><p>Although still in its early stages, neural reprogramming holds significant promise. This study reinforces the hope that, in the future, it may be possible to restore lost or damaged neurons through targeted cellular reprogramming.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100340.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Here the authors show a novel direct neuronal reprogramming model using a very pure culture system of oligodendrocyte progenitor cells and demonstrate hallmarks of corticospinal neurons to be induced when using Neurogenin2, a dominant-negative form of Olig2 in combination with the CSN master regulator Fezf2.</p><p>Strengths:</p><p>This is a major achievement as the specification of reprogrammed neurons towards adequate neuronal subtypes is crucial for repair and is still largely missing. The work is carefully done, and the comparison of the neurons induced only by Neurogenin 2 versus the NVOF cocktail is very interesting and convincingly demonstrates a further subtype specification by the cocktail.</p><p>Weaknesses:</p><p>As carefully as it is done <italic>in vitro</italic>, the identity of projection neurons can best be assessed <italic>in vivo</italic>. If this is not possible, it could be interesting to co-culture different brain regions and see if these neurons reprogrammed with the cocktail, indeed preferentially send out axons to innervate a co-cultured spinal cord versus other brain region tissue.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100340.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ozkan</surname><given-names>Abdulkadir</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard University</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Padmanabhan</surname><given-names>Hari K</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard University</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Shipman</surname><given-names>Seth L</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Azim</surname><given-names>Eiman</given-names></name><role specific-use="author">Author</role><aff><institution>Salk Institute for Biological Studies</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Priyanka</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard University</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sadegh</surname><given-names>Cameron</given-names></name><role specific-use="author">Author</role><aff><institution>Department of Neurological Surgery, University of California Davis, Sacramento</institution><addr-line><named-content content-type="city">Sacramento</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Basak</surname><given-names>A Nazli</given-names></name><role specific-use="author">Author</role><aff><institution>Koç University, School of Medicine Translational Medicine Research Center</institution><addr-line><named-content content-type="city">Istanbul</named-content></addr-line><country>Turkey</country></aff></contrib><contrib contrib-type="author"><name><surname>Macklis</surname><given-names>Jeffrey D</given-names></name><role specific-use="author">Author</role><aff><institution>Department of Stem Cell and Regenerative Biology, and Center for Brain Science, Harvard University</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The manuscript by Ozcan et al., presents compelling evidence demonstrating the latent potential of glial precursors of the adult cerebral cortex for neuronal reprogramming. The findings substantially advance our understanding of the potential of endogenous cells in the adult brain to be reprogrammed. Moreover, they describe a molecular cocktail that directs reprogramming toward corticospinal neurons (CSN).</p><p>Strengths:</p><p>Experimentally, the work is compelling and beautifully designed, with no major caveats. The main conclusions are fully supported by the experiments. The work provides a characterization of endogenous progenitors, genetic strategies to isolate them, and proof of concept of exploiting these progenitors' potential to produce a specific desired neuronal type with &quot;a la carte&quot; combination of transcription factors.</p><p>Weaknesses:</p><p>Some issues need to be addressed or clarified before publication. The manuscript requires editing. It is dense and rich in details while in other parts there are a few mistakes.</p></disp-quote><p>We thank the reviewer for their excellent summary and for their extremely positive review of our paper. We are pleased that the experimental design and conclusions were judged to be wellsupported.</p><p>We have revised the paper to enhance clarity, include additional relevant citations, and refine terminology in some sections of the original version.</p><p>We appreciate the reviewer’s thoughtful review and agree that these revisions enhance the paper.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>Here the authors show a novel direct neuronal reprogramming model using a very pure culture system of oligodendrocyte progenitor cells and demonstrate hallmarks of corticospinal neurons to be induced when using Neurogenin2, a dominant-negative form of Olig2 in combination with the CSN master regulator Fezf2.</p><p>Strengths:</p><p>This is a major achievement as the specification of reprogrammed neurons towards adequate neuronal subtypes is crucial for repair and still largely missing. The work is carefully done and the comparison of the neurons induced only by Neurogenin 2 versus the NVOF cocktail is very interesting and convincingly demonstrates a further subtype specification by the cocktail.</p><p>Weaknesses:</p><p>As carefully as it is done <italic>in vitro</italic>, the identity of projection neurons can best be assessed <italic>in vivo</italic>. If this is not possible, it could be interesting to co-culture different brain regions and see if these neurons reprogrammed with the cocktail, indeed preferentially send out axons to innervate a co-cultured spinal cord versus other brain region tissue.</p></disp-quote><p>We appreciate the reviewer’s positive evaluation of our work and their recognition of its significance in advancing neuronal subtype specification through directed differentiation of endogenous progenitors.</p><p>We agree with the reviewer’s suggestion that a very interesting future stage of this work would be to investigate the projection neuron identity <italic>in vivo</italic>. We aim to pursue follow-up studies to investigate <italic>in vivo</italic> integration and connectivity of such neurons generated by directed differentiation from endogenous SOX6+/NG2+ cortical progenitors. As the reviewer insightfully suggests, co-culturing different brain regions with these neurons could offer an alternative strategy to partially assess potential preferential connectivity into cultured spinal cord vs. alternate tissue.</p><p>We agree with the reviewer that future investigation <italic>in vivo</italic> will further strengthen the implications of this work.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review)</bold>:</p><p>Summary:</p><p>Ozkan, Padmanabhan, and colleagues aim to develop a lineage reprogramming strategy towards generating subcerebral projection neurons from endogenous glia with the specificity needed for disease modelling and brain repair. They set out by targeting specifically SOX6-positive NG2 glia. This choice is motivated by the authors' observation that the early postnatal forebrain of <italic>Sox6</italic> knockout mice displays marked ectopic expression of the proneural transcription factor (TF) Neurog2, suggesting a latent neurogenic program may be derepressed in NG2 cells, which normally express <italic>Sox6</italic>. Cultured NG2 glia transfected with a construct (&quot;NVOF&quot;) encoding Neurog2, the corticofugal neuron-specifying TF Fezf2, and a constitutive repressor form of Olig2 are efficiently reprogrammed to neurons. These acquire complex morphologies resembling those of mature endogenous neurons and are characterized by fewer abnormalities when compared to neurons induced by Neurog2 alone. NVOF-induced neurons, as a population, also express a narrower range of cortical neuron subtype-specific markers, suggesting narrowed subtype specification, a potential step forward for Neurog2-driven neuronal reprogramming. Comparison of NVOF- and Neurog2-induced neurons to endogenous subcerebral projection neurons (SCPN) also indicates Fezf2 may aid Neurog2 in directing the generation of SCPN-like neurons at the expense of other cortical neuronal subtypes.</p><p>Strengths:</p><p>The report describes a novel, highly homogeneous <italic>in vitro</italic> system amenable to efficient reprogramming. The authors provide evidence that Fezf2 shapes the outcome of Neurog2-driven reprogramming towards a subcerebral projection neuron identity, consistent with its known developmental roles. Also, the use of the modified RNA for transient expression of Neurog2 is very elegant.</p><p>Weaknesses:</p><p>The molecular characterization of NVOF-induced neurons is carried out at the bulk level, therefore not allowing to fully assess heterogeneity among NVOF-induced neurons. The suggestion of a latent neurogenic potential in postnatal cortical glia is only partially supported by the data from the <italic>Sox6</italic> knockout. Finally, some of the many exciting implications of the study remain untested.</p><p>Discussion:</p><p>The study has many exciting implications that could be further tested. For example, an ultimate proof of the subcerebral projection neuron identity would be to graft NVOF cells into neonatal mice and study their projections. Another important implication is that <italic>Sox6</italic>-deficient NG2 glia may not only express Neurog2 but activate a more complete neurogenic programme, a possibility that remains untested here.</p><p>Also, is the subcerebral projection neuron dependent on the starting cell population? Could other NG2 glia, not expressing <italic>Sox6</italic>, also be co-axed by the NVOF cocktail into subcerebral projection neurons? And if not, do they express other (Sox) transcription factors that render them more amenable to reprogramming into other cortical neuron subtypes? The authors state that SOX6-positive NG2 glia are a quiescent progenitor population. Given that NG2 glia is believed to undergo proliferation as a whole, are SOX6-positive NG2 glia an exception from this rule? Finally, the authors seem to imply that subcerebral projection neurons and SOX6-positive NG2 glia are lineage-related. However, direct evidence for this conjecture seems missing.</p></disp-quote><p>We appreciate the reviewer’s thoughtful and detailed review of this work. We especially appreciate the positive evaluation of the work and the highlighting of multiple strengths of our approach, including the role of Fezf2 in refining neuronal subtype identity and the use of modified RNA to enable transient expression of Neurog2.</p><p>We acknowledge the reviewer’s comment that single-cell transcriptomic analysis would indeed provide a more granular view of likely heterogeneity. This current study focuses on investigating the feasibility of directed differentiation of corticospinal-like neurons from endogenous progenitors. Future work employing single-cell sequencing could indeed help delineate the heterogeneity of neurons generated by directed differentiation, and potentially contribute toward identification of potential molecular roadblocks in different subsets.</p><p>Regarding the suggestion that SOX6-deficient NG2+ progenitors might activate a broader neurogenic program, we agree that this is an intriguing possibility. We are currently conducting indepth investigation of the loss of SOX6 function in NG2+ progenitors, and we aim to submit this quite distinct work for separate publication.</p><p>The reviewer raises an important point about whether SOX6+/NG2+ progenitors and subcerebral projection neurons are indeed normally lineage-related. In the current work, we utilized postnatal cortical SOX6+/NG2+ progenitors that are thought to be largely derived from EMX1+ and GSH2+ ventricular zone neural progenitors. Our unpublished data from the separate study noted above indicate that SOX6 is expressed by both these lineages <italic>in vivo</italic>. Since subcerebral projection neurons are derived from EMX1+ ventricular zone progenitors (SOX6-expressing), at least some of the SOX6+/NG2+ progenitors are expected to share a lineage relationship with subcerebral projection neurons. While our data strongly suggest such a link, we agree that direct lineagetracing could be pursued in future work.</p><p>Finally, we agree with the reviewer’s suggestion that <italic>in vivo</italic> transplantation to assess the identity and connectivity of neurons generated by directed differentiation would be very interesting, and is a natural next phase of this work. We aim to pursue such work in future investigations.</p><p>We again thank the reviewer for their insightful comments.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The most important clarification for me concerns the initial description of the progenitors. I think there is a mistake with the transgenic line NG2. The dsRed mouse used in Figure 1 C is not described until later in the results describing Figure 2. This was confusing. Moreover, perhaps this is a reason why I get confused and do not understand how the authors conclude that SOX6+ cells are a subset of NG2positive cells. Panel C shows the opposite. Please correct the description and show the quantification of data in panel 1C.</p></disp-quote><p>We thank the reviewer for their thoughtful review and for highlighting this important point. We appreciate the reviewer pointing out the benefit of further clarity regarding the NG2.DsRed transgenic mouse description in Figure 1C. We have revised the text to clarify the use of the transgenic line and ensure that the DsRed mouse is properly introduced. Additionally, we have further clarified the description explaining the basis for concluding that SOX6+ cells are a subset of NG2+ cells and further integrate this conclusion with the data presented.</p><p>During cell sorting from the cortices of NG2.DsRed mice, we observe two distinct populations of NG2-DsRed+ cells based on fluorescence intensity in FACS: NG2-DsRed “bright” and NG2-DsRed “dim” populations. The NG2-DsRed “dim” population consists of a heterogenous mix of NESTIN+ progenitors, GFAP+ astrocytes/progenitors, a subset of NG2+ cells, and other unidentified cells. In contrast, the DsRed “bright” population includes a broader group of progenitors that also give rise to oligodendrocytes (please see Zhu, Bergles, and Nishiyama 2008), along with pericytes.</p><p>Previous studies have shown that, while dorsal/pallial VZ progenitors express SOX6 during embryonic development, SOX6 expression becomes restricted to interneurons postnatally (these do not express NG2 proteoglycan; Azim et al., 2009) and to the broader group of NG2+ progenitors that also give rise to oligodendrocytes. The ICC image in Fig. 1C shows bright NG2+ cells in the cortex, many of which express SOX6. Thus, we conclude that SOX6+ cells constitute a subset of NG2-DsRed+ cells.</p><disp-quote content-type="editor-comment"><p>In a similar line, the work is beautiful, but the manuscript can gain a lot from shortening and some more editing. for example:</p><p>(1) In the abstract, the word inappropriate should be removed. It seems to me that is an unnecessary subjective qualification - it is hardly possible that in biology we found repression of something inappropriate.</p></disp-quote><p>We have removed the word “inappropriate”.</p><disp-quote content-type="editor-comment"><p>(2) FACS-purify these genetically accessible....establish a pure culture. Genetically accessible is nice, and I understand that it conveys that they can be traced in the mouse, but everything is genetically accessible with the right tool, and perhaps it is more informative to explain which gene or report is used for the isolation. These cells are not accessible in humans. Also, I consider it best to remove pure- the culture is pure (purified by FACS) cells.</p></disp-quote><p>We have revised the text to specify the gene/reporter used for isolation instead of using &quot;genetically accessible&quot;, and we removed &quot;pure&quot;, since FACS purification is already explicitly mentioned.</p><disp-quote content-type="editor-comment"><p>(3) In the initial paragraph in the results: &quot;They are exposed to the same morphogen gradients throughout embryonic development, and thus, compared to distant cell types, have similar epigenomic and transcription landscapes.&quot; This is proven in the cited publication, but the way is stated here seems a bit of an unnecessary overstatement. The hypothesis stated after this paragraph is as good as it is with or without this argument.</p></disp-quote><p>We have revised the text and simplified the statement. We agree that the hypothesis remains clear and well-supported without this emphasis.</p><disp-quote content-type="editor-comment"><p>(4) In the result sections, &quot;two distinct populations of DsREd-positive cells were identified based on fluorescence intensity&quot;- I know it is correct, but when reading the percentages, I was confused because those percentages divided the population into three fractions. What the authors do not explain is that they discard the intermediate-expressing population.</p></disp-quote><p>We appreciate the reviewer highlighting this inadvertent point of confusion. We erred by discussing only the two populations of central interest to us (DsRed-bright and DsRed-dim), and did not explicitly mention the DsRed-negative population. We have now clarified the text to include all three cell populations and their percentages of the total cells in all three populations (in the original manuscript and still now, ~75-78% were DsRed-negative). We have also further clarified that only DsRed-Bright cells (identified as progenitors) were used for all subsequent experiments.</p><disp-quote content-type="editor-comment"><p>These examples illustrate the type of editing that would be appreciated but which is entirely up to the authors.</p></disp-quote><p>We thank the reviewer for their thoughtful suggestions toward improving clarity and precision. We have incorporated these recommendations, along with suggestions from the other two reviewers, in the revised paper.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(1) The authors start their results section by showing <italic>in situ</italic> Hybridization for Ngn2 in control and Sox6KO mice. These control sections do not look convincing, as there is not even some signal in the adult VZSVZ region and virtually no background. Please show sections where some positive signal can also be detected in the control sections.</p></disp-quote><p>We agree with the reviewer that making direct comparisons in ISH experiments is an important point. In our ISH experiments, to ensure consistency and appropriate comparisons, we process WT and KO sections together and stop the signal development simultaneously. We could have extended the development time to enhance WT signal to a detectable level, but that would have led to excessive background and over-saturated signal in the KO sections.</p><p>To address the reviewer’s point, we have added a new supplementary figure with an additional pair of WT and KO sections, along with reference data from the Allen Brain Atlas. The WT section shows faint Neurog2 expression in the dentate gyrus region of the hippocampus, while the KO section confirms very substantial upregulation of Neurog2 in the absence of SOX6 function. These additional data enhance the clarity and depth of our results.</p><p>Please see the following link for the Allen Brain Atlas ISH data demonstrating that Neurog2 expression in the postnatal (P4) SVZ/SGZ is inherently low. (<ext-link ext-link-type="uri" xlink:href="https://developingmouse.brainmap.org/experiment/show/100093831">https://developingmouse.brainmap.org/experiment/show/100093831</ext-link>).</p><disp-quote content-type="editor-comment"><p>(2) As a hallmark of projection neurons is where they send their axons, it would be important to include a biological assay for this. Of course, <italic>in vivo</italic> experiments would be great, but if this is not possible, the authors could co-culture sections from the late embryonic cortex, striatum, and spinal cord to see if the reprogrammed neurons preferentially extend their axons towards one of these targets (as normally developing neurons would, see e.g. Bolz et al., 1990).</p></disp-quote><p>We agree with the reviewer’s suggestion that a very interesting future stage of this work would be to investigate the projection neuron identity including connectivity <italic>in vivo</italic>. We aim to pursue follow-up studies to investigate <italic>in vivo</italic> integration and connectivity of such neurons generated by directed differentiation from endogenous SOX6+/NG2+ cortical progenitors. As the reviewer insightfully suggests, co-culturing different brain regions with these neurons could offer an alternative strategy to partially assess potential preferential connectivity into cultured spinal cord vs. alternate tissue. This area of investigation is of substantial interest to our lab, and we aim to pursue it in the coming years– it is a very large undertaking by either approach.</p><disp-quote content-type="editor-comment"><p>(3) However, if the loss of <italic>Sox6</italic> is sufficient for Ngn2 to be upregulated, why did the authors not pursue this approach in their reprogramming experiments? Are these endogenous levels sufficient for reprogramming? Please add some OPC cultures from WT and KO mice to explore their conversion to neurons and possibly combine them with Olig2VP16 and Fezf2.</p></disp-quote><p>We thank the reviewer for this insightful comment and for raising this broader area of inquiry regarding whether SOX6 might be down-regulated to enhance induction of neurogenesis. We are writing a separate manuscript regarding function of SOX6 in these progenitors during normal or molecularly manipulated development. We investigate function of SOX6 using both whole body null mice and a series of conditional null mice. We aim to post that work as a preprint and submit it for review and publication in the coming months. Beyond that work, the potential strategy of downregulating SOX6 function while simultaneously upregulating other molecular controls to refine directed neuronal differentiation is also of substantial interest to us, and we aim to pursue this in follow-up work. Though these are both interesting questions/topics, we respectfully submit that these broad areas of parallel, complex, and future investigation would substantially expand the scope of work in this paper, so we aim to address them in separate studies.</p><disp-quote content-type="editor-comment"><p>(4) Please indicate independent biological replicates as individual data points in all histograms, i.e. also in Figure 2K, Figure 4I, S2H.</p></disp-quote><p>We have updated the figure legends indicating the biological replicates, and explained the broad media optimization that was used successfully in all further experiments.</p><disp-quote content-type="editor-comment"><p>(5) GFP labelling in Figures S2K-N is not convincing - too high background. Please optimize.</p></disp-quote><p>We have redesigned this figure and now present it as a new supplementary figure, with GFP pseudocolored in gray and enlarged subpanels for improved visualization of cell morphology.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>This is an extremely well-written manuscript with very exciting implications. Obviously, not all can be tested here. Some of the suggestions are relatively easy and may be worth testing right away, others may require more extensive study in the future. In my view, completing some of the points below could make this paper a landmark study.</p><p>I start with the key questions:</p><p>(1) Do grafted NVOF cells give rise to subcerebral projection neurons <italic>in vivo</italic>?</p></disp-quote><p>We agree with the reviewer’s suggestion that a very interesting future stage of this work would be to investigate the projection neuron identity including connectivity <italic>in vivo</italic>. As noted above in response to Reviewer 2, we aim to pursue follow-up studies to investigate <italic>in vivo</italic> integration and connectivity of such neurons generated by directed differentiation from endogenous SOX6+/NG2+ cortical progenitors. This question is of substantial interest to us, and we aim to pursue it in the coming years– as the reviewer notes, this is a very large undertaking, and beyond the scope of this paper.</p><disp-quote content-type="editor-comment"><p>(2) What is the fate of the <italic>Sox6</italic> deficient NG2 glia that express Neurog2? One could isolate these cells and subject them to scRNA sequencing to see how far neurogenesis proceeds without addition of exogenous factors.</p></disp-quote><p>We thank the reviewer for this insightful question. As noted in our response to Reviewer 2, we are writing a separate manuscript regarding function of SOX6 in these progenitors during normal or molecularly manipulated development. We investigate function of SOX6 using both whole body null mice and a series of conditional null mice. We aim to post that work as a preprint and submit it for review and publication in the coming months, likely in early summer. We respectfully submit that this broad area of parallel, complex investigation would substantially expand the scope of work in this paper and make this paper too complex and multi-directional, so we aim to publish them as separate papers for the benefit of clarity for readers.</p><disp-quote content-type="editor-comment"><p>(3) Obviously, what happens to Sox6-deficient (or non-deficient cells) when forced to express NVOF? In this context, it might be fair to cite Felske et al (PLoS Biol, 2023) who report Neurog2 and Fezf2-induced reprogramming in the postnatal brain. In their model, these authors did not distinguish between converted astrocytes and NG2 glia. Thus, some of the reprogrammed cells may comprise the SOX6positive cells described here.</p></disp-quote><p>We thank the reviewer for highlighting for us that we inadvertently omitted referencing the important paper by Felske et al., 2023. We have now included this citation.</p><p>We thank the reviewer for raising this broader area of inquiry regarding whether SOX6 might be down-regulated to enhance induction of neurogenesis. Beyond the work noted above regarding function of SOX6 in these progenitors during normal or molecularly manipulated development, the potential strategy of downregulating SOX6 function while simultaneously upregulating other molecular controls to refine directed neuronal differentiation is of substantial interest to us, and we aim to pursue this in follow-up work. We again respectfully submit that this area of complex, future investigation should be addressed in future studies.</p><disp-quote content-type="editor-comment"><p>Very interesting unaddressed questions include:</p><p>(1) Are Sox6+ NG glia of dorsal origin? This is implied but not shown. One could use Emx1Cre lines to assess this. Are Sox6+ glia and subcerebral projection neurons clonally related? This may be more challenging. In this context, it might be again fair to refer to Herrero-Navarro et al (Science Advances 2021) who show that glia lineage related to nearby neurons gives rise to induced neurons with regional specificity.</p></disp-quote><p>The reviewer raises an important question regarding the competence of SOX6+/NG2+ progenitors from distinct origins to generate corticospinal-like neurons by directed differentiation. In ongoing unpublished work, we have identified SOX6 expression by NG2+ progenitors of the three lineages derived from ventricular zone progenitors that express either Emx1, Gsh2, or Nkx2.1 transcription factors. The EMX1+ lineage-derived SOX6+/NG2+ progenitors are directly lineage related to cortical projection neurons. As the reviewer suggests, future experiments could explore potential differences in competence between these three populations.</p><p>We again thank the reviewer for highlighting for us that we also inadvertently omitted referencing the exciting study by Herrero-Navarro that addresses the question of regional heterogeneity within astrocytes and the differential reprogramming potential related to their origins. We have now cited this paper in the manuscript.</p><disp-quote content-type="editor-comment"><p>(2) Do other NG2 glia not give rise to subcerebral projection neurons when challenged with NVOF? Thus, how important is <italic>Sox6</italic> expression really?</p></disp-quote><p>The question of the specific competence of dorsal/cortical SOX6+/NG2+ progenitors to differentiate into corticospinal-like neurons, and the strategy of downregulating SOX6 function while simultaneously upregulating other molecular controls to direct neuronal differentiation, are both of great interest to us. In pilot experiments, we observed reduced competence of ventrallyderived SOX6+/NG2+ progenitors to generate similar neurons. We plan to pursue the SOX6 manipulation in follow up work.</p><disp-quote content-type="editor-comment"><p>(3) Do Sox6+ NG2 glia proliferate like other NG2 glia and thereby represent a replenishable pool of progenitors?</p></disp-quote><p>Yes; as noted in the text shortly after Figure 1, and as presented in Figure S3l-L, these progenitors proliferate robustly in response to the mitogens PDGF-A and FGF2.</p><disp-quote content-type="editor-comment"><p>(4) How heterogenous are the NVOF-induced neurons? The bulk highlights the overall specificity, but does not tell whether all cells make it equally well.</p></disp-quote><p>We agree with the reviewer that this is an interesting question. ICC analysis (Fig. 4G-4H) presents the variation in the levels of a few functionally important proteins in the population of NVOFinduced neurons. This could be due to any or all of at least three potential possibilities: (1) potential diversity in the population of purified SOX6+/NG2+ progenitors; (2) technical variability in the amount of NVOF plasmid delivered to individual progenitors during transfection; and/or (3) natural stochastic TF-level variations generating closely-related neuron types, that also occurs during normal development. Future experiments could explore these questions.</p></body></sub-article></article>